PSI Director calls for stronger pandemic intelligence after UK Covid-19 Inquiry Module 2 report published www.psi.ox.ac.uk/news-and-opinion/psi-director-calls-for-…
Peter Horby
Sir Peter William Horby is a British physician, epidemiologist, Moh Family Foundation Professor of Emerging Infections and Global Health, and Director of the Pandemic Sciences Institute at the University of Oxford. He is the founder, and former director of the Oxford University Clinical Research Unit in Hanoi, Vietnam which was founded in 2006. In 2014, Horby established the Epidemic Research Group Oxford (ERGO). ERGO incorporates a number of international projects such as the European Commission funded PREPARE, the African coaLition for Epidemic Research, Response and Training (ALERRT), and the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC). Since 2016, Horby has been chair and executive director of ISARIC. More on Wikipedia
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Want to make a meaningful impact in global health security?
DPhil (PhD) in infection prevention control and biocontainment measures for high consequence infectious diseases. www.ndm.ox.ac.uk/study/dphil-themes?project=developing-an…
⏰ Application deadline: 10th October, 5pm UK time. Jan 2026 start! -
Peter Horby @peterhorby.bsky.social reposted
MORU
@MORUBKK
Simple new method that measures viral clearance means promising antibody treatments for #covid & flu can be quickly assessed for effectiveness, say researchers in @TheLancet, & save time, money, lives in next pandemic
www.tropmed.ac/news/simple-new-method-that-measures-viral…
Full paper: www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Peter Horby @peterhorby.bsky.social reposted
London School of Hygiene & Tropical Medicine
@LSHTM
World’s first rigorous clinical trial of treatments for bubonic #plague:
UK & #madagascar researchers find treatment at home with oral antibiotics highly effective & safe low-cost alternative to injections
👉www.lshtm.ac.uk/newsevents/news/2025/cost-effective-treat… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic to see this published - first ever trial of treatment for bubonic plague
Huge thanks to the wonderful team in Madagascar #institutpasteur and our funders #fcdo #wellcome
An important but incredibly challenging study - everyone deserves to benefit from science.
NEJM
@NEJM
Data on treatments for bubonic plague are limited. In this open-label, randomized, controlled trial in Madagascar, ciprofloxacin monotherapy was noninferior to a standard aminoglycoside–ciprofloxacin regimen. Full IMASOY trial results and Research Summary: www.nejm.org/doi/full/10.1056/NEJMoa2413772
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic morning discussing pandemic prevention, One Health and system-wide approaches. Now debating the Pandemic Agreement and what it means in practice. www.linkedin.com/posts/pandemic-sciences-institute_pandem…
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
In a collaborative new study, researchers at @PSIOxford have partnered with global colleagues to discover how #ai could accelerate infectious disease research and help to prepare the world for the next pandemic 🔬🦠🤖
Find out more 👉 www.ndm.ox.ac.uk/news/advances-in-ai-can-help-prepare-the… -
Peter Horby @peterhorby.bsky.social reposted
remap-cap
@remap_cap
REMAP-CAP's @DerdeLennie adds her voice to a beautiful celebration of #internationaldayofwomenandgirlsinscience 👇
-
Peter Horby @peterhorby.bsky.social reposted
ALERRT
@ALERRT_Global
New publication in The Lancet: Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu. A prospective observational cohort study at Kamituga General Hospital.
www.sciencedirect.com/science/article/pii/S01406736250004… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
There seem to be THREE simultaneous filovirus outbreaks - Marburg in Tanzania, Ebola in DRC (most likely culprit Zaire Ebolavirus) and Sudan Ebolavirus in Uganda.
We need adequately funded public health and research and development programmes and support.
Ministry of Health- Uganda
@MinofHealthUG
Permanent Secretary, Dr. @DianaAtwine addresses the media this afternoon.
“An outbreak of Sudan Ebola Virus Disease has been confirmed in Kampala, Uganda following confirmation from 3 National Reference Laboratories.” -
Peter Horby @peterhorby.bsky.social
@PeterHorby
🔥 RECOVERY sotrovimab result now available.
Despite widespread vaccination and natural immunity, sotrovimab reduced mortality in COVID-19 inpatients with high levels of SARS-CoV-2 antigen.
www.medrxiv.org/content/10.1101/2025.01.24.25321081v1
Peter Horby @peterhorby.bsky.social
@PeterHorby
Although sotrovimab likely to have no useful activity against current SARS-CoV-2 variants, these data, along with the RECOVERY casirivimab-imdevimab
result, show that mAbs which effectively neutralise can benefit some hospitalised patients. -
Peter Horby @peterhorby.bsky.social reposted
WHO African Region
@WHOAFRO
As #tanzania responds to the confirmed outbreak of #marburg virus disease, @WHO is working closely with the national health authorities to reinforce control measures to halt the outbreak as soon as possible and protect the health of the population.
www.afro.who.int/countries/united-republic-of-tanzania/ne… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Marburg raises its head again: so soon after Rwanda outbreak. There are no approved treatments or vaccines for Marburg - from each outbreak we need to incrementally gather the data we need for effective control and treatment.
World Health Organization (WHO)
@WHO
WHO informed its Member States and International Health Regulation State Parties of an outbreak of suspected Marburg Virus Disease in the Kagera region of #tanzania
So far, we are aware of 9 suspected cases incl. 8 deaths across 2 districts.
WHO risk assessment of this suspected outbreak:
National level: High
Regional level: High
Global level: Low
More www.who.int/emergencies/disease-outbreak-news/item/2025-D… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Controversial COVID study that promoted unproven treatment retracted after four-year saga www.nature.com/articles/d41586-024-04014-9
Ironic that the co-authors complain they were “victims of cyber-harassment” - they should try being on the receiving end of HCQ believers, including Raoult himself. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
An extraordinarily strong lesson on the importance of good science, critical thinking, and being truly objective.
The damage done to trust and to patients by the hydroxycholoroquine debacle should never be repeated.
Would love to know the reasons for retraction.
Martin Landray
@MartinLandray
Extraordinary: Raoult’s damaging paper on hydroxychloroquine for COVID-19 finally retracted.
So grateful to all the people who helped with the RECOVERY trial, allowing us to debunk the myth of hydroxychloroquine for severe COVID-19
www.science.org/content/article/infamous-paper-popularize… -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
Extraordinary: Raoult’s damaging paper on hydroxychloroquine for COVID-19 finally retracted.
So grateful to all the people who helped with the RECOVERY trial, allowing us to debunk the myth of hydroxychloroquine for severe COVID-19
www.science.org/content/article/infamous-paper-popularize… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Md Zakiul Hassan recognised as 2024 ISID Emerging Leader www.ndm.ox.ac.uk/news/md-zakiul-hassan-recognised-as-2024…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Influenza going up in the UK. For those involved in the RECOVERY trial of influenza treatments - please try to enrol patients. If this season is short and sharp, we will have a limited time window for recruitment.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Lancet Infectious Diseases commissioned a series of papers to mark 10 years from the Ebola west Africa outbreak.
2 links below for free access, active until Feb 01, 2025.
Ebola disease: bridging scientific discoveries and clinical application: authors.elsevier.com/c/1kFtS_XVyhTsaX
Peter Horby @peterhorby.bsky.social
@PeterHorby
Embedding treatment in stronger care systems
authors.elsevier.com/c/1kFtR5E-UogXrk -
Peter Horby @peterhorby.bsky.social
@PeterHorby
"A new requirement" that further raises the onerrous burdens of applying for research funding and, ironically, likely increasing the inequality in who is funded to do research (will further concentrate funding in well resourced entities).
National Institute for Health and Care Research
@NIHRresearch
Today we've launched a new requirement that all applicants must demonstrate how their research will address existing inequalities in health and social care as a condition of funding. Applicants will now be required to show how inclusion is being built into all stages of the research lifecycle. www.nihr.ac.uk/news/inclusion-now-key-condition-nihr-funding
-
Peter Horby @peterhorby.bsky.social reposted
Jakub Hantabal
@JakubHantabal
Today I had the pleasure of presenting my DPhil project on host-pathogen interactions of henipaviruses at the @PSIOxford Nipah Virus Research Day.
Thanks to everyone at @Carroll_Lab_Ox and all of our collaborators for their support!
#nipah #immunology #henipavirus -
Peter Horby @peterhorby.bsky.social reposted
Eleonora Svanberg
@EleonoraSberg
I'm a PhD student at @UniofOxford and I think I'm living in a fairytale :-)
Foxes playing around in the snow at Magdalen College this morning — absolutely magical! -
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
To develop a shared knowledge of #emergingviruses in biodiverse regions, @PSIOxford and @UMS_EcoCampus 🇲🇾 have signed a Memorandum of Understanding to foster impactful research and deliver benefits to global #publichealth. 🌏🔬
Find out more 👉 www.ndm.ox.ac.uk/news/partnership-with-universiti-malaysi… -
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Researchers at @PSIOxford traced the impact of the #covid19 pandemic on global movement and the evolution of seasonal #flu. Their findings are helping to deepen the understanding of distributional patterns of #respiratoryviruses.🌏🦠
Find out more 👉 www.ndm.ox.ac.uk/news/research-traces-impact-of-covid-19-… -
Peter Horby @peterhorby.bsky.social reposted
Tedros Adhanom Ghebreyesus
@DrTedros
Encouraging news from #rwanda: world's first clinical trial for #marburg virus disease treatment started today, as a result of @WHO’s partnership with @RwandaHealth.
World Health Organization (WHO)
@WHO
NEWS:
#rwanda today started the world's first clinical trial for Marburg virus disease treatments, in partnership with WHO.
The trial involves testing the safety and efficacy of Remdesivir—a drug against viruses already used to treat COVID-19, and MBP091—a special antibody designed to fight Marburg virus.
This trial is the result of two years’ work by nearly 200 researchers, developers, ministry of health officials and partners globally and from 17 African countries at risk of outbreaks of filoviruses such as Ebola and Marburg. -
Peter Horby @peterhorby.bsky.social reposted
WHO African Region
@WHOAFRO
In a historic step in medical research, Rwanda today started the world's first clinical trial for Marburg virus disease treatment in partnership with @WHO.
The trial involves testing the safety & efficacy of Remdesivir, a drug against viruses already used to treat COVID-19, & MBP091, a special antibody designed to fight Marburg virus.
The trial is the result of two years’ work by nearly 200 researchers, developers, ministry of health officials & partners globally & from 17 African countries at risk of outbreaks of filoviruses such as Ebola and Marburg. -
Peter Horby @peterhorby.bsky.social reposted
The Global Preparedness Monitoring Board
@TheGPMB
H5N1, Mpox & Marburg remind us that our world is at risk for pandemics and that we are unprepared.
@TheGPMB’s latest report highlights 15 key risk drivers that leaders must work together to address so we are all ready for the next pandemic. www.gpmb.org/reports/report-2024 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
H5N1, MPox, Marburg…..the pandemic was not an aberration, it is the world we live in. We need to deal with the world as it is, to create the world as we wish it to be.
-
Peter Horby @peterhorby.bsky.social reposted
Ministry of Health | Rwanda
@RwandaHealth
Amakuru mashya | Update
Virusi ya Marburg - 04.10.2024 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Rwanda suffering from its first outbreak of Marburg virus disease - a virus related to Ebola.
Great to see the strong public health response and clear communications from @RwandaHealth
There are potential vaccines and treatments for Marburg but they have not yet been tested.
Ministry of Health | Rwanda
@RwandaHealth
People can continue with their daily activities - there is no ban on any activity as part of the Marburg prevention measures. People should not panic as we have identified all the hotspots of the disease and are taking appropriate action.
#presseronmarburg -
Peter Horby @peterhorby.bsky.social reposted
Long Covid UK
@long_covid
🚨@covidinquiryuk
⚠️CONTENT WARNING⚠️
Very emotional & graphic description of ICUs from Prof. Kevin Fong (Former National Clinical Adviser in Emergency Preparedness Resilience & Response):
“The scale of death was truly truly astounding”
#covidisnotover
#longcovid -
Peter Horby @peterhorby.bsky.social reposted
James Hay
@jameshay218
It was great to have @adamjkucharski visiting @PSIOxford over the past few days. Brilliant seminar on how we can learn more about pandemics as they unfold using incidental data from NPIs. More seminars to come!
Pandemic Sciences Institute
@PSIOxford
Data generated from the implementation of control measures during COVID-19 is filling epidemiology knowledge gaps & preparing us for future outbreaks.
Thanks to @adamjkucharski from @LSHTM_CEPR for opening our new PSI seminar series yesterday.
More ⬇️
www.psi.ox.ac.uk/news-and-opinion/psi-seminar-series-laun… -
Peter Horby @peterhorby.bsky.social reposted
World Health Organization (WHO)
@WHO
For the first time, WHO offers recommendations for national health authorities, regulators, and funders to improve clinical trials.
The guidance addresses issues like poor trial design, lack of diversity and inclusion of at-risk populations, infrastructure gaps, and inefficiencies that delay progress.
www.who.int/news/item/25-09-2024-new-global-guidance-puts… -
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
Virology—The next fifty years www.cell.com/cell/fulltext/S0092-8674(24)00785-2
-
Peter Horby @peterhorby.bsky.social reposted
Nick Mark MD
@nickmmark
ICU doc here. The most life-saving treatment developed for COVID is Dexamethasone.
Dexamethasone is generic, cheap, widely available. Dexamethasone costs less than a dollar per day and saved millions of lives. It also completely destroys your argument.
Robert F. Kennedy Jr
@RobertKennedyJr
The main problem with hydroxychloroquine was that it is a generic drug with little profit potential. When pharma companies commandeer our health agencies, they quash inexpensive therapies and mandate profitable ones.
Brownstone Institute
@brownstoneinst
Following Trump’s proposal, HCQ came under an unwarranted full-scale attack from federal officials, the press, “fact-checkers,” and university professors.
~David Gortler
Trump’s 63 Million Doses of Hydroxychloroquine Could Have Been Great for America
brownstone.org/articles/trumps-63-million-doses-of-hydrox… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Thanks Adam, I will try bluesky
Adam Kucharski
@adamjkucharski
Many of the epi/public health people I follow on here (and you might as well) are now much more active on 🟦sky – in case you're wondering where the party might be going...
-
Peter Horby @peterhorby.bsky.social reposted
Dr. Nahid Bhadelia
@BhadeliaMD
This book was a behemoth for the editors I am sure- and years in the making. But I’m so honored to part of the critical effort on “Principles and Practice of Emergency Research Response” with some incredible thinkers & doers in our field including Dr Fauci, @DrTedros, @doctorsoumya, Dr Collins and so many others I respect. And some I’ve had the great fortune to work with over the years.
link.springer.com/book/10.1007/978-3-031-48408-7?page=1 -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
For 10+ years, ISARIC & @WHO have been developing case report forms (CRFs) for infectious disease outbreaks.
In @MDPIOpenAccess, our researchers analyse how a data-driven approach to designing CRFs can lead to a more informed public health response ⬇️
doi.org/10.3390/epidemiologia5030039 -
Peter Horby @peterhorby.bsky.social reposted
Moritz Kraemer
@MOUGK
Excited to announce this partnership between @fiocruz, Pontifical Catholic University of Rio de Janeiro, global.health and @ISARIC1 on the secure and distributed analysis of clinical outbreak data isaric.org/towards-rapid-and-secure-sharing-of-epidemiolo…
More soon! -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Global scientific collaboration is vital in preparing for pandemic threats 🌍
77 people from low & middle-income countries shared their expertise at #pandemicsciences24 thanks to generous bursary support from @TheFluLab, @gatesfoundation, @CEPIvaccines, @lifearc1 & @moderna_tx. -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Apply for this PSI-based role before 8 August 👇
ISARIC
@ISARIC1
CLOSING SOON: We are #hiring a Clinical Project Administrator to support the development of ISARIC's research agenda. The position is based in Oxford, UK.
*Apply by 8 August*
Learn more ➡️ my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa… -
Peter Horby @peterhorby.bsky.social reposted
Moritz Kraemer
@MOUGK
Perspective on the "Impacts of climate change-related human migration on infectious diseases"
Now out in @NatureClimate
rdcu.be/dPqbu -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Join this @CEPIvaccines livestream with experts including PSI's Professor Dame Sarah Gilbert:
🕞 29 July, 15:45 BRT (19:45 BST)
📺 Livestream link: us06web.zoom.us/j/83718148480
CEPI
@CEPIvaccines
Could #h5n1 develop into a fast-spreading human outbreak? Is the world ready to respond?
Listen to experts @RickABright, Dame Sarah Gilbert, Dr Nicole Lurie & more next week at #gpps2024 to hear how we can prepare for an equitable 100-day response to a bird flu pandemic. -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
📢 In an outbreak, every day counts. @CEPIvaccines and ISARIC have announced a collaboration to help accelerate global response to infectious disease outbreaks and reduce the threat of epidemics and #pandemics.
Read more ⬇️
isaric.org/from-silo-to-synergy-working-together-to-accel… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Earlier this month, the International Pandemic Sciences Conference 2024 brought together 700+ delegates from 60+ countries to further global collaboration in pandemic sciences.
Watch our full conference highlights 👇
youtu.be/tKIx9GHR9fs
#pandemicsciences24This media couldn't be displayed. See it on the original post. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
What is the best way to stop a pandemic? open.substack.com/pub/kucharski/p/what-is-the-best-way-to…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
That’s because the response to Covid is I. module 2, not module 1.
Freddie Sayers
@freddiesayers
I've just read the first formal report of the UK's Covid enquiry by Baroness Hallett. While she is meticulously careful to avoid arriving at any conclusions on important questions (eg were lockdowns worth it?) she has included a few sentences that leap out from the page: 🧵
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Is Britain ready for the next pandemic?
The score sheet is sobering.
www.telegraph.co.uk/global-health/science-and-disease/is-… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Ivory Coast becomes first country to launch new malaria vaccine www.cidrap.umn.edu/malaria/ivory-coast-becomes-first-coun…
-
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
Crucial thread below. Several countries now have digital tools at the heart of their pandemic strategies, if they didn’t already (spoiler: these are countries that did relatively well against COVID).
Meanwhile, many European countries seem to be taking a ‘play it by ear until the next pandemic arrives’ attitude to getting modern pandemic tools in place.
And we all know how that ended last time.
Christophe Fraser Group
@ChristoPhraser
New in @ScienceMagazine: app-based contact tracing for covid 🤒🤳📲 as well as reducing transmission, generated data for epidemic monitoring & analysis in real-time with unprecedented resolution. Example below: sharp spikes in transmission in England during last Euros, 2021 🇪🇺⚽
-
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
We have launched a stakeholder consultation to identify the most important clinical problems for epidemic-prone #infectiousdiseases. This will help guide some of our core research work.
Learn how to be a part of this consultation ⬇️ isaric.org/research/research-prioritisation/ -
Peter Horby @peterhorby.bsky.social reposted
Tropical Medicine Oxford
@TropMedOxford
In collaboration with @sophieyacoub @OUCRU_Programme, @ISARIC1 is lauching this survey for patients, carers and researchers affected by #dengue
Reply by 19 July
More at www.oucru.org/project/den-core/
ISARIC
@ISARIC1
📢 We have launched a Delphi survey to help improve treatment of hospitalised dengue patients 🔍
If you have had dengue, have looked after someone with dengue, or are involved with dengue research, share your experiences here by 19 July 🔽
qualtrics.kcl.ac.uk/jfe/form/SV_0wbsL3bURWpfVmm -
Peter Horby @peterhorby.bsky.social
@PeterHorby
New (animal) data on Cow-H5N1 virus.
1. Infection by oral or resp route leads to systemic spread
2. Transmits inefficiently by respiratory route in ferrets
3. May have ability to infect cells of upper respiratory tract of humans
Overall, increased concern
rdcu.be/dM9Gs -
Peter Horby @peterhorby.bsky.social reposted
World Health Organization (WHO)
@WHO
Watch Prime Minister of Barbados @miaamormottley talk about the critical need for funding global public goods and ensuring health equity.
#investinwho #healthforall -
Peter Horby @peterhorby.bsky.social
@PeterHorby
So true Adam - WHAT'S THE PLAN? We know the last pandemic plans were not fit for purpose, and I have not seen plans for control of intermediate / transitional outbreak scenarios.
Adam Kucharski
@adamjkucharski
Suppose more human H5N1 cases crop up (alongside the many that are probably being undetected currently).
What’s the plan?
Suppose household transmission clusters start appearing, or cases that haven’t had any animal contact.
What’s the plan?
Suppose we start seeing human cases exported to other countries, and evidence of high severity in certain age groups, alongside growing evidence of human-to-human transmission.
What’s the plan?
Not ‘what’s a retweetable sound bite that wouldn’t get the reproduction number below 1’.
Not ‘what’s a snippet of a pre-2020 pandemic flu plan that assumes vast numbers of deaths and doesn’t account for subsequent innovations in use of rapid tests, digital contact tracing etc’
What, here in 2024, is the plan for dealing with an outbreak of a potentially pandemic pathogen like H5N1?
Helen Branswell 🇨🇦
@HelenBranswell
Colorado reports the 4th human infection with the #birdflu virus circulating in cows. Farmworker. Symptoms like cases 1 & 2 — conjunctivitis. At this point it's clearly an #h5 infection; @CDC will be testing to see if there is enough virus to confirm the N type. Not surprising.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
We welcomed >700 delegates from > 60 countries for two hugely exciting days of science, discussion and debate at the second International Pandemic Sciences Conference.
Save the date
30 June - 1 July 2025
International Pandemic Sciences Conference 2025
Pandemic Sciences Institute
@PSIOxford
As the #pandemicsciences24 conference draws to a close, thank you to our 700+ attendees from over 60 countries who have joined us over the last two days 👏
We hope to see you next year!
➡️ Save the date | International Pandemic Sciences Conference 2025: 30 June - 1 July -
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
Important point by @mlipsitch at #pandemicsciences24: the success of the 100 days mission for vaccine development during a pandemic depends on success of non-pharmaceutical interventions before vaccines become available.
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Day 2 of the International Pandemic Sciences Conference featured:
✅ A dedicated breakfast for those early in their career
✅ Interdisciplinary discussions on #nipah virus
✅ Poster and oral presentations.
Take a look back at our Day 2 highlights
⬇️
#pandemicsciences24 -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
As the #pandemicsciences24 conference draws to a close, thank you to our 700+ attendees from over 60 countries who have joined us over the last two days 👏
We hope to see you next year!
➡️ Save the date | International Pandemic Sciences Conference 2025: 30 June - 1 July -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Experts from research funding organisations discuss how to effectively work together to support global infectious disease research 🤝
Our lunchtime panel features @CEPIvaccines @MRCza @wellcometrust
@gatesfoundation and is chaired by @Alice_J_Norton.
#pandemicsciences24 -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
As we get ready to kick off Day 2 of #pandemicsciences24, watch yesterday’s highlights here 👇
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
The International Pandemic Sciences Conference 2024 starts today 🙌
Leading experts from academia, policy & industry are joining us for sessions on:
✅ vaccines
✅ therapeutics
✅ diagnostics
✅ policy
✅ epidemiology
✅ ethics
✅ pathogen biology
#pandemicsciences24 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
We have @CEPIvaccines, @FINDdx for diagnostics, a therapeutics consortium would complete the set. @UNITAID @PSIOxford
Unitaid
@UNITAID
The lack of funding for therapeutics, especially when compared to vaccines, has significantly hampered efforts to develop and ensure equitable access to COVID-19 treatments. It’s time to establish a #therapeuticscoalition to change this and prepare for future pandemics.
-
Peter Horby @peterhorby.bsky.social reposted
GloPID-R
@GloPID_R
📣 Out now in our newsletter!
@Alice_J_Norton highlights our vibrant scientific activity⬇️
✅ Pandemic PACT on Outbreaks
✅ Africa Hub + mpox mapping
✅ Data Sharing Roundtable series
✅ @UniofOxford Vice-Chancellor’s Awards finalists!
➡️www.glopid-r.org/newsletter/newsletter-25th-edition/ -
Peter Horby @peterhorby.bsky.social reposted
International Pandemic Preparedness Secretariat
@IPPSecretariat
Come & join IPPS @ #pandemicsciences24!
🕙1 July, 10:00-13:00- Shingai Machingaidze, STEG Co-Chair, speaks at the plenary "Before 100 days – Optimising early pandemic responses"
🕒1 July, 15:00-17:30- @HeulwenPhilpot, Head of Secretariat, speaks at the "Policy & politics" session
Pandemic Sciences Institute
@PSIOxford
It's not too late to join us online for #pandemicsciences24 on 1-2 July 🖥️
Our line-up features world-leading speakers & panellists – from scientists to industry experts & funders – sharing invaluable insights on pandemic preparedness.
Secure your spot 👇www.psi.ox.ac.uk/conference24 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Yet another burden to disincentivise research and research careers, and increase inequality (harder for lower resourced academics to comply).
Environmental sustainability policy
wellcome.org//grant-funding/guidance/environmental-sustai… -
Peter Horby @peterhorby.bsky.social reposted
Led By Donkeys
@ByDonkeys
RAF Squadron Leader Sidney McFarlane has a message to Sunak and Starmer. It’s Windrush Day tomorrow. The survivors deserve justice.
(Location: White Cliffs of Dover) -
Peter Horby @peterhorby.bsky.social reposted
Oxford Vaccine Group
@OxfordVacGroup
Could you help us to save lives with a vaccine against Marburg virus?💉🦇
📝 Study Details:
🔴 2 doses of vaccine given at Oxford Vaccine Group
🔴 Up to 13 study visits
🔴 Follow-up for 1 year after first vaccination
Find out more👇🏾 -
Peter Horby @peterhorby.bsky.social reposted
Oxford Vaccine Group
@OxfordVacGroup
We recently launched a study on a new vaccine for the Marburg virus, a deadly pathogen!
🦠 Learn more about the Marburg Virus Symptoms and the first identified outbreaks from our infographic!
📝 Study info: www.ovg.ox.ac.uk/studies
@UniofOxford | @OxPaediatrics |@PSIOxford -
Peter Horby @peterhorby.bsky.social reposted
Dr. Mirela G. Tulbure 🛰 🌎 + 🐍 + 🌊
@MirelaGTulbure
Do grant proposal texts matter for funding decisions? A field experiment
Spoiler alert...NO!
#grants #academia -
Peter Horby @peterhorby.bsky.social
@PeterHorby
H5N1: international failures and uncomfortable truths - The Lancet www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
We are #hiring a Communications Officer to support activities for an exciting new partnership, and work closely with our Head of Communications on PSI-wide initiatives.
Apply by 18 June 2024 👇
my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa… -
Peter Horby @peterhorby.bsky.social reposted
Chikwe Ihekweazu
@Chikwe_I
The #whopandemichub team visited @fiocruz_en including @cidacs_fiocruz with @minsaude, @pahowho Country Office & @PSIOxford to align on data-based & pathogen genomic surveillance activities for further collaboration with the aim to strengthen pandemic intelligence in the country
-
Peter Horby @peterhorby.bsky.social reposted
OUCRU
@OUCRU_Programme
📢 Last chance to apply for #modra! Don't miss out on this opportunity to join our transformative training programme.
📌 Apply by May 31st: forms.cloud.microsoft/pages/responsepage.aspx?id=SEdRItq7…
📌 modracademy.org -
Peter Horby @peterhorby.bsky.social reposted
Oxford Population Health (OxPop)
@Oxford_NDPH
🎥 #dyk that according to @WHO, on average #ebola will kill half of all people infected? Join us on Wednesday 12 June at @CurzonOxford for our screening of 'Survivors', a film showcasing the lives of three people in Sierra Leone during the devastating Ebola epidemic.😷🌍
The event is free and open to all. Food will be provided.
Register now 👉 www.ndph.ox.ac.uk/events/survivors
@PeterHorby @PSIOxford @OxfordMedSci @UniofOxford -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial www.medrxiv.org/content/10.1101/2024.05.23.24307731v1
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
⏰ Last chance to register
The International Pandemic Sciences Conference 2024 is taking place from 1-2 July in #oxford.
Register to attend in-person by 3 June to explore the latest advancements in pandemic sciences and network with experts 👇
web.cvent.com/event/2e7cb90c-63a3-4d13-8d0d-5235c08cc02a/… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
The COVID-19 pandemic reversed trends in mortality observed before the pandemic: global age-standardised all-cause mortality rates increased by 21·9% for males and 16·6% for female aged 15 years and older compared with 2019.
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
There are just 5⃣ days to go until our late-breaking abstract submission deadline.
Don't miss out on a chance to present new, timely & relevant research at #pandemicsciences24 on 1-2 July.
Submission deadline: 23:59 BST Mon 20 May
Submit now 👇
web.cvent.com/event/2e7cb90c-63a3-4d13-8d0d-5235c08cc02a/… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
"Bird flu strain found in US cows flown to UK lab for testing".
I assume it's the virus that has been flown, not US cows.
Clarity of expression please Grauniad!
P.S. Ian Brown is a real expert in animal influenza, worth paying heed to.
The Pirbright Institute
@Pirbright_Inst
“It shows us it can get into niches you wouldn’t expect”
Pirbright's Prof. Ian Brown comments on the unexpected occurrence of avian flu in dairy cows in the US.
Read the article in the @guardian ⬇️ www.theguardian.com/world/article/2024/may/11/bird-flu-st… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Really helpful @svscarpino @MOUGK
Is there a link to follow as timeline updates?
My understanding is that US is struggling with an integrated (one health) surveillance and control programme for this.
Sam Scarpino
@svscarpino
1/ Are you struggling to keep track of all the #h5n1 developments in the US?
Together w/ @jkbren & @MOUGK, we started an open-access timeline of key events related to the outbreak.
As you can see, the situation is rapidly progressing, so we will keep updating. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
"Subsidiarity, a structural principle of justice, suggests that decision-making authority primarily lies with the level of governance closest to the issue". Critically important given the mistrust hangover from the pandemic.
Tropical Medicine Oxford
@TropMedOxford
Research Highlight from Caesar Atuire @atuire @CGHRinfo
#decolonisingglobalhealth: why the new Pandemic Agreement should have included the principle of #subsidiarity
We need to empower local units to make decisions & address issues
www.ndm.ac/tropmed.res-hi
www.sciencedirect.com/science/article/pii/S2214109X24001864 -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 Call for abstracts on late-breaking research for #pandemicsciences24 on 1-2 July.
Abstracts can cover data & insights that are:
✅ new in the past 3 months
✅ highly relevant & timely
✅ not previously submitted.
📅 Deadline: 20 May
Submit now:
web.cvent.com/event/2e7cb90c-63a3-4d13-8d0d-5235c08cc02a/… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Congratulations to the research and policy team for reaching the finals of the Vice-Chancellor's Awards.
@PSIOxford @GloPID_R
Pandemic Sciences Institute
@PSIOxford
Congratulations to @GloPID_R's Research & Policy team who are finalists in the @UniofOxford Vice-Chancellor’s Awards 🎉
The team was nominated for outstanding research engagement on a roadmap for funders to improve clinical trial coordination.
More 👇
www.psi.ox.ac.uk/news-and-opinion/pandemic-policy-roadmap… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
MERS-CoV still around and still a threat. KSA has great experience of detecting and controlling health-care associated MERS transmission - other places are less aware and less prepared.
See: pubmed.ncbi.nlm.nih.gov/28153558/
Maria Van Kerkhove
@mvankerkhove
. @WHO Disease Outbreak News for Middle East respiratory syndrome coronavirus (#mers-CoV) in the Kingdom of Saudi Arabia 🇸🇦 www.who.int/emergencies/disease-outbreak-news/item/2024-D…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
COVID vaccine campaign saved $732 billion in averted infections, costs www.cidrap.umn.edu/covid-19/study-hhss-covid-vaccine-camp…
-
Peter Horby @peterhorby.bsky.social reposted
Moritz Kraemer
@MOUGK
Coming up tomorrow 7 May, I am hosting the distinguished speaker series @OxfordStats and delighted to have Prof. @suchard_group from UCLA speak on Pandemic Scale Phylogenetics.
Sign up here: www.stats.ox.ac.uk/events/distinguished-speaker-seminar-p…
Drinks reception following the talk. -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
PSI colleagues @PeterHorby, Moh Family Foundation Fellow @drzakiul & @AmandaRojek met Prof Abu Faisal Pervez in Bangladesh this week, to review progress on a promising #nipah virus study to improve patient care 🇧🇩
Study partners include @icddr_b and IEDCR & @CDCGlobal. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
1 in 5 US retail milk samples test positive for H5N1 avian flu fragments. This suggests extent of infection in dairy cows may be under estimated. ‘Fragments’ does not mean there is an infection risk but this needs confirmation by looking for viable virus. www.cidrap.umn.edu/avian-influenza-bird-flu/1-5-us-retail…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Sorry, I’m rubbish at this:
Here is part two.. geographic distribution, lots of urban cases (see Lagos).
Data are from NCDC.
Link to figures: try this
www.researchgate.net/profile/Friday-Ehiaghe/publication/3…
Peter Horby @peterhorby.bsky.social
@PeterHorby
I think probably predictable.
www.researchgate.net/profile/Francis-Igiebor?_tp=eyJjb250…
MPox cases Nigeria 2017-2022. Gender distribution: male>>female and …
Jake Dunning
@OutbreakJake
That said, a lot of mpox transmission in Africa is not sexual, and genital lesions can occur in generalised mpox that occurs following non-sexual transmission. Mpox finding a foothold in GBMSM sexual networks outside Africa in 2022 was unexpected and (reasonably?) not predicted.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
I think probably predictable.
www.researchgate.net/profile/Francis-Igiebor?_tp=eyJjb250…
MPox cases Nigeria 2017-2022. Gender distribution: male>>female and …
Jake Dunning
@OutbreakJake
That said, a lot of mpox transmission in Africa is not sexual, and genital lesions can occur in generalised mpox that occurs following non-sexual transmission. Mpox finding a foothold in GBMSM sexual networks outside Africa in 2022 was unexpected and (reasonably?) not predicted.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Thought provoking and wonderfully honest. Should we “surrender the heroic imagery of the intrepid shoe-leather epidemiologist.”? gh.bmj.com/content/9/4/e015692
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Genital MPox was first identified SEVEN years ago. In retrospect, there have been clear red flags for years. We need to pay much closer attention. We need annual expert assessment of major infectious disease risks and their mitigation. www.science.org/content/article/africa-intensifies-battle…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
New mpox clade 1 lineage identified in DR Congo outbreak. Why near simultaneous growth of clade 1(a) transmission and emergence of clade 2b and this new clade 1(b)? Can loss of population immunity from smallpox vaccination programme fully explain this? www.cidrap.umn.edu/mpox/new-mpox-clade-1-lineage-identifi…
-
Peter Horby @peterhorby.bsky.social reposted
OUCRU
@OUCRU_Programme
🔴 LIVE UPDATE: #recoverytrial has revolutionised the way we research #infectiousdiseases. We're excited to host the first #recoverymeeting2024 in Nepal to discuss its impact & future directions!
@NDMOxford @Oxford_NDPH @OUCRUID @PSIOxford @wellcometrust -
Peter Horby @peterhorby.bsky.social reposted
OUCRU
@OUCRU_Programme
📢 Now at #recoverymeeting2024
Discover the future of #recoverytrial explore #influenza, community-acquired #pneumonia & research opportunities beyond COVID-19 with Dr Leon Peto
@NDMOxford
@Oxford_NDPH
@OUCRUID
@PSIOxford -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Excited to start RECOVERY trial international collaborators’ meeting in Nepal @PSIOxford @Oxford_NDPH @OUCRU_Programme
@FCDOResearch -
Peter Horby @peterhorby.bsky.social reposted
Helen Branswell 🇨🇦
@HelenBranswell
The number of dairy cow herds where #h5n1 #birdflu infection has been detected has increased to 20, in 6 states. It was 17 yesterday.
Breakdown is: Texas, 9; NM, 4; Kansas, 3; Mich, 2; Idaho & Ohio, 1 each.
www.aphis.usda.gov/livestock-poultry-disease/avian/avian-… -
Peter Horby @peterhorby.bsky.social reposted
Carroll Lab
@Carroll_Lab_Ox
Check out Emily’s poster A367 if you’re at #microbio24 @MicrobioSoc - session starts at 5:15pm!
Emily Clayton
@EmilyCVirology
Pleased to be presenting a poster on my research titled ‘High-throughput screening of FDA-approved compounds using a Recombinant Cedar Virus Platform for Henipavirus Antiviral Discovery’ here at the Microbiology Conference 2024 in Edinburgh. Catch me at poster stand A367 today🦇
-
Peter Horby @peterhorby.bsky.social reposted
Carroll Lab
@Carroll_Lab_Ox
Dung (@DungNgu12672749) from our group presented on the enhancement of SARS-CoV-2 infection by the anti-fungal drugs Amphotericin B and Nystatin @MicrobioSoc #microbio24
-
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease @ISARIC1 www.nature.com/articles/s41590-024-01778-0
-
Peter Horby @peterhorby.bsky.social reposted
Marc Bonten
@MarcBonten
Very happy with the first patient enrolled in the #recovery trial in Europe. @Ecraid and @UniofOxford collaborate to continue this adaptive trial - highly successful during the pandemic - for patients with influenza in EU countries. @peterhorby
www.ecraid.eu/news/recovery-trial-activated-france-first-… -
Peter Horby @peterhorby.bsky.social reposted
Sudeep Adhikari
@DrS_Adhikari
My new correspondence @TheLancet. Globalisation of clinical trials would not only benefit researchers from LMICs, but also patients from LMICs who deserve equal rights to getting standard of care and evidence-based treatment @DrSBhusal @BasnyatBuddha www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
-
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
📢18+ residents of UK🇬🇧: Help us better understand public sentiment towards those affected by mpox, formerly known as #monkeypox. Participate in the anonymous survey about #mpox stigma➡️ ncov.medsci.ox.ac.uk/surveys/?s=YCP8AN9FLPP3733Y
#stigmasurvey -
Peter Horby @peterhorby.bsky.social reposted
International Pandemic Preparedness Secretariat
@IPPSecretariat
Data on research funding & clinical evidence is crucial for an R&D ecosystem to respond to future outbreaks & achieve the #100daysmission. The new pandemicpact.org does just that, enabling understanding of R&D capacity for informed funding, prioritisation & partnerships 💻
-
Peter Horby @peterhorby.bsky.social reposted
International Pandemic Preparedness Secretariat
@IPPSecretariat
To achieve the #100daysmission when a PHEIC is declared, work needs to be done in inter-pandemic periods:
🤝Coordinate R&D budgets for prototype libraries
🧪Fund Dx
💊Enhance Tx pipelines
🥼Take a preparatory regulatory approach
⚕️Make clinical trial infrastructure sustainable -
Peter Horby @peterhorby.bsky.social
@PeterHorby
That comparison is now closed and we will be examining the results over the coming months.
-
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY update:
49,000 pts enrolled.
And on Sunday 31st March, we closed the final COVID comparisons.
We continue to study treatments for flu & community-acquired pneumonia.
And are ready to respond to future outbreaks if needs be.
Thank you to so many for so much support. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Good medicines in a warehouse rather than in patients is a tragic failure, on many levels.
MSF calls for global emergency stockpile of Ebola treatments www.doctorswithoutborders.org/latest/msf-calls-global-eme… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 NEWS: Speakers & panellists announced for the International Pandemic Sciences Conference 2024.
We're thrilled to be joined by so many global experts from academia, policy & industry this July 🌍
Meet our speakers 👇
www.psi.ox.ac.uk/news-and-opinion/speaker-line-up-announc…
Register👇
www.psi.ox.ac.uk/conference24 -
Peter Horby @peterhorby.bsky.social reposted
Oxford Vaccine Group
@OxfordVacGroup
💡Learn more about the Nipah virus and how you can help with our study.
NIV001 Study Details:
> 2 x vaccine doses given (ChAdOx1 NipahB Vaccine or Placebo) at the OVG
> Total study duration = 12 months
> Reimbursement of £1,020 - £1,380
FIND OUT MORE ⬇️
www.ovg.ox.ac.uk/studies -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Sick cows in 2 states test positive for avian flu. Avian flu is infecting a widening range of mammals.
www.cidrap.umn.edu/avian-influenza-bird-flu/sick-cows-2-s… -
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants www.nature.com/articles/s41467-024-45400-1
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fatal avian influenza A/H5N1 case in Vietnam - 21 year old male student. vnexpress.net/benh-nhan-cum-a-h5-dau-tien-trong-nam-tu-vo…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
How the Covid pandemic has affected every UK generation www.theguardian.com/world/2024/mar/21/young-and-old-how-t…
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Together with @GloPID_R, today we’ve launched Pandemic PACT, a new tool to track global funding for pandemic research.
🔗 Explore the tool:
www.pandemicpact.org
➡️ Find out how Pandemic PACT is supporting pandemic preparedness via @TheLancet:
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Dengue is causing major problems across the globe, needs renewed attention.
Sarah Newey
@sneweyy
“The emergency room is overwhelmed… there are too many patients & so there are long delays for a medical consultation,” emergency room doctor Prof André Ribas Freitas said. “The situation here is much worse [than previous years]”
Story with @liliasebouai www.telegraph.co.uk/global-health/science-and-disease/unp… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Join @GloPID_R tomorrow for the online launch of Pandemic PACT, a new tool that tracks data about research funding & evidence for diseases with #pandemic potential.
➡️ 20 March | 13.30-15.30 GMT
➡️ Register | www.eventbrite.com/e/online-navigating-tomorrow-lessons-l…
GloPID-R
@GloPID_R
We're launching Pandemic PACT tomorrow!
🗓️20 March - 13.30-15.30 GMT
👉🏼www.eventbrite.com/e/online-navigating-tomorrow-lessons-l…
Join us & learn more about this ground breaking initiative!
@PSIOxford @Alice_J_Norton @IPPSecretariat @UKCDR @NIHRglobal @EDCTP @EU_Commission @IDRC_CRDI @wellcometrust @UKRI_News -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
This week @OxIHTM Masters students presented policy briefings on urgent global health issues to @MalariaNTDAPPG at the Houses of Parliament.
They were joined by assignment leader PSI's @Alice_J_Norton, alongside @Bisiadenipekun & @NicolasPulik.
More 👇
www.tropicalmedicine.ox.ac.uk/news/ihtm-present-policy-br… -
Peter Horby @peterhorby.bsky.social reposted
The Guardian
@guardian
Covid vaccines cut risk of virus-related heart failure and blood clots, study finds www.theguardian.com/science/2024/mar/12/covid-vaccines-cu…
-
Peter Horby @peterhorby.bsky.social reposted
Charlotte Summers
@charlot_summers
Feel like I need to repost this today having spent time this afternoon speaking to people affected by the SFP changes and hearing from @adbeggs about the decline in intercalated applicants in his area.
Charlotte Summers
@charlot_summers
There is a crisis in clinical academia in the UK. We talk of the need to expand medical schools, embed research into the NHS to improve care, & the importance of a vibrant life sciences sector for the economy of the UK, & yet we seem unable to tackle the underlying issues 1/9
-
Peter Horby @peterhorby.bsky.social reposted
GloPID-R
@GloPID_R
📢Don’t miss our Pandemic PACT launch!
🗓️20 March 2024 - 13.30-15.30 GMT
➡️Learn about our new grant tracker + RRNAs
➡️Reflect on #covid19 lessons learnt
➡️Discuss what still needs to be done!
Register now👉🏼 www.eventbrite.com/e/online-navigating-tomorrow-lessons-l… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
The new Pandemic PACT programme tracks data about research funding and evidence for diseases with #pandemic potential.
Join our partners @GloPID_R for the launch event to learn more about the new tool:
🗓️ 20 March | 13.30-15.30 GMT
📍 Online
Register 👇
www.eventbrite.com/e/online-navigating-tomorrow-lessons-l…
GloPID-R
@GloPID_R
📢Our powerful Pandemic PACT programme will:
✅collate & analyse🌎funding tracking data & evidence across multiple disciplines for a wide range of diseases of outbreak potential
Register now for our launch event!
🗓️20 March 2024 - 13.30-15.30 GMT
➡️www.eventbrite.com/e/online-navigating-tomorrow-lessons-l… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Would require adequately powered clinical trials - cannot assume it will work. Also, will only be available some way into a large scale epidemic or pandemic.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
I agree this might be true for H5N1 but its all the other the HxNx's
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Apologies: now with working link
wwwnc.cdc.gov/eid/article/30/3/23-1098_article
Peter Horby @peterhorby.bsky.social
@PeterHorby
Avian flu makes me nervous ++ We need to be ready for it becoming more transmissible between humans.
Between 2020–2023, 26 countries reported >48 mammal species infected by H5N1. Geographic area and No. of species affected has increased.
/eid/article/30/3/23-1098_article -
Peter Horby @peterhorby.bsky.social
@PeterHorby
A fantastic piece capturing the sapping burdens of academia. Much of the paperwork is not only useless, it is harmful to research since it is both a barrier and an opportunity cost. Also increases inequity: if it's hard in Oxford, how much harder in poorly resourced Universities?
Jeremy Farrar
@JeremyFarrar
A mountain of small things academic.oup.com/brain/article/147/3/739/7617464
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Avian flu makes me nervous ++ We need to be ready for it becoming more transmissible between humans.
Between 2020–2023, 26 countries reported >48 mammal species infected by H5N1. Geographic area and No. of species affected has increased.
/eid/article/30/3/23-1098_article -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
We're in Uganda this week for a @WHO & @MinofHealthUG meeting on future #filovirus outbreaks 🇺🇬
PSI colleagues are pleased to have joined regional efforts from 18 countries to harmonise and accelerate vaccine and treatment trials for #ebola and #marburg. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Stigma associated with infectious disease outbreaks causes severe psychological distress, depression, anxiety, and posttraumatic stress. During outbreaks, stigma needs to be better assessed and addressed.
@PSIOxford
/eid/article/30/3/23-0934_article -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
There are just a few hours left to submit an abstract for the International #pandemic Sciences Conference this summer in historic Oxford.
⌛️ Abstract & bursary deadline: Mon 26 Feb 23.59 GMT
🗓️ Conference: 1–2 July
Apply now ⬇️
www.psi.ox.ac.uk/conference24 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
"There are several distinctive characteristics of Nipah virus that raise important ethical questions, many of which are not present for other priority pathogens."
@PSIOxford @Ethox_Centre @MORUBKK
Phaik Yeong Cheah
@phaikyeong
Ethical issues in Nipah virus control and research: addressing a neglected disease jme.bmj.com/content/early/2023/12/08/jme-2023-109469
-
Peter Horby @peterhorby.bsky.social reposted
Medical Sciences
@OxfordMedSci
Interested in a career in Clinical Trial Management?
Clinical trial management professionals from across @OxfordMedSci share their valuable insights and provide guidance for individuals interested in pursuing a career in trial management.
Learn more 👉 www.medsci.ox.ac.uk/about-us/who-we-are/departments-netwo… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 NEWS: We've extended the deadline for abstract submission & bursary applications for the International Pandemic Sciences Conference 2024.
➡️ Abstract & bursary deadline: 26 February
➡️ Conference: 1-2 July
Apply now for a chance to share your work 👇
www.psi.ox.ac.uk/conference24 -
Peter Horby @peterhorby.bsky.social reposted
-
Peter Horby @peterhorby.bsky.social reposted
Peter Openshaw
@p_openshaw
Congratulations also to @FelicityLiew for a great talk on #longcovid , highlighted in the Chair's summing up
Lena Group Respiratory Hub 🫁
@Lena_Group4Resp
#rti2024 Day 2 🎉
🌟Congratulations to the Rising Stars of the Forum on Respiratory Tract Infections for their valuable presentations!
#respiratorymedicine #respiratorytractinfections -
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
Estimating population effectiveness interventions against COVID: summary 1/ NPIs were highly effective in France. 2/ Vaccine saved 160k lives France until end study period. 3 If a vaccine available after 100 days, 70k lives would have been saved in France. www.sciencedirect.com/science/article/pii/S1755436524000057
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
From early work on #hiv & SARS-CoV-1, through to leading the RECOVERY trial of COVID-19 treatments, our Director @PeterHorby gives @ajpollard1 an insight into his life-saving work in this latest @OxfordVacGroup podcast.
🎧 Listen now:
podcasts.ox.ac.uk/pandemic-people-sir-peter-horby
Oxford Vaccine Group
@OxfordVacGroup
New episode of The Oxford Colloquy!
Listen below to Sir Andrew Pollard (@ajpollard1) and Sir Peter Horby (@PeterHorby) discuss Peter's early work with HIV, his work on SARS-1, and the RECOVERY trial in March 2020.
Listen now: podcasts.ox.ac.uk/pandemic-people-sir-peter-horby
@PSIOxford @NDMOxford -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Balanced, sensible, and practical advice from Susan Gichoga @SciforAfrica on equitable science funding for Africa.
Innovative funding systems are key to fighting inequities in African science www.nature.com/articles/d41586-024-00348-6 -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 Call for abstracts!
Abstract submissions are open for the International Pandemic Sciences Conference 2024 on 1-2 July in Oxford & online.
📅 Submission deadline: 19 Feb
Find all the info you need on our conference website ➡️
web.cvent.com/event/2e7cb90c-63a3-4d13-8d0d-5235c08cc02a/…
#pandemicsciences24 -
Peter Horby @peterhorby.bsky.social reposted
Andrew Mitchell
@AndrewmitchMP
British science will help save countless lives. I saw first-hand the research at @JennerInstitute @PSIOxford @OxfordVacGroup and learnt about the game-changing R21 vaccine to work towards making malaria history
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Delighted to have @AndrewmitchMP from @FCDOGovUK visit the research labs at @JennerInstitute, @PSIOxford and @OxfordVacGroup. The visit emphasised UK Government and Oxford's joint efforts towards #vaccinedevelopment and #pandemicpreparation.
Read more 👉 www.ndm.ox.ac.uk/news/uk-minister-meets-with-oxford-pande… -
Peter Horby @peterhorby.bsky.social reposted
GloPID-R
@GloPID_R
📢Save-the-date➡️Pandemic PACT Programme Launch!
🗓️20 March '24 - 13.30-15.30 – hybrid event
✅COVID CIRCLE legacy
✅#pandemic lessons learnt
✅strategies➡️#preparedness
@UKCDR @PSIOxford @BlavatnikSchool @NIHRglobal @UKaid @EDCTP @HorizonEU @IDRC_CRDI @wellcometrust @UKRI_news -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
Using portable ultrasound to study #plague buboes!
We're collaborating with @pasteurMG and Worldwide Radiology to initiate the first ever study to prospectively collect data about the clinical evolution of bubonic plague buboes among patients in #madagascar:
🧵(1/3) -
Peter Horby @peterhorby.bsky.social reposted
Amy Maxmen, PhD
@amymaxmen
"Do we have blue blood & do others have red blood?"
This is what a Congolese researcher asked me when trying to understand why one of the world's worst crises gets so little attention.
Please read & share my new #longread on the Central African Republic. undark.org/2024/01/24/central-african-republic-mortality/ -
Peter Horby @peterhorby.bsky.social reposted
The Lambe Lab
@jenneratingVacc
It was a privilege to be part of the first panel session discussing how best to enable pandemic & epidemic preparedness
International Pandemic Preparedness Secretariat
@IPPSecretariat
"Fundamentally, we need fully funded #diagnostics #therapeutics & #vaccines to be accessible, global, & open to all. That is the greatest failing we've had for a many outbreaks" Teresa Lambe OBE, Calleva Head of Vaccine Immunology & Prof of Vaccinology & Immunology @UniofOxford
-
Peter Horby @peterhorby.bsky.social reposted
Tulio de Oliveira
@Tuliodna
Today in Science, we highlight why the world should be Investing in Africa’s scientific future. www.science.org/doi/10.1126/science.adn4168
-
Peter Horby @peterhorby.bsky.social reposted
CEPI
@CEPIvaccines
We've partnered with @BarinthusBio and @PSIOxford - the scientists behind one of the life-saving COVID vaccines - to fast-track the development of a vaccine against MERS coronavirus ⬇️
cepi.net/news_cepi/new-partnership-aims-to-advance-vaccin… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
It's 25 years since Nipah virus disease (a recognised pandemic threat) was identified but fatality rate remains >50%.
Zakiul Hassan @icddr_b and Moh Family Foundation Fellow @PSIOxford asks what can we do to improve patient care?
www.sciencedirect.com/science/article/pii/S1473309923007077 -
Peter Horby @peterhorby.bsky.social reposted
Jacob de Wolff 🇳🇱🚲☕️
@jfdwolff
Hurrah, thanks @PeterHorby @MartinLandray
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Abstract submission is open for the 2024 Oxford Global Health & Bioethics International Conference, hosted by our friends @Ethox_Centre @bermaninstitute @GHBNet & @EpidemicsEthics.
➡️ Abstract deadline: 5 Feb
➡️ Conference: 9-10 July
Find out more 👇
www.oxjhubioethics.org/conference -
Peter Horby @peterhorby.bsky.social reposted
Christophe Fraser Group
@ChristoPhraser
New in @Nature: we used digital measurements for 7 million people exposed to confirmed COVID-19 cases to determine risks for virus transmission, captured well by @NHSCOVID19app. We found that number of hours of exposure is a major predictor, along with proximity.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
A call to action for 'always on, always busy' research-oriented health systems.
Ambitious, but whilst we wait, we waste health and resources.
The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
A study by @PSIOxford, @MORUBKK and @TropMedOxford researchers in @JME_BMJ has outlined potential issues in #publichealth ethics and the politicisation of prevention efforts against the #nipahvirus.
Find out more 👉 www.ndm.ox.ac.uk/news/ethical-considerations-in-nipah-vir… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic opportunity - Chair to the New and Emerging Respiratory Virus Threats Advisory Group.
As Chair since 2018, I highly recommend this fascinating role.
www.gov.uk/government/organisations/department-of-health-… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
The @GloPID_R Funders Roadmap aims to ensure clinical trial responses to outbreaks with epidemic & pandemic potential are:
1⃣ Effective
2⃣ Equitable
3⃣ Coordinated
Read more on how the framework is supporting better clinical trials 👇
www.psi.ox.ac.uk/news/funders-roadmap-is-supporting-bette…
@Alice_J_Norton -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 Registration is now open for the International Pandemic Sciences Conference 2024.
🗓️ 1 – 2 July
📍 Oxford & online
Secure your spot amongst global research leaders and join us to accelerate practical solutions to #pandemic threats.
Register now👇
web.cvent.com/event/2e7cb90c-63a3-4d13-8d0d-5235c08cc02a/… -
Peter Horby @peterhorby.bsky.social reposted
Isabel Oliver
@isaperena
This excellent report contains the technical information on influenza A(H1N2)v work continues to understand risks to health
Ash Otter
@asherichia
Influenza A(H1N2)v: rapid technical assessment by the @UKHSA @APHAgovuk and @TheCrick
www.gov.uk/government/publications/influenza-ah1n2v-techn… -
Peter Horby @peterhorby.bsky.social reposted
Marc Bonten
@MarcBonten
We’re paying our @ecraid Oxford friends a visit. Great presentations on the Pandemic Sciences Insitute by @PeterHorby and on trials in primary care by @ChrisColButler on holy ground.
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
PSI Investigators Prof Sarah Gilbert & Prof Teresa Lambe are in sunny Cape Town this week connecting with #immunologists at #iuis2023 🇿🇦
They’ve presented on:
✅ pandemic preparedness
✅ vaccines against outbreak pathogens
✅ expanding access to vaccines in LMICs -
Peter Horby @peterhorby.bsky.social
@PeterHorby
"projects aiming at disruptive innovation are best allocated to on-site teams".
The importance of physical institutions.
Moritz Kraemer
@MOUGK
Remote collaboration fuses fewer breakthrough ideas
www.nature.com/articles/s41586-023-06767-1 -
Peter Horby @peterhorby.bsky.social reposted
Maria Van Kerkhove
@mvankerkhove
1/8
An incredible few days at the #mers and Other Emerging Zoonotic Coronaviruses meeting in Riyadh 🇸🇦 bringing together >200 researchers, country representatives and partners to discuss progress made towards tackling MERS and the priority nCoV research gaps to #tacklemers -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
At this week’s Quadripartite Global Technical Meeting on MERS-CoV and Other Emerging Zoonotic Coronaviruses in #riyadh:
➡️ Our Director @PeterHorby presented @ISARIC1's work on #mers
➡️ @NDMOxford student @BatawiSarah spoke about systems serology for coronaviruses
#onehealth -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Are you an #epidemic or #pandemic sciences leader in Africa?
Join our webinar with @SciforAfrica & @MastercardFdn for a Q&A about new support to establish networks of research excellence across Africa.
🗓️ Weds 6 Dec
⏰ 15.30 EAT
Sign up 👇
us06web.zoom.us/webinar/register/WN_ibQO07ihRxK57k7Vl6gvXw -
Peter Horby @peterhorby.bsky.social
@PeterHorby
The fantastic Sarah Batawi (DPhil student at Oxford) talking on systems serology for coronaviruses. @WHO meeting on MERS-CoV.
-
Peter Horby @peterhorby.bsky.social reposted
Cillian Gartlan
@CillianGartlan
Some behind-the-scenes from our upcoming micro-documentary with @OxfordSparks ‘Pandemics: The Unanswered Questions’. Stay tuned!
This is part of a public engagement project made possible with funding from @ReubenCollege and @PSIOxford -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 NEWS: Calling outstanding leaders in #pandemic sciences in Africa.
We've joined forces with @SciforAfrica & @MastercardFdn to support innovative networks of research excellence across Africa.
🗓️ Apply before 31 January 2024
Find out more 👇
scienceforafrica.foundation/funding/call-applications-epi… -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
We're excited to announce that our ongoing bubonic #plague trial in #madagascar has reached its minimum target enrolment sample size of 190 participants, bringing us closer to finally finding answers for effective treatment of plague. Learn more ➡️ isaric.org/research/bubonic-plague/
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Watch PSI Investigator Professor David Clifton share how large language model DrugGPT could support clinicians by making recommendations about medicines ⬇️
#oxfordai
University of Oxford
@UniofOxford
AI has the potential to transform healthcare from diagnosis to treatment.
@Oxford_NDPH's Prof Angeliki Kerasidou and @oxengsci's Prof David Clifton discuss some of the potential risks and benefits of using artificial intelligence in global health and medicine. ⬇️
#oxfordai -
Peter Horby @peterhorby.bsky.social reposted
Medical Sciences
@OxfordMedSci
STUDENTS: Looking for a PhD programme starting in 2024/25?
We have fully-funded studentships in various areas of medical sciences, working with world-class academics.
Closing dates are coming up soon for most programmes, so apply soon ➡️
www.medsci.ox.ac.uk/study/graduateschool/courses/dtc-stru… -
Peter Horby @peterhorby.bsky.social reposted
UK Biobank
@uk_biobank
Here is our statement about a misleading @ObserverUK article www.ukbiobank.ac.uk/learn-more-about-uk-biobank/news/resp… - we do not share identifiable information with anyone.
If you are a participant and concerned about the claims, please contact us on 0800 0 276 276 (9am-5pm) or email UKBiobank@ukbiobank.ac.uk -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Or @StMungos
Charlotte Summers
@charlot_summers
Want to take action on homelessness?
Why not support one or all of:
@crisis_uk
www.crisis.org.uk
@Shelter
www.shelter.org.uk
@centrepointuk
centrepoint.org.uk -
Peter Horby @peterhorby.bsky.social reposted
Medical Sciences
@OxfordMedSci
NEWS: RECOVERY trial expands to investigate treatments for influenza
The features of the RECOVERY Trial that made it successful against COVID-19 make it well placed to also improve the care of severe influenza patients.
@NDMOxford @Oxford_NDPH
www.medsci.ox.ac.uk/news/recovery-trial-expands-to-invest… -
Peter Horby @peterhorby.bsky.social reposted
Moritz Kraemer
@MOUGK
New estimates suggest that mpox has been circulating in humans since at least 2016.
www.science.org/doi/full/10.1126/science.adg8116 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Agree, baffling. Unless of course the Spectator is more interested in promoting ideology than good science.
Adam Kucharski
@adamjkucharski
It's baffling that after almost *four years*, outlets like Spectator are still publishing articles that get the fundamentals of COVID transmission and lagged outcomes so wrong (more on this in quoted thread)...
-
Peter Horby @peterhorby.bsky.social reposted
International Pandemic Preparedness Secretariat
@IPPSecretariat
Our #100daysmission Science and Technology Expert Group met in-person for the first time this week 🤝
At a two-day meeting in Oxford chaired by @VictorDzau and Shingai Machingaidze, members discussed 2023 progress on delivering the 100 Days Mission 💊🔬💉 -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
We were delighted to welcome a delegation from @IPPSecretariat this week, for a tour of PSI & @OxfordVacGroup labs.
The visit was part of the group's annual meeting on accelerating pandemic preparedness in support of the #100daysmission 🌍
More here ⬇️
www.psi.ox.ac.uk/news/oxford-welcomes-global-pandemic-exp… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
CEPI and University of Oxford advance vaccine against potentially deadly Arenaviruses – congratulations to project leader Professor Teresa Lambe. cepi.net/news_cepi/cepi-and-university-of-oxford-advance-…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
COVID-19 vaccination campaign saved 2.4 million lives, according to health economists | Brown University www.brown.edu/news/2023-10-30/vaccine-impact
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Great to see the NDM and @Oxford_NDPH's #recoverytrial expanding to tackle the long-term challenge of #influenza, now in partnership with @Ecraid 🤝 The study will now investigate the drugs Oseltamivir, Baloxavir marboxil and corticosteroids.
Read more👉 www.ndm.ox.ac.uk/news/recovery-trial-expands-to-investiga… -
Peter Horby @peterhorby.bsky.social reposted
Amanda Rojek
@AmandaRojek
Can we agree on what a healed #mpox lesion looks like? www.ijidonline.com/article/S1201-9712(23)00741-5/fulltext
Variability in assessment a big challenge - for patient care, infection prevention advice, and clinical trials -
Peter Horby @peterhorby.bsky.social reposted
Nature Portfolio
@NaturePortfolio
A study in @Nature reports that an estimated 95,000–167,000 inpatients at English National Health Service hospitals caught SARS-CoV-2 while in hospital during England’s ‘second wave’ of COVID-19, between June 2020 and March 2021. go.nature.com/46SdcNl
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
DPhil project opportunity👇
@NDMOxford is looking for a clinician-researcher with experience of working in #nigeria, for a project on #mpox outbreaks.
📅 Apply by 31 October
Learn more:
www.ndm.ox.ac.uk/study/dphil-themes?project=the-epidemiol… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
The @AcuteCareTrials @ISARIC1 @UnityHealthTO Colloquium in Toronto laid the groundwork for the evolution of global research collaboration that could lead to better treatments for emerging infections & acute care.
Read more on the conference ⬇️
www.psi.ox.ac.uk/news/conference-brings-together-clinical… -
Peter Horby @peterhorby.bsky.social reposted
Dr. Pragya D Yadav, FAMS, FNAAS, FICMM, FIVS
@hellopragya22
I am glad to be part of this fascinating and important discussion on dealing with these deadly diseases
@PeterHorby @xhschan @UniofOxford @PSIOxford
Congratulations to the young researcher for the excellent presentation
Pandemic Sciences Institute
@PSIOxford
Thanks to our global experts Professor CT Tan & @hellopragya22, and researchers from the @uniofoxford for your insightful presentations.
From clinical trials to ethics, and treatments to vaccines, today's talks captured the breadth of research to combat #nipahvirus 🌍 (2/2) -
Peter Horby @peterhorby.bsky.social reposted
Chikwe Ihekweazu
@Chikwe_I
Congrats to a dear colleague, @HananBalkhy, on her election as Regional Director @WHOEMRO. The first woman to hold this position!
Confident in Dr Balkhy’s leadership, expertise, experience & compassion to work with Member States & partners to advance #healthforall in the region. -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
It's now 25 years since the first outbreaks of deadly #nipah virus, yet there are still no approved vaccines or treatments.
As Nipah continues to impact communities, including in Kerala 🇮🇳, 60 scientists joined our seminar today to explore the latest Nipah research. (1/2) -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Could you be our new Chief Scientific Officer?
We're looking for an exceptional individual to lead PSI's science strategy.
Join our team in Oxford as we strive to make the world safer through science.
Apply now 👇
www.psi.ox.ac.uk/opportunities/current-vacancies
@NDMOxford @OxfordMedSci #sciencejobs -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
🔎 Calling all explorers age 10+ in Oxford!
Join the Pandemic Detectives in this interactive experience to unlock disease outbreaks.
🗓️ 10 Oct, 5–8pm
We're excited to take part in Science Wonder Discovery Evening @BegbrokeScience Farmhouse.
Book ⬇️
sciencewonder.co/discover -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fabulous news: the Oxford R21 malaria vaccine receives
@WHO recommendation paving the way for global roll-out.
A huge boost for global health
Congratulations @JennerInstitute @OxfordVacGroup
@SerumInstIndia
University of Oxford
@UniofOxford
The Oxford malaria vaccine:
- Can be manufactured at mass scale & modest cost
- Enables as many as 100s of millions of doses to be supplied to countries suffering a significant malaria burden
- The jab marks culmination of 30 years of malaria vaccine research at @JennerInstitute -
Peter Horby @peterhorby.bsky.social reposted
Dr. Peter A Singer, OC
@PeterASinger
Promising malaria vaccine clears clinical hurdle, could get WHO endorsement next week | Science | AAAS www.science.org/content/article/promising-malaria-vaccine…
-
Peter Horby @peterhorby.bsky.social reposted
Infectious Disease Tracker
@HmpxvT
Italy 🇮🇹 has recorded 36 local cases of dengue fever so far this year, presenting an emerging health threat to the population.
-
Peter Horby @peterhorby.bsky.social reposted
Infectious Disease Tracker
@HmpxvT
⚠️ BREAKING:
Bangladesh 🇧🇩 reports close to 1,000 deaths in the country's most severe dengue fever outbreak in recorded history. -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
News from Melbourne 🇦🇺
Professor Dame Sarah Gilbert joined leading researchers in #vaccinology this week at @TheDohertyInst to discuss the challenges of rapid vaccine development.
Watch the press conference 👇
www.doherty.edu.au/news-events/news/covid-19-vaccines-wit…
Doherty Institute
@TheDohertyInst
Interesting panel discussion today with preeminent vaccinologists Prof Dame Sarah Gilbert, Prof Terry Nolan & Prof Paul Young on #covid19 - challenges, lessons learnt and where to next, hosted by @ProfSharonLewin
youtu.be/7lJo0MqamFE
@UniMelbMDHS @TheRMH @UQ_News -
Peter Horby @peterhorby.bsky.social reposted
MORU
@MORUBKK
Paxlovid® (nirmatrelvir) clears COVID-19 more rapidly than molnupiravir, report @wellcometrust-funded @TropMedOxford supported #platcov researchers In @TheLancetInfDis - it's the 1st ever direct comparison between the 2 leading COVID antivirals!
www.thelancet.com/journals/laninf/article/PIIS1473-3099(2… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Looking for a new challenge? We are seeking a dynamic Chief Scientific Officer for the Oxford Pandemic Sciences Institute.
Come and join our wonderful team, working collaboratively, and globally to make the world safer through good science.
@PSIOxford
www.linkedin.com/jobs/view/3725844757 -
Peter Horby @peterhorby.bsky.social reposted
Laurie Garrett
@Laurie_Garrett
Ivermectin -- again:
"In this double-blind, randomized, placebo-controlled trial including 1206 US adults w/#covid19 during Feb2022 to Jul2022, the median time to sustained recovery was 11 days in the #ivermectin group & 11 days in the placebo group...the posterior probability that ivermectin reduced symptom duration by more than 1 day was less than 0.1%."
jamanetwork.com/journals/jama/fullarticle/2801827 -
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
NEW: Oxford has been recognised as one of the top science and innovation clusters in the world, according to new data released today from the upcoming 2023 #globalinnovationindex (@GI_Index). ⬇️
www.ox.ac.uk/news/2023-09-20-oxford-ranked-third-most-int… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
The burden on those making grant applications must be reduced. It is a major barrier, especially to less well resourced researchers.
In a recent application I was involved in, the actual science started on page 100 of 168 pages.
Science and Innovation at Cancer Research UK
@CRUKresearch
As part of the Research Funders Policy Group, we’re working with other UK research funders to share best practice, align policy & reduce bureaucracy. Find out more: wellcome.org/what-we-do/our-work/joint-statement-generati…
@AMRC @TheBHF @NIHRresearch @RAEngNews @royalsociety @UKRI_News @wellcometrust
Peter Horby @peterhorby.bsky.social
@PeterHorby
It takes hundreds of person hours to complete the endless supplementary information requested, which I doubt anyone reads.
It is no wonder people resort to AI. It is that or stay up all night and all weekend. -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 NEWS: Scientists from Oxford & Liverpool launch new vaccine trial for Middle East Respiratory Syndrome (MERS).
#mers is a deadly viral illness with no current vaccines, posing a potential #pandemic threat.
Read the full story ⬇️
www.psi.ox.ac.uk/news/oxford-and-liverpool-scientists-lau… -
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
Global diversity & antimicrobial resistance typhoid fever pathogens: Insights from meta-analysis of 13,000 Salmonella Typhi genomes. Great to see this. Incredible global collaboration in science, not possible by anyone institution, organisation or country pubmed.ncbi.nlm.nih.gov/37697804/
-
Peter Horby @peterhorby.bsky.social reposted
Oxford Vaccine Group
@OxfordVacGroup
👏An Oxford Vaccine Group study has administered a new vaccine against the tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to human volunteers for the first time.👏
Read more: www.ovg.ox.ac.uk/news/first-in-human-trials-commence-for-… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched www.ndm.ox.ac.uk/news/first-volunteers-receive-vaccine-fo…
-
Peter Horby @peterhorby.bsky.social reposted
Marion Campbell
@MarionKCampbell
One of my bugbears this week - #baselinetesting in clinical trials 1/9
#methodologymonday #55 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Couldn't agree more.
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Great to hear, but i hope that a number 1 condition is that UK relaxes its extremely challenging rules about hiring international scientists @PeterHorby
-
Peter Horby @peterhorby.bsky.social reposted
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Great to hear, but i hope that a number 1 condition is that UK relaxes its extremely challenging rules about hiring international scientists @PeterHorby
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Congratulations to Prof Dame Sarah Gilbert for being awarded the @rcpsglasgow President’s Medal at a ceremony in Glasgow earlier this week 👏
The award is in recognition of Prof Gilbert's work to develop a vaccine for COVID-19.
Read more ⬇️
rcpsg.ac.uk/college/speaking-up-for-the-profession/news-a… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Science saved us from a worse pandemic (diagnostic tests, treatments, vaccines, molecular epi), it did not cause the pandemic.
More bureaucracy = less science, less innovation & less collaboration = we are all worse off.
Reams of paper will be cold comfort @ the next pandemic
Tulio de Oliveira
@Tuliodna
This new NIH policy is not only silly but damaging to global health. When the USA will learn that some countries are much more experienced than them on dealing with epidemics! We have showed the world that we can help with quick detection of pathogens and variants and it is of global interest to get these programs well funded to protect them.
-
Peter Horby @peterhorby.bsky.social reposted
Tulio de Oliveira
@Tuliodna
This new NIH policy is not only silly but damaging to global health. When the USA will learn that some countries are much more experienced than them on dealing with epidemics! We have showed the world that we can help with quick detection of pathogens and variants and it is of global interest to get these programs well funded to protect them.
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Day 2 of #ukpsn2023 is in full swing with a panel on the importance of #sciencecommunication during a pandemic.
Delegates heard insights from @BBCFergusWalsh, @PSIOxford's Prof Dame Sarah Gilbert, @ProfCalumSemple and @p_openshaw. -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
What do we need to prioritise in readiness for the next pandemic?
➡️ PSI and OVG researcher Prof Teresa Lambe joins members of #100daysmission Science & Tech Expert Group to set out 5 recommendations in @TheLancet
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
@jenneratingVacc @OxfordVacGroup
International Pandemic Preparedness Secretariat
@IPPSecretariat
“The global community should use lessons from the COVID-19 pandemic as a mandate for improved pandemic preparedness”
#100daysmission Science & Technology Expert Group & IPPS Deputy Head @charlie_baker23 in a new opinion piece for @TheLancet 🧪💊💉
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic news. At last we can throw ourselves fully back into working with our European colleagues to do great science. www.bbc.co.uk/news/uk-66737714
-
Peter Horby @peterhorby.bsky.social reposted
Dre Joanne Liu
@DreJoanneLiu
From private incentives to public health need: rethinking research and development for pandemic preparedness by @ElsTorreele and al www.thelancet.com/journals/langlo/article/PIIS2214-109X(2…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
We cannot give up on the global pandemic treaty www.ft.com/content/17fec31b-909e-4bea-8c0f-cc3e2a597cd8
"pandemic amnesia has already set in". Sadly, I think this may be right. Perhaps too early to call it, but we are not seeing the political commitment and ambition we need. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Congratulations Eddie. Extremely well deserved. And stay strong.
The Royal Society
@royalsociety
Professor Edward Holmes FRS is awarded the Royal Society's Croonian Medal for being a global authority on virus evolution & emergence, who played a key role in the discovery of SARS-CoV-2 and was the first to publicly release the genome sequence. #rsmedals royalsociety.org/grants-schemes-awards/awards/croonian-le…
-
Peter Horby @peterhorby.bsky.social reposted
OUCRU
@OUCRU_Programme
🤝 @OUCRU_Programme & Ho Chi Minh City CDC forged a powerful collab in #preventivemedicine. Together, they'll boost testing techniques, conduct scientific research, assess community immunity & public interventions. A remarkable partnership to improve #diseasecontrol in Vietnam!
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
🗨️"This is a ground-breaking commitment from CEPI... that will drive the critical research we need to be better prepared for future pandemics" - @ajpollard1, PSI Investigator and Director of @OxfordVacGroup
Find out more about our new partnership👇
www.psi.ox.ac.uk/news/cepi-and-university-of-oxford-to-ac…
CEPI
@CEPIvaccines
We are delighted to announce a new $80m Strategic Partnership with @UniofOxford to support the design, manufacture and vaccination strategies for globally accessible vaccines against outbreak pathogens, including Disease X.
#100daysmission cepi.net/cepi-and-university-oxford-accelerate-vaccine-de… -
Peter Horby @peterhorby.bsky.social reposted
CEPI
@CEPIvaccines
We are delighted to announce a new $80m Strategic Partnership with @UniofOxford to support the design, manufacture and vaccination strategies for globally accessible vaccines against outbreak pathogens, including Disease X.
#100daysmission cepi.net/cepi-and-university-oxford-accelerate-vaccine-de… -
Peter Horby @peterhorby.bsky.social reposted
Gail Carson
@gail_carson
royalsociety.org/topics-policy/projects/impact-non-pharma… @ISARIC1 @CCPUKstudy an example of the benefits of preparedness
-
Peter Horby @peterhorby.bsky.social reposted
John Paget, PhD
@PagetPhd
These numbers are astounding:
'An estimated 1.87 million (95% CI, 0.71 million-4.43 million) excess deaths occurred among individuals 30 years and older in China during the first 2 months after the end of the zero COVID policy'
@ed_goldstein5 #covid19
jamanetwork.com/journals/jamanetworkopen/fullarticle/2808734 -
Peter Horby @peterhorby.bsky.social reposted
GloPID-R
@GloPID_R
We're delighted to launch our Africa Hub @MRCza!
Learn more here➡️www.glopid-r.org/our-work/glopid-r-africa-hub/ -
Peter Horby @peterhorby.bsky.social reposted
Oded Rechavi
@OdedRechavi
How funding works in academia
x.com/finetraitt/status/1692284811996532802/video/1 -
Peter Horby @peterhorby.bsky.social reposted
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
This is why SARI surveillance is not enough: presentation of H5 avian influenza sofar in affected mannals has been highly neurotropic. For humans not know but why not assume that too?
Michelle Wille
@DuckSwabber
Acute encephalitis with mild pneumonia in a child in China caused by the H5N6 virus. HPAI found in patient’s serum, CSF, and tracheal aspirate specimens. Virus similar virus in human infection and in ducks in China.
👉www.tandfonline.com/doi/full/10.1080/22221751.2022.2122584 -
Peter Horby @peterhorby.bsky.social reposted
NHS Million
@NHSMillion
We couldn’t agree more 💙
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Complete and utter nonsense. Approval of drugs rightly requires robust evidence of safety and efficacy - which is missing for Covid for both those drugs.
Andrew Bridgen
@ABridgen
It was not only Americans who died unnecessarily, the fact is that if Ivermectin and Hydroxychloroquine had been approved to treat Covid 19, the experimental ‘vaccines’ would have been unnecessary and could not legally have been given emergency use authorisation.
-
Peter Horby @peterhorby.bsky.social reposted
Eric Topol
@EricTopol
Top 10 ranked life science universities in 2023
www.economist.com/britain/2023/08/08/britain-doubles-down… (4 of 10 in England) -
Peter Horby @peterhorby.bsky.social
@PeterHorby
There is an awful lot to be learned from the pandemic, and acted upon, about trial effectiveness and efficiency.
This paper astonishes PMID: 33633370 - "the vast majority of trials of therapeutics for COVID-19 are not designed to yield actionable information"
@DrWoodcockFDA
Rick Bright
@RickABright
But what about 3 years of clinical trials by the @NIH @NIAIDNews at the tune of $1.5 billion? Hasn’t that provided at least 1 viable treatment for #longcovid?
Peter Horby @peterhorby.bsky.social
@PeterHorby
We can and must do better. We are wasting huge amounts of money, human resources, and goodwill. But more than that, patients are being denied advances in care.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Terrible news that ProMed seems to be imploding. ProMed has been at the fore-front of epidemic intelligence for decades. This international treasure needs saving (and perhaps modernising).
James Wood
@jw132
Anyone concerned with early #pandemic detection and emerging disease surveillance will be appalled to hear about the effective loss of @ProMED_mail functioning. See below tweet for the letter from key editors
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
📢 NEWS: PSI and #whopandemichub announce a new partnership to enhance global surveillance of #pandemic threats.
Find out how the collaboration will improve the detection and tracking of infectious diseases 👇
www.psi.ox.ac.uk/news/new-partnership-to-enhance-global-s…
@WHO -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Completely agree with @MarionKoopmans that this is irresponsible nonsense. It is a tick borne disease - talk of lockdowns is ridiculous click-bait.
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Extremely irresponsible reporting. This is a tickborne disease, that is present in some parts of europe, causing a rare but severe disease. Lockdowns are nonsense in this context. Tick protection is www.gbnews.com/health/britain-lockdown-virus-alert-cchf
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Day 2 of #pandemicsciences23 featured parallel presentations, posters, panel discussions and more.
Take a look back at our highlights 👇 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great to sign an MoU between PSI and #whopandemichub
Looking forward to working closely to enhance global health security.
Oliver Morgan
@OWMorgan
Great first conference of the Pandemic Sciences Institute in Oxford www.psi.ox.ac.uk
Pleased to sign an MoU between PSI and #whopandemichub
Academic partnerships are key for building stronger public health surveillance for the future -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Thank you to everyone who joined our first International pandemic sciences conference - an amazing cast of speakers and a truly collaborative spirit. See you in Oxford next year! 1-2 July 2024. Save the date.
Pandemic Sciences Institute
@PSIOxford
100+ presenters reflected on lessons from #covid19 & explored the remarkable research being pioneered around the 🌍 to counter infectious disease threats. Thank you to all who joined us online & in #oxford for #pandemicsciences23! See you at next year's conference 1-2 July 2024.
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
How can artificial intelligence & machine learning be used to plan a public health response? @upshur_ross chairs a panel discussion during the closing session of #pandemicsciences2023
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic first day, exciting Day 2 begins.
Pandemic Sciences Institute
@PSIOxford
As we get ready for Day 2 of #pandemicsciences23, watch yesterday's highlights👇🏽
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
The International Pandemic Sciences Conference is underway in #oxford!
Leading experts from the fields of academia, policy, industry & civil society join us for sessions on:
✅pandemic preparedness
✅vaccines & treatments
✅emerging pathogens ✅ethics
#pandemicsciences23 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Really excited about the meeting that starts tomorrow. Already having pre-meetings - Nipah, @icddr_b
Pandemic Sciences Institute
@PSIOxford
🗨️ We hope this meeting will encourage academic excellence, foster equitable partnerships & showcase the application of science to safeguarding global health for future generations.
Read more from @PeterHorby on his vision for #pandemicsciences23 👇
www.psi.ox.ac.uk/news/psi-hosts-oxford-conference-to-prep… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
The inaugural International Pandemic Sciences Conference kicks off on Monday!
Hear from leading experts about the most impactful research breakthroughs and join a network of pandemic scientists by registering online 👇
fitwise.eventsair.com/pandemic2023/register
#pandemicsciences23 -
Peter Horby @peterhorby.bsky.social reposted
World Organisation for Animal Health
@WOAH
It's #worldzoonosesday!
#dyk? 60% of pathogens that cause human diseases come from animals. We're working with #onehealth partners to save millions of lives and trillions of dollars by coordinating pandemic prevention efforts, rather than fighting #zoonoses after they’ve spread. -
Peter Horby @peterhorby.bsky.social reposted
NHS Million
@NHSMillion
If everyone who has been grateful for the NHS over the past 75 years followed and retweeted we’d reach a million by midnight.
Please take just two seconds to show you care. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Stray and companion cats (I’m presuming some are house-bound cats as bird to feline transmission being stated as unlikely), many different cites, one lab. Lab cross-contamination ruled out? Cat food?
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Colleagues from Poland did release a sequence, EPI_ISL_17949824. Shows a virus related to viruses known to circulate in Eastern Europe, although the surveillance is limited and therefore caution is needed before drawing conclusions.
-
Peter Horby @peterhorby.bsky.social reposted
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Colleagues from Poland did release a sequence, EPI_ISL_17949824. Shows a virus related to viruses known to circulate in Eastern Europe, although the surveillance is limited and therefore caution is needed before drawing conclusions.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Also a chance to meet up with colleague from SARS-1 days - Dr Shigeru Omi, emeritus regional director of WHO Western Pacific Region.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
From Beijing to Kunming (the spring city) for the @APEC ‘Capacity building forum on managing respiratory tract infections’. Hearing experiences and lessons from @APEC countries (and UK). Prof Cao stressing importance of clinical research.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Delighted to be back in China working with friends and colleagues at National Center for Respiratory Medicine. I feel very proud to have received an Honorary Professor position at China-Japan Friendship Hospital.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Also congratulations to Dr Gail Carson, rightly recognised for her long selfless service to global health with an OBE in the King’s Birthday Honours 2023. @PSIOxford @ISARIC1 www.ox.ac.uk/news/2023-06-17-members-oxford-university-re…
-
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
In summary: understanding the impact of different pandemic measures is an important question, but any analysis has to account for the underlying transmission dynamics. Otherwise the results are likely to be nonsense. 8/8
-
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
There's something a eerily familiar about todays' 'new' IEA report on lockdowns, right down to the text, tables, and half-baked methods. And, of course, the massive estimated effect of masks that somehow hasn't made it into the headlines... 1/
Adam Kucharski
@adamjkucharski
There are many problems with below study, but what's striking is how many people sharing 'lockdowns do nothing' claims unquestioningly don't seem to realise that paper at the same time concludes mandated mask wearing has a substantial effect... 1/
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Enjoying Epidemics Forum by @PasteurDakar with two greats of African epidemic sciences - Prof Muyembe and Prof Amadou Sall
-
Peter Horby @peterhorby.bsky.social reposted
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Analysis of US CDC comparing mortality due to COVID19 with that due to influenza. If that is not convincing those that say “ it is just a bit of flu” i give up www.cdc.gov/flu/weekly/index.htm
-
Peter Horby @peterhorby.bsky.social reposted
Jake Dunning
@OutbreakJake
A reminder for UK clinicians that mpox remains on the list of notifiable diseases, and for UK lab specialists that mpox virus remains on the list of notifiable pathogens. The sooner we notify our Public Health agencies about new cases, the sooner any new outbreaks will be spotted
-
Peter Horby @peterhorby.bsky.social reposted
Oxford Population Health (OxPop)
@Oxford_NDPH
#recoverytrial is honoured to receive the 'best public sector innovation' award at #prixgalien last night. Congrats to all winners www.prnewswire.co.uk/news-releases/the-galien-foundation-…
-
Peter Horby @peterhorby.bsky.social reposted
Carroll Lab
@Carroll_Lab_Ox
Our DPhil student @hannahjklim is in Malaysian Borneo as part of her project on surveillance of avian influenza spillover - an ongoing collaboration with University of Malaysia Sabah and many others
Congratulations on the presentations! @PSIOxford
Hannah
@hannahjklim
Really enjoyed presenting my DPhil research on surveillance of avian influenzas at the University of Malaysia Sabah today and for colleagues at the Sabah State Health Department yesterday! Thank you to all of my wonderful colleagues at UMS and @GSRajahram ☀️
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Have you registered yet for the International Pandemic Sciences Conference 2023 on 10-11 July?
We have two big updates today!
🌍 Bursary applications now open for LMIC delegates
🗓️ Final abstract submission deadline: 8 May
Find out more and apply 👇
fitwise.eventsair.com/pandemic2023/ -
Peter Horby @peterhorby.bsky.social reposted
Oxford Vaccine Group
@OxfordVacGroup
Have you ever wondered how vaccines are developed? It's a long and rigorous process, but it's essential for ensuring their safety and effectiveness.
Once a vaccine passes all 3 phases, it's approved by regulatory agencies.
Check out the basic steps of vaccine research🔻 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Early steroid use for severe COVID-19 tied to fewer deaths www.cidrap.umn.edu/covid-19/early-steroid-use-severe-covi…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
This argues "a transactional approach [to pathogen sharing] is not compatible with rapidly accessing pathogens" whereas a transactional approach to drug development is essential.
Nothing changes - give us your pathogens for free as a public good and we'll sell you drugs 4 profit
Amy Maxmen, PhD
@amymaxmen
I'm seeing way too many groups congratulate themselves for a job well done in the pandemic. Don't. Esp not this?
“[Protection of] intellectual property rights (IP) is one of the lessons from COVID-19,” said the president of Pharma trade org IFMPA.
healthpolicy-watch.news/pharmaceutical-ceos-to-g7-protect… -
Peter Horby @peterhorby.bsky.social reposted
Amy Maxmen, PhD
@amymaxmen
I'm seeing way too many groups congratulate themselves for a job well done in the pandemic. Don't. Esp not this?
“[Protection of] intellectual property rights (IP) is one of the lessons from COVID-19,” said the president of Pharma trade org IFMPA.
healthpolicy-watch.news/pharmaceutical-ceos-to-g7-protect… -
Peter Horby @peterhorby.bsky.social reposted
Jenner Institute
@JennerInstitute
R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana | University of Oxford www.ox.ac.uk/news/2023-04-13-r21matrix-m-malaria-vaccine-…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Opinion: Will we ever reach a point where Covid is no longer a threat? www.independent.co.uk/voices/covid-infection-bird-flu-vac…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Amadou Sall (Director of @PasteurDakar Institue & @ALERRT_Global partner) plus
@trevormundel @TariroMakadzang
Discussing how to improve global clinical research infrastructure for pandemic preparedness -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
NEWS: A new Future Vaccines Manufacturing Hub co-led by @ucl and Professor Sarah Gilbert here at @UniofOxford aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
Read more ⬇️
www.psi.ox.ac.uk/news/ps12-million-investment-for-future-…
@UKRI_News @EPSRC @SciTechgovuk -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Call for abstracts 📢
Abstract submission is *open* for the International Pandemic Sciences Conference on 10-11 July in Oxford.
🗓️ Submission deadline: 14 April
Submit an abstract in one of our four conference topics👇
fitwise.eventsair.com/pandemic2023/abstract -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Nice. May be a useful tool to get less biased surveillance data to supplement sampling from dead birds and mammals.
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
"During the pandemic we learnt a lot about vaccine development... It's really important now that we continue with that work, and don't lose the knowledge that was so hard to gain."
Watch Sarah Gilbert discuss the work that led to the @KingFaisalPrize 👇
www.psi.ox.ac.uk/news/sarah-gilbert-receives-king-faisal-… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
An exemplar of how to approach new health challenges and outbreaks.
Kenneth Baillie
@kennethbaillie
This is the best example I've seen of academic researchers working hand-in-glove with national public health agencies to tackle a new threat. Because we had the ISARIC4C (isaric4c.net) study infrastructure in place before the outbreak...
-
Peter Horby @peterhorby.bsky.social reposted
Kenneth Baillie
@kennethbaillie
Am delighted to say we've just published two papers in Nature arising from the ISARIC4C study. We used our pre-approved "sleeping" protocol to investigate the unexplained outbreak of hepatitis in kids last year. A thread...
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
New partnership to combat deadly pathogens www.gov.uk/government/news/new-partnership-to-combat-dead…
-
Peter Horby @peterhorby.bsky.social reposted
World Organisation for Animal Health
@WOAH
About 2.2M poultry birds died or were culled due to #avianinfluenza between February 17 and March 9. There have also been outbreaks in mammals, highlighting virus spillover to mammalian species.
Read our latest HPAI report to learn more👇
www.woah.org/en/document/high-pathogenicity-avian-influen… -
Peter Horby @peterhorby.bsky.social reposted
National Institute for Health and Care Research
@NIHRresearch
This week marks the 3rd anniversary of the NIHR funded and supported RECOVERY trial -
a ground-breaking, lifesaving study estimated to have saved millions of lives around the world. RECOVERY is ongoing and provides a proven model for future clinical trials. @UniofOxford -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Looking for a change?
Wanting an exciting and rewarding role?
Fancy joining a dynamic team creating a new Institute?
Look no further ....
Pandemic Sciences Institute
@PSIOxford
PSI is now hiring:
- Research Assistants
- Administrative Assistant
- Research Data Manager
- Postdoctoral Research Scientists
- Senior Programme Manager
- Deputy Business Manager
For more details visit: www.psi.ox.ac.uk/opportunities/current-vacancies -
Peter Horby @peterhorby.bsky.social
@PeterHorby
🔥I'm excited about our upcoming International Pandemic Sciences Conference- making the exceptional routine.
Can't wait to welcome you to Oxford on 10-11 July for a feast of multidisciplinary science & debate, & a fabulous lineup
Please share with your colleagues & networks.
Pandemic Sciences Institute
@PSIOxford
NEWS: Registration is now open for the International Pandemic Sciences Conference 2023.
🗓️ 10 – 11 July
📍 Oxford & online
Join us for 2 days dedicated to the discovery, creation & equitable application of solutions to #pandemic threats.
Register now👇
www.psi.ox.ac.uk/conference2023 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Potentially - but not yet evaluated in a clinical trial
Juan P. Jaworski
@jpjviro
mAbs available?
@VUMChealth #jamescrowelab -
Peter Horby @peterhorby.bsky.social reposted
WHO African Region
@WHOAFRO
Today, #tanzania 🇹🇿 confirmed its first-ever cases of #marburg virus disease after laboratory tests were carried out following reports of cases and deaths in the country’s north-west Kagera region 👉🏿 www.afro.who.int/countries/united-republic-tanzania/news/…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Tanzania declares Marburg virus outbreak.
Three different filovirus outbreaks in Africa in 6 months - need pre-approved platform trials for vaccines and treatments that can start rapidly.
www.cidrap.umn.edu/marburg/tanzania-declares-marburg-viru… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Congratulations to Professor Dame Sarah Gilbert, a recipient of the 2023 #kingfaisalprize for Medicine today 👏
Professor Gilbert was recognised for her work with colleagues @UniofOxford and beyond to develop the Oxford/AstraZeneca COVID-19 vaccine, saving an estimated 6m lives.
King Faisal Prize جائزة الملك فيصل
@KingFaisalPrize
تتسلم البروفيسورة ساره كاثرين غيلبيرت #جائزة_الملك_فيصل للطب 2023؛ وموضوعها "الأوبئة وتطوير اللقاحات".
Professor Sarah Catherine Gilbert receives the #kingfaisalprize for Medicine 2023, concentrated on "Pandemics and Vaccine Development". -
Peter Horby @peterhorby.bsky.social
@PeterHorby
NOT avian influenza in Ukraine - see Update.
FAO and a representative of the Ukrainian government. confirm there are no reported cases of avian influenza in humans or poultry in the Kherson area as was alleged in the TASS story .
mailwww.promedmail.org/post/8709054 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Does anyone have any additional information on this report of 18 people hospitalised, 2 of whom have died, associated with bird flu in Ukraine?
ProMED-mail www.promedmail.org/post/8709043 -
Peter Horby @peterhorby.bsky.social reposted
World Organisation for Animal Health
@WOAH
Over 272 MILLION poultry died or were culled due to #avianinfluenza since October 2021.
On #worldpoultryday, and everyday, we must work together to stop the spread and prevent new outbreaks, for #everyoneshealth.
Learn more👇
www.woah.org/en/disease/avian-influenza/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
I agree we need to move away from reactive military or fire-fighting analogies and models. The power to detect pandemic threats and to respond effectively will come from a deep and broad strengthening of everyday capabilities and trust. Coupled with good science.
Peter Horby @peterhorby.bsky.social
@PeterHorby
However, countries with strong healthcare and public health systems on paper did not all fair well in the COVID pandemic. So we need to dissect what it was about the evidence base, situational awareness, capabilities, and decision making that led to suboptimal responses.
Peter Horby @peterhorby.bsky.social
@PeterHorby
And then fix them.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Importance of absolute event rate: paxlovid 54% effective in preventing hospital admission or death. But very low event rate means about 1 event prevented per 1000 patients treated. @$500 per course = $500,000 to prevent 1 hospital admission or death www.thelancet.com/journals/laninf/article/PIIS1473-3099(2…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Join us at the Blavatnik School of Government to celebrate and learn lessons from the Oxford COVID-19 Government Response Tracker
@BlavatnikSchool @PSIOxford
www.bsg.ox.ac.uk/events/covid-19-pandemic-celebrating-ser… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
On oseltamivir (tamiflu) it depends if you are talking about for influenza prophylaxis, mild influenza illness, or severe influenza disease. In which case I would say good, fair, poor respectively.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY trial wins the #mrcimpactprize
Outstanding Team Impact Prize
Congratulations & enormous thanks to everyone involved - front line staff in @NHSuk and elsewhere, patients and their relatives, funders @UKRI_News @NIHRresearch @wellcometrust, @FCDOResearch & trial team.
Julia Maddock
@JuliaRMaddock
#mrcimpactprize outstanding team impact prize goes to the recovery trial team. Congratulations to @PeterHorby and team for your amazing work @The_MRC
Peter Horby @peterhorby.bsky.social
@PeterHorby
Hugely informative and efficient trial that has improved care worldwide.
We did things differently: simpler, faster and cheaper.
Need to take forward lessons from RECOVERY to continue to improve care of patients with respiratory infections and other conditions. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
European scientists highlight worrisome H5N1 avian flu mutations | CIDRAP www.cidrap.umn.edu/avian-influenza-bird-flu/european-scie…
-
Peter Horby @peterhorby.bsky.social reposted
Gail Carson
@gail_carson
@ISARIC1 is delighted to welcome @icddr_b as our newest member. We look forward to working with you. 🙏🏻
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Delighted to be joining WHO R&D Blueprint meeting on integrating research into outbreak response.
Critically important and still much to do, but achievable with partnership, trust and resources. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Hugely exciting new opportunity - we're looking for a Chief Scientific Officer to help us create a safer world through science. @PSIOxford
Nowhere (in my opinion) has a more exciting research portfolio - Ebola, mpox, plague, MERS-CoV, Lassa, Nipah, bird flu, disease X +++
Pandemic Sciences Institute
@PSIOxford
We’re #hiring!
We're recruiting a Chief Scientific Officer, a critical role to support the Institute's Director in delivering our scientific strategy.
🗓️Applications close 17 March 2023
More details and apply 👇
www.psi.ox.ac.uk/opportunities/current-vacancies -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
We’re #hiring!
We're recruiting a Chief Scientific Officer, a critical role to support the Institute's Director in delivering our scientific strategy.
🗓️Applications close 17 March 2023
More details and apply 👇
www.psi.ox.ac.uk/opportunities/current-vacancies -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
"It's important to have women and people of all genders represented in science... because science looks to understand the way the world works and help to define it. And everybody needs to participate in that."
Listen to @PSIOxford's Laura Merton share her story this #iwd2023 👇
Nuffield Department of Medicine
@NDMOxford
"I've been fortunate to have a very international career and from 🇨🇦 to 🇨🇬, from 🇱🇰 to 🇿🇦, I've met brilliant #womenscientists who have served as great mentors" Laura Merson, Head of Data at @ISARIC1 on why a career in science is so fulfilling. #iwd2023
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
We’re bringing together some of the very best experts from @UniOfOxford and beyond to ensure the world is better prepared to counter future #pandemic threats.
This video from our friends @AKQA tells more of our story.
Watch the full-length film👇
www.development.ox.ac.uk/pandemic-sciences-instituteThis media couldn't be displayed. See it on the original post. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
New and Emerging Respiratory Virus Threats Advisory Group is recruiting independent scientific experts - an exciting opportunity to get involved in science-policy exchange. Closing date 20th March.
DHSC Public Appointments
@appointmentsDH
Members – New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)
The Department of Health and Social Care is looking to appoint five Members to the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). We are looking for cand…www.linkedin.com/feed/update/urn:li:ugcPost:7025846223823… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
NHS COVID-19 app saved estimated 10,000 lives in its first year, new research finds www.medsci.ox.ac.uk/news/nhs-covid-19-app-saved-estimated…
-
Peter Horby @peterhorby.bsky.social reposted
Paul Nuki
@PaulNuki
Best piece I have read on the evidence base for facemasks.
We should find a way to fill the evidence gap before the next pandemic or the mask wars will play out all over again
alasdairmunro.substack.com/p/how-to-not-be-completely-wro… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic opportunity - if thinking about getting involved, please apply. I can recommend it.
DHSC Public Appointments
@appointmentsDH
Members – New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)
The Department of Health and Social Care is looking to appoint five Members to the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). We are looking for cand…www.linkedin.com/feed/update/urn:li:ugcPost:7036336000352… -
Peter Horby @peterhorby.bsky.social reposted
DHSC Public Appointments
@appointmentsDH
Members – New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)
The Department of Health and Social Care is looking to appoint five Members to the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). We are looking for cand…www.linkedin.com/feed/update/urn:li:ugcPost:7036336000352… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
“I hope they make a vaccine, and if they do I want my children to take it."
Nice piece on the origins and continuing threat of Nipah virus, and the need for better diagnostics, drugs and vaccines.
www.telegraph.co.uk/global-health/science-and-disease/sur… -
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
🥇 | Congratulations to the Oxford-AstraZeneca team who recently received their Copley Medal from the Royal Society.
Announced in August 2023, this is the first time a whole team have been awarded the Society’s oldest award for scientific achievement, first awarded in 1731. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
So well deserved - Kenny is one of the very best clinical scientists in the world. Roslin are extremely lucky to have him. I have huge respect for the breadth and quality of his research and his humility and generosity, whilst holding down a challenging clinical role.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Bangladesh reports more Nipah virus cases cidrap.umn.edu/nipah/bangladesh-reports-more-nipah-virus-…
-
Peter Horby @peterhorby.bsky.social reposted
Medical Sciences
@OxfordMedSci
NEWS: A survey of over 2,000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic.
www.medsci.ox.ac.uk/news/covid-19-increased-public-trust-… -
Peter Horby @peterhorby.bsky.social reposted
DHSC Public Appointments
@appointmentsDH
Members – New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)
The Department of Health and Social Care is looking to appoint five Members to the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). We are looking for cand…www.linkedin.com/feed/update/urn:li:ugcPost:7025846223823… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
The WHO R&D Blueprint list of priority pathogens (from which this article is derived) specifically excludes influenza since these viruses have there own programme - leads to misrepresentation that they are not important. In my view zoonotic influenza viruses are greatest threat.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Same effort and determination now need to ensure vaccines and drugs are available in Mpox endemic settings in Africa.
Rick Bright
@RickABright
There wouldn’t be vaccine/drugs w/o decade of leadership of @BARDA, companies @BavarianNordic, @SigaTech, @chimerix, 1000s clinical trial volunteers, PAHPA & Project BioShield legislation, congressional $.
Collaboration, public-private partnerships save lives.
H/t & gratitude -
Peter Horby @peterhorby.bsky.social reposted
Charlotte Summers
@charlot_summers
Many of the best recruiting centres for COVID clinical trials in UK have been DGHs. As an example of a hub-spoke model, for HEAL-COVID, Weston-Super-Mare DGH has recruited brilliantly with support/collaboration with team at BRI. Although same trust, geographically separated..etc.
-
Peter Horby @peterhorby.bsky.social reposted
Louise Sigfrid
@louise_sigfrid
Sudan virus disease outbreak in Uganda: urgent research gaps #epidemic #preparedness @GloPID_R @Alice_J_Norton @SACochrane @GlobalHealthBMJ gh.bmj.com/content/7/12/e010982
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Nipah virus remains a rare but dangerous zoonotic infection for which we need better biological, epidemiological, socio-anthropological understanding, plus affordable near patient tests, treatments and vaccines.
@icddr_b @PSIOxford @CDCgov
Vinod Scaria
@vinodscaria
🔴Nipah Virus Disease / #bangladesh 🇧🇩
Child dies from #nipah virus disease in Rajshahi. The patient was from Pabna. A week earlier, a 35-year-old woman died suffering from Nipah virus disease at the hospital after drinking date juice.
#epidemicwatch
www.newagebd.net/article/192477/minor-boy-dies-of-nipah-v… -
Peter Horby @peterhorby.bsky.social reposted
Denis Wirtz
@deniswirtz
NIH funding for FY2022: Ranking of universities/institutions
1 Johns Hopkins U. $840M
2 UCSF $824M
3 Pitt $675M
4 Duke $673M
5 Penn $668M
6 Stanford $652M
7 U Michigan $644M
8 Leidos Biomed. Res. $625M
9 Wash U $621M
10 Columbia U $617M
(Source: NIH RePORT) -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Happy Lunar New Year. Wishing you all health and happiness.
Chúc Mừng Năm Mới
恭喜发财 -
Peter Horby @peterhorby.bsky.social reposted
Jake Dunning
@OutbreakJake
Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?
Excellent observations and recommendations from @ElsTorreele et al.
www.sciencedirect.com/science/article/pii/S1473309922008106
Free access link here: authors.elsevier.com/a/1gSEU5E-UoYvmg
@ERGO_Horby @PSIOxford -
Peter Horby @peterhorby.bsky.social
@PeterHorby
My first job as a qualified doctor was on these wards - tragic, inspiring and deeply motivating. Led me to dedicate my career to emerging infectious diseases.
Martyn Butler OBE
@Martyn_Butler
The Ward Revisited
The Broderip @ Middlesex Hosp was the first dedicated #aids ward in London opened in 87 by Princess Diana.
Exhibition: 6 Jan – 5 Feb
Open: Tues – Sat 11.00 – 18.00 and Sun 12.00 – 17.00
VIDEO: vimeo.com/787678327
More Info: www.fitzroviachapel.org/the-ward-revisited/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
The"emotional response" comment was referring to the early widespread use of CP outside of clinical trials, not the current debate about use in immunosuppressed patients. Had the early use been randomised we would not be having the debate as we would have a clear answer.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Not meant to criticise the current efforts to improve care in immunosuppressed patient.
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Congratulations to Prof Sarah Gilbert being awarded the @KingFaisalPrize 2023 🥇 It's great to see the #oxfordvaccine team's effort in the fight against #covid are being recognised.
Find out more 👉 www.ndm.ox.ac.uk/news/sarah-gilbert-awarded-2023-king-fai… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Whilst higher steroid doses didn’t help in COVID-19 patients requiring simple oxygen only, we are still evaluating in COVID-19 patients who require non-invasive or invasive ventilation.
Andrew Desio, PharmD BCPS BCCP BCCCP BCIDP
@PharmDFarmD
I was a little down that higher steroid doses didn’t help. Higher doses in septic/PNA cases not from Covid seemed to help, and additional immune modulation with with toci seemed helpful too - sad this didn’t translate to higher steroid doses doing more pubmed.ncbi.nlm.nih.gov/32043986/
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
We are proud to have @CIRGedinburgh in the RECOVERY team. Thank you.
Still more to do and learn in 2023: empagliflozin, sotrovimab, paxlovid, molnupiravir and high dose dex in COVID-19. Flu interventions opening in Scotland.
CIRG Edinburgh
@CIRGedinburgh
The #recoverytrial has successfully recruited over 48,000 participants and four treatments have been effective against COVID-19. We're quite proud to be a part in this trial and looking forward to continuing into 2023! @PeterHorby
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
The first FDA-approved monoclonal antibody to treat COVID-19.
"The FDA approval is based on the results from the RECOVERY trial"
www.gene.com/media/press-releases/14979/2022-12-21/fda-ap…
Peter Horby @peterhorby.bsky.social
@PeterHorby
>1 million people hospitalized with COVID-19 have been treated with Actemra and it is approved for severe COVID-19 in > 30 countries.
Shows the power of a large-scale pragmatic platform trial to efficiently generate actionable evidence that improves care.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Vitally important to ensure that availability and pricing ensures access to this treatment to everyone who needs it, wherever they live.
Yet again, huge thanks to everyone who contribute to RECOVERY - you have helped to save lives worldwide. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Ebola - what has changed?
“The doctors and nurses working there were pretty heroic and remarkable people… but they just didn’t have the environment to work in to make them successful. I guess that’s the polite way of putting it.”
www.telegraph.co.uk/global-health/climate-and-people/pitc… -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Research at the Outbreak of a Pandemic – thanking our donors www.medsci.ox.ac.uk/news/research-at-the-outbreak-of-a-pa…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
The patients were all hypoxic and nearly all (99%) were receiving oxygen.
Raj Mehta
@raj_mehta
I agree, but I have also seen a lot of community hospitalists & ICU docs use this dose, based on factors such as patient weight or perceived disease severity. 🤷🏽♂️
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
China's exit from zero-COVID strategy needs to be very carefully managed to minimise health and social impact. Opportunity to learn from experience of others - useful modelling from excellent Hong Kong colleagues.
www.medrxiv.org/content/10.1101/2022.12.14.22283460v1 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Oxford Ebola vaccine manufactured and shipped in record time by SII | University of Oxford
@OxfordVacGroup
@SerumInstIndia
@PSIOxford
www.ox.ac.uk/news/2022-12-15-oxford-ebola-vaccine-manufac… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY pre-print out.
In hypoxic hospitalised COVID-19 patients requiring either no oxygen or simple oxygen only, higher dose corticosteroids significantly increased the risk of death compared to usual care, which included low dose corticosteroids.www.medrxiv.org/content/10.1101/2022.12.16.22283578v1Post not available here, view on X
Peter Horby @peterhorby.bsky.social
@PeterHorby
Shows the critical importance of the right dose of corticosteroids in the right patients - more is not better in this patient group.
RECOVERY continues to assess higher dose corticosteroids in COVID-19 patients who require ventilatory support.
Peter Horby @peterhorby.bsky.social
@PeterHorby
A huge thank you to everyone who has, and continues to, contribute to RECOVERY. Through trials like this we will keep improving the care of COVID patients worldwide.
-
Peter Horby @peterhorby.bsky.social reposted
Srinivas Murthy
@srinmurthy99
Latest from @remap_cap in @JAMA_current
Longer-term outcomes in critically ill COVID19 patients.
In-hospital treatment effects durable out to 180 days, with even better data for anti-platelets on the longer term.
jamanetwork.com/journals/jama/fullarticle/2799870 -
Peter Horby @peterhorby.bsky.social reposted
Select Subcommittee on the Coronavirus Crisis
@COVIDOversight
Dr. @RickABright at final @COVIDOversight hearing:
"COVID will not be our last public health crisis. We must learn from the past and prepare for the future." -
Peter Horby @peterhorby.bsky.social
@PeterHorby
World Health Organization names Sir Jeremy Farrar as Chief Scientist, Dr Amelia Latu Afuhaamango Tuipulotu as Chief Nursing Officer www.who.int/news/item/13-12-2022-world-health-organizatio…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Nice succinct report showing huge challenge of developing MAbs with sustained potency against evolving SARs-CoV-2 spike. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB | NEJM www.nejm.org/doi/full/10.1056/NEJMc2214302
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
We're honoured to see the #covid RECOVERY Trial team nominated for the inaugural @The_MRC Impact Prize 🥇. Great to see the team's efforts being recognised.
@Oxford_NDPH, @PSIOxford
Find out more about the prize 👉 www.ndm.ox.ac.uk/news/oxford2019s-recovery-trial-team-amo… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic to see results from HEAL-COVID. Congratulations to the team.
Charlotte Summers
@charlot_summers
Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial. www.medrxiv.org/content/10.1101/2022.12.07.22283175v1
-
Peter Horby @peterhorby.bsky.social reposted
Jake Dunning
@OutbreakJake
Our study in CAR started before monkeypox became 'a thing' outside Africa in 2022. It's observational & only a small number recruited so far, but that in itself is a big achievement. Studying mpox & its treatment in rural CAR is far from easy. Amazing work by colleagues in CAR.
NEJM
@NEJM
Tecovirimat is an antiviral agent used to treat monkeypox. In this report, its use as part of an expanded access program in the Central African Republic is reported. www.nejm.org/doi/full/10.1056/NEJMc2210015
-
Peter Horby @peterhorby.bsky.social reposted
Evelyne_Kestelyn
@evelynekestelyn
Leave it up to @ThwaitesGuy to use a powerful #everest analogy to propose a new way forward to ‘make it #tb’s decade’ and suggest #collaborative & #sustainable trial platforms across LMICs…@OUCRU_Programme @MORUBKK @KEMRI_Wellcome
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
John Amuasi - a true emerging leader. Wish I could be there with you and other ALERRT colleagues and friends.
The Global Health Network
@info_TGHN
"Research is key to our collective survival" - John Amuasi bringing clarity of purpose to #tghn2022
-
Peter Horby @peterhorby.bsky.social reposted
Ben Kikaire
@bKikaire
Dr. Anani Badge from Ivory Coast presented parts of the FISSA study outputs @info_TGHN conference. The study was conducted by @ALERRT_Global partners in 15 sites in SSA. I coordinated the sites in East African region. ALERRT is funded by @EDCTP
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Exciting new approach using multivalent mRNA technology. Mega multivalent vaccination is not new and not to be scared of - see 17 and 23 component pneumococcal vaccines.
Universal flu vaccine may be available within two years, says scientist www.theguardian.com/society/2022/nov/25/universal-flu-vac… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
NHS faces ‘perfect winter storm’ with tenfold rise in hospital flu cases www.theguardian.com/politics/2022/nov/24/nhs-winter-10-ti…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Oxford’s Ebola vaccine recommended for deployment against Uganda outbreak | University of Oxford www.ox.ac.uk/news/2022-11-17-oxford-s-ebola-vaccine-recom…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great new opportunity to join our fantastic team at a very exciting time.
Pandemic Sciences Institute
@PSIOxford
#psi is hiring a Senior Biostatistician - for more details: my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa…
-
Peter Horby @peterhorby.bsky.social reposted
BBC News Africa
@BBCAfrica
One man in Uganda's Mubende district has lost eight family members to the country's recent Ebola outbreak. Find out how he and others are trying to cope with the spread of the deadly virus, and a continued lockdown👇🏾
To understand more 👉🏾 www.bbc.co.uk/news/world-africa-63080543 -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
#on Sat 29th Oct at Oxford Brookes @ScienceBazaar we challenged the public to save the world with our 'What if?' scenario of the popular board game Pandemic @Zmangames_ highlighting the work of Professor Dame Sarah Gilbert's group at the PSI @VaccineTrials #
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Pandemic Sciences Institute @PSI delighted to be hosting @WHOGOARN UK partners day tomorrow. Welcoming GOARN, a long-standing contributor to global health security. Operational research and rapid response capacity on the agenda.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Uganda’s Ebola outbreak projected to kill 500 as response repeats mistakes of Wuhan www.telegraph.co.uk/global-health/science-and-disease/uga…
-
Peter Horby @peterhorby.bsky.social reposted
Charlotte Summers
@charlot_summers
Flu is on the rise in the UK. If you are eligible for a vaccination, please consider getting one.
www.gov.uk/government/news/national-flu-and-covid-19-surv… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Scandalous that so little is done about diseases like monkeypox until high income countries are affected.
But there has been international cooperation to try to improve the situation:
See BMJ article www.bmj.com/content/377/bmj.o1321.long
Plus a clinical trial has started in DRC NCT05559099 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great news for @globaldothealth and global health. Well done Moritz Kramer and colleagues
Pandemic Prevention Initiative
@PPI_Insights
1/ Today, @RockefellerFdn announced $3 million in new funding for @globaldothealth – a leading open-source platform for scientific pandemic data – to expand international partnerships and modernize the global effort for coordinated pandemic prevention, surveillance, and response.
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Embark on your new journey in medical science with us. We offer 120 places on doctoral and taught Masters’ programmes.
Details here: www.ndm.ox.ac.uk/study -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Benefits of Streamlined Trial Designs: Lessons Learned From UK RECOVERY Study - “simplicity and clarity enable adequate sample sizes for reliable estimates of outcome and encourage participation of clinicians and patients—all at a low cost per participant” jamanetwork.com/journals/jamainternalmedicine/fullarticle…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Zoonotic influenza remains a complex and constant threat.
Vietnam reports first avian flu infection in 8 years. Thoughts are with the family.
#https://www.cidrap.umn.edu/news-perspective/2022/10/vietnam-reports-first-avian-flu-infection-8-years -
Peter Horby @peterhorby.bsky.social
@PeterHorby
New placebo controlled trial results do not support the use of ivermectin in outpatients with mild to moderate COVID-19. Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 jamanetwork.com/journals/jama/fullarticle/2797483
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Retweeting this as Mike Ryan is telling a hugely important story. It is horrific that social media made him feel "more at risk" than working in war-zones and on very dangerous infections. As he points out, how does a teenager feel?
Mrigank Shail, MD
@mrigankshail
"We haven't actually created communication platforms. We haven't created engagement platforms. We've created lots of shouting platforms...We've ended up in a world of soundbites, not a conversation, not a dialog." @WHO's @DrMikeRyan shares why social media feels unsafe. #whs2022
-
Peter Horby @peterhorby.bsky.social reposted
Oxford Vaccine Group
@OxfordVacGroup
Ebola in Uganda: An Ebola vaccine designed by our @jenneratingVacc is one of two that could be trialled later this month, this outbreak has caused by a relatively rare strain of the virus is escalating rapidly.
This is a rare type of Ebola which has not been recorded since 2012. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Just out: fascinating read paper on the experiences of the Data Monitoring Committee for the RECOVERY trial.
A good DMC are critically important but usually unsung - the RECOVERY DMC has made a hugely important contribution.
rdcu.be/cXSeD -
Peter Horby @peterhorby.bsky.social
@PeterHorby
#ukhsa22 conference in sunny Leeds. Fantastic talks to a large, enthusiastic audience. Great to see the energy, youth and a bright future for the #ukhsa. CMO talking about pandemics and the “extraordinary power of science”.
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Access to the best training shouldn’t depend on where you are in the world. Our new online PGDip in #globalhealth Research from @TropMedOxford and @info_TGHN will open doors for researchers in low and middle-income countries.
Find out how to apply 👉 www.ndm.ox.ac.uk/about/news/online-postgraduate-diploma-t… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great news - Monkeypox Treatment Trial Begins in the Democratic Republic of the Congo. We are now on track to have clear evidence on efficacy of tecovirimat in both major monkeypox virus clades. www.niaid.nih.gov/news-events/monkeypox-treatment-trial-b…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Always a pleasure to hear and learn from you Larry. Come again soon.
Lawrence Gostin
@LawrenceGostin
My deep gratitude to my dear @UniofOxford friends for all I learned on pandemics during my Astor Lectures. Medical humanities has a rich tradition: Mark Harrison & @EricaCharters (history) @ImogenGoold (law) @michaelethox (ethics) @PeterHorby (science). #covid19 changed the world
-
Peter Horby @peterhorby.bsky.social reposted
IDDO @iddonews.bsky.social
@IDDOnews
Standardised #covid19 clinical data collection helps inform clinical decisions and public health responses. Contribute and request access to COVID-19 data held in the IDDO @ISARIC1 data sharing platform www.iddo.org/covid19/data-sharing @LSHTM @TropMedOxford @wellcometrust
📷@NIH -
Peter Horby @peterhorby.bsky.social
@PeterHorby
We’re hiring! Exciting new position as head of communications for the Pandemic Sciences Institute. Join a fabulous team on an awesome journey!
Pandemic Sciences Institute
@PSIOxford
#psi now hiring Head of Communications. For further details: my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Experience with COVID-19 can help us optimise immunomodulatory strategies in other inflammatory infectious diseases. As always, randomised trials needed.
Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone
/eid/article/28/10/22-0625_article -
Peter Horby @peterhorby.bsky.social reposted
Professor Chris Whitty
@CMO_England
COVID-19 and 'flu will be circulating this winter.
Immunity wanes over time. The new COVID vaccines add protection against Omicron.
Vaccines are widely available for the vulnerable. If you are eligible please get vaccinated for COVID and 'flu.
Department of Health and Social Care
@DHSCgovuk
Book your autumn Covid booster now if you are:
🔷 aged 65 and over
🔷 pregnant
🔷 at higher risk due to a health condition
🔷 immunosuppressed
🔷 a frontline health and social care worker
🔷 an unpaid carer
More ⤵️
www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-va… -
Peter Horby @peterhorby.bsky.social reposted
Michael Marks
@dr_michaelmarks
How do self collected swabs for #monkeypox perform? Our preprint says well! www.medrxiv.org/content/10.1101/2022.09.19.22280087v1 Opens door to remote monitoring inc. in trials
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
#psi is now hiring Senior Clinical Research Manager
For further details: my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa… -
Peter Horby @peterhorby.bsky.social reposted
Ministry of Health- Uganda
@MinofHealthUG
Uganda confirms an outbreak of Ebola Virus Disease (EVD) in Mubende District, Uganda.
The confirmed case is a 24 year old male a resident Ngabano village of Madudu Sub County in Mubende District presented with EVD symptoms and later succumbed. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
#amileforthequeen the royal mile covered in flowers would be a fitting tribute
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Great news from NDM's @JennerInstitute: the R21 #vaccine could help to reduce deaths from #malaria by 70% by 2030 and eradicate it by 2040.
BBC News (UK)
@BBCNews
New malaria vaccine is world-changing, say scientists www.bbc.com/news/health-62797776
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
A NEW Oxford clinical trial to test Tecovirimat a treatment for #monkeypox is OPEN!
If you've been diagnosed with monkeypox and still have symptoms, you might be eligible. Check out the website for more details 👇👇
platinumtrial.ox.ac.uk56 Dean Street
We're participating in this vital research into a potential new treatment for monkeypox
If you've been diagnosed with monkeypox and still have symptoms, you might be eligible. Check out the website for more details 👇👇
www.platinumtrial.ox.ac.uk -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Legionella seems to be confirmed as cause of outbreak in Argentina - "and relax"
www.who.int/emergencies/disease-outbreak-news/item/2022-D…
Peter Horby @peterhorby.bsky.social
@PeterHorby
Cases of severe pneumonia of unknown aetiology reported from Argentina.
Cases in healthcare workers are a concerning signal - could indicate person-to-person transmission or a point source (such a legionella).
www.paho.org/en/documents/informative-note-cases-pneumoni… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
If Legionella is confirmed as the cause of the pneumonia cases in Argentina, this is good news for public health. Common organism, common to see outbreaks, not more than a localised threat, treatable, and we know how to neutralise the source.
Tulio de Oliveira
@Tuliodna
Argentina health department confirmed the ‘unknown pathogen’ of the pneumonia cases as Legionela pneumonia bacteria today. Fast action and transparency to fight outbreaks. Genomes should follow in the next few days 🇦🇷 www.eltucumano.com/noticia/actualidad/284759/el-malbran-c…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Cases of severe pneumonia of unknown aetiology reported from Argentina.
Cases in healthcare workers are a concerning signal - could indicate person-to-person transmission or a point source (such a legionella).
www.paho.org/en/documents/informative-note-cases-pneumoni… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
If UK wants to be a science superpower, we need to take a leaf out of the Australian play-book. Just look at the investments outlined in this piece.
Melbourne launches multimillion-dollar centre for pandemic treatments todayuknews.com?p=909150
Peter Horby @peterhorby.bsky.social
@PeterHorby
And this...
www.theguardian.com/science/2022/aug/27/kate-bingham-ex-v… -
Peter Horby @peterhorby.bsky.social reposted
Angela Rogers
@AJRogers_ICU
Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinical worsening & longer time to discharge. It highlights the need for targeted anti-viral trials in severe COVID. www.acpjournals.org/doi/epdf/10.7326/M22-0924
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
First trial of antiviral monkeypox drug that could speed recovery begins in UK www.theguardian.com/world/2022/aug/23/first-trial-antivir…
-
Peter Horby @peterhorby.bsky.social reposted
Kai Kupferschmidt
@kakape
The principal investigators behind the RECOVERY trial (for #covid19 treatments) have now started a trial testing tecovirimat (tpoxx) for the treatment of #monkeypox. First patient was enrolled on Friday.
"This is the first ever trial in patients with monkeypox", says @PeterHorby. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
First ever treatment trial for #monkeypox now open for people in the UK with active disease.
Please visit our website platinumtrial.org and talk with your doctor.
We are accepting confidential referrals from anywhere in the UK.
@Oxford_NDPH
@NDMOxford
@PSIOxford
@NIHR
Oxford Population Health (OxPop)
@Oxford_NDPH
NEW Oxford clinical trial to test a treatment for #monkeypox launches
Visit the PLATINUM trial website ➡️ platinumtrial.ox.ac.uk
📽️ Watch Sir Peter Horby introduce PLATINUM: youtu.be/KFAvu1dEBcg
@UniofOxford @NDMOxford @PSIOxford @NIHRresearch -
Peter Horby @peterhorby.bsky.social reposted
Oxford Population Health (OxPop)
@Oxford_NDPH
NEW Oxford clinical trial to test a treatment for #monkeypox launches
Visit the PLATINUM trial website ➡️ platinumtrial.ox.ac.uk
📽️ Watch Sir Peter Horby introduce PLATINUM: youtu.be/KFAvu1dEBcg
@UniofOxford @NDMOxford @PSIOxford @NIHRresearch -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Important initiative: too few good treatments for influenza, none proven effective in severe influenza, significant annual burden, major pandemic threat.
#recoverytrial team are committed to improving outcomes in patients with influenza, and will be applying.
National Institute for Health and Care Research
@NIHRresearch
NEW #researchfunding opportunity: Could you lead a platform study to evaluate therapeutic interventions for patients admitted to hospital with Influenza?
Find out more and apply: www.nihr.ac.uk/funding/22124-a-platform-trial-to-evaluate… -
Peter Horby @peterhorby.bsky.social reposted
Julia Epi
@EpiJulia
The role of vaccination and public awareness in medium-term forecasts of monkeypox incidence in the UK
Paper: doi.org/10.1101/2022.08.15.22278788
Code: github.com/SamuelBrand1/MonkeypoxUK
Authors: @SamBrand101, @JoeBHilton, @LGuzmanRincon, @TAH_Sci, @MattJKeeling, @nokesdj
#julialang #epitwitter -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY Update:
1 trial
10 answers
More to come
Impossible without the 48,000 people who have taken part.
Thank you.
You have made such a difference to millions of patients & their families all around the world
...and still we continue the search for even better treatment -
Peter Horby @peterhorby.bsky.social reposted
Kai Kupferschmidt
@kakape
I think this link should work for non-subscribers (I hope): www.nytimes.com/2022/08/04/opinion/monkeypox-communicatio… www.nytimes.com/2022/08/04/opinion/monkeypox-communicatio…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Monkeypox: how will we know if the treatments work? - The Lancet Infectious Diseases www.thelancet.com/journals/laninf/article/PIIS1473-3099(2…
-
Peter Horby @peterhorby.bsky.social reposted
The Lancet
@TheLancet
The ongoing #monkeypox outbreak has been declared a Public Health Emergency of International Concern.
Now is a key moment. It warrants the strongest medical, scientific, and political global effort.
More in our latest issue: www.thelancet.com/journals/lancet/issue/vol400no10349/PII… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
A joint action plan for elimination of person to person transmission of monkeypox globally.
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
I see one after another state of emergency being declared for cities, states. What about getting together with cities globally that have had a big voice in HIV prevention and figuring out a joint action plan? That includes looking at safety around big events, stigma etc
-
Peter Horby @peterhorby.bsky.social reposted
Medical Sciences
@OxfordMedSci
OPEN Fellowships 2022: Call for applications now open!
Upto £20K available to enable researchers to collaborate with policymakers - exploring mutual interests and generating benefits to research, policy and the wider world. Deadline: Mon 10 Oct.
➡️ www.ox.ac.uk/research/support-researchers/policy-engageme… -
Peter Horby @peterhorby.bsky.social reposted
RECOVER
@RECOVER_EUROPE
Congratulations to @ISARIC, one of our partners in @RECOVER_EUROPE, for their new report on #covid19 data. The paper focuses on a prospective, standardised, global dataset of patients that were hospitalised with the #sarscov2 virus. @NaturePortfolio www.recover-europe.eu/recovers-partner-isaric-published-r…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great opportunity to join the new Pandemic Sciences Institute @PSIOxford - seeking an enthusiastic person to help coordinative our emerging Nipah virus programme.
Great team, exciting new Institute, fascinating diseases - what more could you ask for?
Pandemic Sciences Institute
@PSIOxford
PSI is now hiring a Nipah Project Manager. For further details - my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies.
Little progress been made over the last 30 years. Clinical trials to improve treatment of Lassa fever are way overdue.
wwwnc.cdc.gov/eid/article/28/8/21-1787_article via @CDCgov -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Sleepwalking into the next pandemic | “Epidemics and pandemics can be prevented if research capacity is boosted for emerging infections. There is no excuse for failure.”
So true, but key is in the co-creation of capabilities that solve day to day problems
www.nature.com/articles/s41591-022-01918-9 -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY publication in @TheLancet
Baricitinib reduces risk of death in patients hospitalised for COVID-19.
514/4148 (12%) pts allocated to baricitinib vs
546/4008 (14%) pts allocated to usual care
died within 28 days
(age-adjusted rate ratio 0·87; 95% CI 0·77–0·99; p=0·028). -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Said it before: elimination of person-to-person transmission of monkeypox must be the explicit public health goal. I.e. say it, plan it, and do it.
World Health Organization (WHO)
@WHO
"This is an outbreak that can be stopped, if countries, communities and individuals inform themselves, take the risks seriously, and take the steps needed to stop transmission and protect vulnerable groups"-@DrTedros #monkeypox
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Baricitinib in patients admitted to hospital with COVID-19. The total randomised evidence to date suggests that JAK inhibitors reduce mortality in patients hospitalised for COVID-19 by about one-fifth. www.sciencedirect.com/science/article/pii/S0140673622011096
-
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
The Good Clinical Trials Collaborative has produced guidelines on what makes a Good Randomised Clinical Trial.
Multi-sector, multi-discipline, multi-national, and multi-dimensional co-development & consultation.
Principles not Process
www.goodtrials.org/guidance -
Peter Horby @peterhorby.bsky.social reposted
David Spiegelhalter
@d_spiegel
Why there should have been more high-quality evaluations of public health measures
Alasdair Munro
@apsmunro
A recent article in BMJ EBM claimed we should accept mechanistic studies as a higher form of evidence for “complex systems”
This is wrong
Failing to generate better quality evidence on NPIs was undoubtedly one of the biggest mistakes of the pandemic
alasdairmunro.substack.com/p/the-pandemic-evidence-failur… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Come on @wellcometrust @WHO - the ambition must be elimination of person to person transmission, in all countries.
Wellcome
@wellcometrust
The monkeypox response must include:
⚫️ Support for more research
⚫️ Strengthened disease surveillance
⚫️ Contact tracing
⚫️ Equitable access to tests, treatments and vaccines for those most at risk
[4/4] -
Peter Horby @peterhorby.bsky.social
@PeterHorby
WHO declares highest alert over monkeypox - BBC News www.bbc.co.uk/news/health-62279436
-
Peter Horby @peterhorby.bsky.social reposted
Dr. Glaucomflecken
@DGlaucomflecken
An American experiences universal health care
This media couldn't be displayed. See it on the original post. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
A multi-country study of monkeypox being launched – first cases enrolled in Geneva www.tropicalmedicine.ox.ac.uk/news/a-multi-country-study-…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Absolutely, must be aiming at elimination in newly affected countries without a zoonotic reservoir.
Adam Kucharski
@adamjkucharski
In theory, monkeypox should be at the 'easier' end of the spectrum in terms of outbreak control. But the reality is proving very different – and we really don't want it to become established in multiple new countries...
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Squeezed in Oxford too - in fact clawing money back. MRC and NIHR not even allowing us to use RECOVERY trial underspend to continue the trial “UKRI and DHSC/NIHR have not planned to extend funding beyond November 2022 so any underspend at this point will need to be reclaimed”
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Love this cycle superhighway - huge improvement. Thank you. Illegal parking outside Magdalen continues to be a hazard, I’ve personally witnessed two serious accidents there. Come on Magdalen, sort it out.
Christophe Fraser Group
@ChristoPhraser
Thanks for your efforts! It’s improved my daily commute. This was a spot with occasional car road rage, so really appreciate it. St Aldates still awful, and cycling past @magdalenoxford always features at least one illegally parked delivery truck in cycle lane. Keep them coming!
-
Peter Horby @peterhorby.bsky.social reposted
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Always important to beware. Good they picked this up
10 News Queensland
@10NewsQLD
#breaking: Queensland has detected its first case of Hendra virus in five years.
-
Peter Horby @peterhorby.bsky.social reposted
George Freeman MP. FRGS. FRSA.
@MPGeorgeFreeman
Ministers should set the highest standards in office.
I’m sorry but this is appalling conduct for a Minister of the Crown.
This is exactly why we need a new Prime Minister: to restore the Ministerial code & respect for the responsibilities of service in public office.
David Lammy
@DavidLammy
Is it too much to ask in @BorisJohnson Britain that the new Education Minister set an example to our nations children and not show the general public her middle finger.
-
Peter Horby @peterhorby.bsky.social reposted
Nicole Mather
@NicoleMatherLS
I am delighted that @IBM is a founding technology partner of @PSIOxford driving accelerated discovery through the convergence of AI, High Performance Computing & Quantum-to enable preparedness for future patients - excited to work with @ChristoPhraser @PeterHorby @UK_Life_Science
Pandemic Sciences Institute
@PSIOxford
We now welcome our UK #pandemic science partners to hear about offering & aspirations to accelerate understanding and insights by generating actionable knowledge and data (from pathogens through to patients and populations) at launch of @PSIOxford
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
So true. Don't know whether to laugh 😆, cry 😢, or just be angry 😤
Andrés Pizzorno
@PizzornoAndres
-
Peter Horby @peterhorby.bsky.social reposted
Kevin Fenton
@ProfKevinFenton
Thanks to @Dr_D_Robertson for compiling @ONS data on the recent epidemiology. They illustrate the gradual and sustained increases being observed in the prevalence of COVID infection, by different geographies and across different age-groups.
Dr Duncan Robertson
@Dr_D_Robertson
In case people have been distracted, Covid rates *are still increasing* with *1 in 25* and *1 in 19* who would have tested positive last week: rises in all regions in all age groups
Leading to increased hospitalizations and increased numbers in hospital
www.ons.gov.uk/peoplepopulationandcommunity/healthandsoci… -
Peter Horby @peterhorby.bsky.social reposted
WHO African Region
@WHOAFRO
Ghana has announced the preliminary finding of two cases of #marburg virus disease and if confirmed these would the first such infections recorded in the country
➡️ www.afro.who.int/countries/ghana/news/ghana-reports-first… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Another RCT not showing benefit of convalescent plasma (CP) in patents hospitalised with COVID-19. Why was so much CP used outside of RCTs?
journal.chestnet.org/article/S0012-3692(22)01201-6/pdf
PMID: 32492084 / 33232588 / 34000257 / 34504336 / 34901997 / 33093056 / 34464358 / 34606578 / 33974559 -
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
It will be great to have you join us today @NDMOxford
@PSIOxford will harness the @UniofOxford research excellence as well as its global research collaborations between academia, industry and governments – all of whom are represented here today at the launch #globalhealth
Nuffield Department of Medicine
@NDMOxford
Today we are excited to attend the launch of @PSIOxford, sitting within the wider @UniofOxford sphere with an aim to safeguard #health economic stability for future generations – through scientific leadership and a global perspective #healthforall
-
Peter Horby @peterhorby.bsky.social reposted
Pandemic Sciences Institute
@PSIOxford
Prof. Dame Jenny Harris, Chief Executive at UK #health Security Agency, joins us, acknowledging “this is a really enabling moment” at the launch of @PSIOxford #pandemic #globalhealth
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great paper on human cases of H5N6 avian influenza. At least 13 types of reassortant H5N6 viruses have infected humans in China.
Feels like a long game of avian influenza roulette - must not be complacent, these viruses remain a major global health threat. wwwnc.cdc.gov/eid/article/28/7/21-2482_article -
Peter Horby @peterhorby.bsky.social
@PeterHorby
We have seen the irreversible drift to standard of care many times - not only is it potentially wasteful or even harmful, it also blocks the evaluation of new drugs since the standard of care has unknown efficacy
Martin Landray
@MartinLandray
Hype-based Medicine
vs.
Evidence-based Medicine
A very nice summary from @KariTikkinen -
Peter Horby @peterhorby.bsky.social reposted
Oliver Morgan
@OWMorgan
What is Pandemic and Epidemic Intelligence?
Read our recent paper in @NatureMedicine rdcu.be/cQzxN
Find out more about the #whopandemichub -
Peter Horby @peterhorby.bsky.social
@PeterHorby
GOARN has been a huge success and deserves all our support. Congratulations Gail and Dr Mohannad
GOARN
@WHOGOARN
@WHOGOARN welcomes @DrGailCarson @ISARIC1 & @DrMohannadAlNsour @EMPHNET as our new leadership team in the Steering Committee. They were unanimously selected as Chair & Vice Chair for the next two years to shape a stronger & more impactful network. #oneworldoneresponse
-
Peter Horby @peterhorby.bsky.social reposted
rani – Resilience Action Network International
@rani_action
"It is our position that when the smallpox vaccines are released to address monkeypox, it should start here in Africa, where the burden is larger, the risk higher and the geographical spread is also broader." @AfricaCDC's @laktarr001
www.reuters.com/world/africa/africa-reports-1597-suspecte… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Powerful, moving story from a brave couple. This is why we do clinical trials - simply to save and improve lives.
Medical Research Council
@The_MRC
The #recoverytrial discovery of dexamethasone two years ago as an effective treatment in cases of severe #covid19 has saved many lives - including John Hanna's.
Watch the full film here: www.youtube.com/watch?v=ZNuvzBqba1Y #covidresearchThis media couldn't be displayed. See it on the original post. -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
Interesting to see data on rising flu cases from Australia. Often a bellwether for Europe later in the year.
Would seem wise to have a platform trial for severe influenza up and running in advance of the likely surge.
RECOVERY trial could do this if funding permitted. -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
Here is what we have all achieved together in the RECOVERY trial
... and we keep going, studying new treatments for COVID-19, expanding internationally, and planning trials to tackle the burden of severe influenza and many other common diseases -
Peter Horby @peterhorby.bsky.social
@PeterHorby
@Garmin @garminfitness great watches - except the strap retainers are rubbish - me and two friends, all resorted to hair ties / elastic bands - otherwise watch will fall off and lost in sea forever.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic new opportunity to join us at the Oxford Pandemic Sciences Institute - can guarantee it's not boring!
Science writer position @PSIOxford
my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa… -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
P values are to trial results…
what the thermometer is to cooking.
They can tell you how hot it is…
but they don’t tell you how good it is (neither taste nor consistency).
Tommaso Scquizzato, MD
@tscquizzato
Study categorisation from @pocock_stuart at #pratoanaes2022
➡️ WOW! and PHEW! interpreted the same but very different
➡️ PHEW! and DAMN! interpreted differently but virtually the same
We need to get wiser, a p-value is no substitute for brain. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great opportunity to join our exciting new Pandemic Sciences Institute at Oxford.
Pandemic Sciences Institute
@PSIOxford
Now hiring a Scientific Writer @PSIOxford - further details can be found: my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
(No beneficial) Effect of Early Treatment with Ivermectin among Patients with Covid-19 | NEJM www.nejm.org/doi/full/10.1056/NEJMoa2115869
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Monkeypox - African scientists know what the world is up against. “It’s as if your neighbor’s house is burning and you just close your window and say it’s fine,” www.science.org/content/article/monkeypox-is-a-new-global…
-
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
Serious outbreak to be taken seriously.
Time for good public health approach, including detection, application of interventions we know work, and randomised trials of things we think might work (but don’t know yet).
This is not COVID but there are lessons from COVID.
Kevin Fenton
@ProfKevinFenton
THIS!! Important @UKHSA monkeypox update:
By 30 May, 190 U.K. cases were confirmed, with 183 in England. 86% of the cases were London resident. Most (87%) cases aged 20-49 years and 111 cases were gay, bisexual, or other men who have sex with men. www.gov.uk/government/news/ukhsa-latest-findings-into-mon… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Influenza will undoubtedly be back, possibly with vengeance.
We need to take forward the lessons from COVID to also tackle the annual scourge and pandemic threat of influenza.
#recoverytrial - #influenza -
Peter Horby @peterhorby.bsky.social
@PeterHorby
I hope the rhetoric will be matched with real investment. Words and actions are so often poles apart.
Jeremy Farrar
@JeremyFarrar
Very strong support for @WHO , @ACTAccelerator & all partners, inclusive multilateralism,commitment Global Health professionals, Surveillance & Data, R&D& Distributed Manufacturing & sustained predictable funding for & beyond pandemics. www.who.int/initiatives/act-accelerator/about
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Clinical features and management of human monkeypox. Important reflections on two antivirals given for monkeypox.
But we must remember that there is no robust evidence of efficacy of either drug in humans with monkeypox.
www.thelancet.com/journals/laninf/article/PIIS1473-3099(2…
Peter Horby @peterhorby.bsky.social
@PeterHorby
These drug have been approved for use under exceptional circumstances based only on efficacy data in animal models and safety data in healthy human volunteers.
This was only permitted because trials in humans were thought not to be possible.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Now that clinical trials are possible, we must take this opportunity to properly evaluate safety & efficacy in human disease.
If we do not, we risk being locked into using drugs of unproven effectiveness forever.
Unknown benefit, unknown harm, unknown cost-effectiveness. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Waking up to monkeypox - great piece from Piero Olliaro @PSIOxford @ISARIC1 & Emmanuel Nakoune @I_P_Bangui
Mustn't neglect health threats like monkeypox only until they are at our door. Health for all and research for all.
sciencwww.bmj.com/content/377/bmj.o1321 -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
This is fantastic news. Important not just for this pandemic and next but right the way across the spectrum of threats to individual and public health.
Robust evidence from clinical trials is critical to informed treatment decisions.
Efficiency, diversity, quality ✔️
Mary De Silva
@MaryDeSilva5
So proud to announce that the UK-Argentina proposed resolution on strengthening #clinicaltrials has been passed by the #worldhealthassembly Committee @WHO @DHSCgovuk @MartinLandray apps.who.int/gb/ebwha/pdf_files/WHA75/A75_ACONF9-en.pdf
-
Peter Horby @peterhorby.bsky.social reposted
Jake Dunning
@OutbreakJake
Clinical features and management of human monkeypox: a retrospective observational study in the UK www.thelancet.com/journals/laninf/article/PIIS1473-3099(2…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Got a new rash? Helpful piece on monkeypox rash and differentiating different types of rash
www.bbc.co.uk/news/health-61551164 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Someone said “monkey flu” to me today.. add that to the list of priority pathogens too
Jake Dunning
@OutbreakJake
So true, apart from the monkeycoronapox hybrid bit. I would never say that (well, maybe as a joke, and only to the right people who would know I am joking and appreciate the joke). #idtwitter
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Monkeypox epidemiology - is the simultaneous detection of multiple cases in multiple locations more consistent with dispersion from a single super-spreading event (such as a festival), or from multiple unrecognised chains of community transmission?
Post not available here, view on X
Peter Horby @peterhorby.bsky.social
@PeterHorby
Shoe leather epidemiology will sort this out. Initiation from a super spreading event would be reassuring and indicate control will be easier.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Also phylogenetics will help - the more similar the sequences are, the more likely they come from same source. Although relative stability of monkeypox virus may make this less informative. View from phylogenetic experts on this would be helpful.
-
Peter Horby @peterhorby.bsky.social reposted
Oxford Giving
@OxfordGiving
The donation will drive forward several core research strands, provide support for doctoral students, and secure the future of a number of academic leadership posts @PSIOxford, including those held by Professors @PeterHorby and @ChristoPhraser.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Major boost for Oxford’s mission to counter future pandemic threats
This extremely generous gift from the Moh Family Foundation launches the Pandemic Sciences Institute as a global asset to strengthen health security for all @PSIOxford
www.ox.ac.uk/news/2022-05-19-major-boost-oxford-s-mission… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Read up, and then don't speculate wildly please
Adam Kucharski
@adamjkucharski
Note to COVID Twitter commentators suddenly pivoting to MPX: if you hadn't heard of monkeypox until very recently, please step away from the keyboard and read up a bit before speculating wildly.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Infectious diseases - always expect the unexpected. Whilst monkeypox is on our radar and we are working on this @PSIOxford @ISARIC1 with colleagues in the Central African Republic @I_P_Bangui - would not have anticipated this. Now transferring learning from Africa to Europe.
UK Health Security Agency
@UKHSA
NEWS 📣: We've detected 2 additional cases of #monkeypox, one in London and one in the South East of England, bringing the total number of monkeypox cases confirmed in England since 6 May to 9, with recent cases predominantly in gay, bisexual or men who have sex with men.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Many diseases that must not fade into the long shadows of the last pandemic (as so often happens)
Maria Van Kerkhove
@mvankerkhove
🆕Another high threat CoV—Middle East respiratory syndrome coronavirus (#mers)—has not gone away either…
Surveillance for MERS-CoV, SARS-CoV-2, flu needs to continue/be supported/enhanced - linking to strong public health actions that save lives. @WHO
www.who.int/emergencies/disease-outbreak-news/item/2022-D… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
First patient recruited to RECOVERY trial in India. Congratulations and thanks to all at ICMR and All India Institute of Medical Sciences Rishikesh
@ICMRDELHI
@FCDOResearch
@aiimsrishi
@wellcometrust -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Get vaccinated - it is incredibly effective in preventing severe COVID.
Rate of admission to critcal care with confirmed COVID-19 by vaccination status for patents admitted 1 May 2021 to 31 January 2022 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
I feel a horror movie coming on….
nature
@Nature
Young brain fluid improves memory in old mice go.nature.com/3FASGnM
-
Peter Horby @peterhorby.bsky.social reposted
Andy Conway Morris 🇬🇧🇪🇺🇺🇦
@andymoz78
As a state-school educated lad who teaches undergraduates at Cambridge I can safely tell both Allison and Emma that this is utter b***cks
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
The effect of hand hygiene frequency on reducing acute respiratory infections in the community: a meta-analysis
Epidemiol Infect. 2022 Mar 21;150:e79.
Relative risks of acquiring respiratory tract infection per day with one hand wash or 1 h of face mask worn.
Prof. Akin Abayomi
@ProfAkinAbayomi
Handwashing has always been one of the most effective ways of preventing disease.
It is a simple gesture that delivers huge returns in terms of keeping us healthy and safe. Handwashing is also an important component in COVID-19 prevention. -
Peter Horby @peterhorby.bsky.social reposted
Prof. Akin Abayomi
@ProfAkinAbayomi
Handwashing has always been one of the most effective ways of preventing disease.
It is a simple gesture that delivers huge returns in terms of keeping us healthy and safe. Handwashing is also an important component in COVID-19 prevention. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
This, + multidimensional other harms - lost schooling, decreased GDP, missed vaccinations, mental health, lost foreign investment for poorest countries, more people pushed into poverty, food insecurity, global distrust etc
Never again: invest properly in prevention
World Health Organization (WHO)
@WHO
The total number of deaths associated with #covid19 worldwide from 2020-2021 may be closer to 14.9 million: New estimates by WHO & @UNDESA.
That’s 9.5 million more deaths than reported www.who.int/news/item/05-05-2022-14.9-million-excess-deat… #healthdata -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Congratulations Martin. Nice tie!
Martin Landray
@MartinLandray
Yesterday was an extraordinary day.
A visit to Buckingham Palace to receive a knighthood from HRH The Princess Royal.
Accompanied by my wonderful wife.
And joined afterwards by my amazing children. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Annual meeting of the African Coalition for Epidemic Research, Response and Training (ALERRT) in Entebbe, Uganda. Fantastic event, with wonderful colleagues and friends.
Peter Horby @peterhorby.bsky.social
@PeterHorby
So much achieved in preparedness and response (Lassa, Ebola, Monkeypox, COVID). Much more still to do.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Remdesivir associated with mortality benefit in non-ventilated COVID patients.
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
“spreads” is the wrong word - cases have been detected elsewhere. We have no certainty the cause is an infection and if it is whether it is ‘spreading’ or occurring simultaneously in different locations due to concurrence of necessary conditions.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Ebola raises ahead again in DRC. DRC authorities have extensive expertise, so hopefully this will be controlled quickly. Ebola, hepatitis…epidemic threats are a constant companion. Need to make sure health security investment promises are fulfilled.
WHO African Region
@WHOAFRO
Today health authorities in #drc declared an outbreak of #ebola after a case was confirmed in Mbandaka. This is the 3rd outbreak in the province since 2018. So far, just one case has been confirmed.
➡️ www.afro.who.int/countries/democratic-republic-congo/news… -
Peter Horby @peterhorby.bsky.social reposted
Robert Harneis
@outreforet
Also plenty of studies show there is benefit from Ivermectin in outpatients. But the vital question is why such determined opposition to its use when it costs less than the packaging and is very safe? So it doesn't work you say, so what? Let us use it. Why the medical tyranny?
-
Peter Horby @peterhorby.bsky.social
@PeterHorby

1 October 2021
Dear Miss Horby,
I am delighted to bring you this issue of the RSTMH members newsletter in which we share the full programme for our Annual Meeting, announce the winner of our photo competition at ECTMIH 2021 and mark World Rabies Day.
Prof. Devi Sridhar
@devisridhar
Sorry he’s in meetings - he could call you back later? 😆
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Agree with Gary Linker - deeply patronising and dismissive interview of someone who understands our future is in grave danger. Brave women. www.facebook.com/649391445/posts/10158794687471446/?d=n
-
Peter Horby @peterhorby.bsky.social reposted
Peter Openshaw
@p_openshaw
Very nice demonstration of the translation of RECOVERY findings into clinical practice via #isaric data pubmed.ncbi.nlm.nih.gov/35337642/
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
No benefit from ivermectin in outpatients.
Two important results today. Show the predictive value of plausible mechanism of action.
Effect of Early Treatment with Ivermectin among Patients with Covid-19 | NEJM www.nejm.org/doi/full/10.1056/NEJMoa2115869 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Benefit from convalescent plasma shown in outpatient trial.
Early Outpatient Treatment for Covid-19 with Convalescent Plasma | NEJM www.nejm.org/doi/full/10.1056/NEJMoa2119657 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
And a focus on longer term impact in children and young people. 1:50 affected
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
#royalsociety meeting on COVID-Science. Dr MacDermott on long-Covid. Systematic review with #isaric Leadership
-
Peter Horby @peterhorby.bsky.social reposted
Eric Topol
@EricTopol
Ivermectin: the largest randomized, double-blind trial yet conducted, with early treatment, indicates there is no difference compared with placebo. It doesn't work. Period.
www.nejm.org/doi/full/10.1056/NEJMoa2115869
just published @NEJM -
Peter Horby @peterhorby.bsky.social
@PeterHorby
And remember, because of exponential growth, increasing infectiousness can cause more deaths than increasing the case fatality rate.
Eric Topol
@EricTopol
Debunking a myth that future variants will inevitably be more mild, less pathogenic:
"The severity associated with future SARS-CoV- 2 variants is inherently unpredictable."
www.medrxiv.org/content/10.1101/2022.03.24.22272915v1 by @davidandthebees @emcat1 an d collaborators -
Peter Horby @peterhorby.bsky.social
@PeterHorby
The RECOVERY Trial - two years on | University of Oxford www.ox.ac.uk/news/features/recovery-trial-two-years
-
Peter Horby @peterhorby.bsky.social reposted
Kenneth Baillie
@kennethbaillie
In our latest paper from ISARIC4C we show that covid and flu together is a dangerous combination: 4x greater odds of needing a ventilator; 2x greater odds of dying. So we should test more widely for flu, and if you are offered a vaccine, please take it www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Sir Paul Nurse on UK pandemic preparedness
"We do not have a sustainable system in place. Why not .. identify a range of institutions around the country – so in an emergency you could activate a network very rapidly?”
We'd be foolish not to.
www.theguardian.com/world/2022/mar/20/public-health-measu… -
Peter Horby @peterhorby.bsky.social reposted
Christophe Fraser Group
@ChristoPhraser
One of the things that worries me is whether governments will come to think that lockdowns are an easy fail-safe - for them, not for the population - and so fail to invest in the infrastructure of health that is needed to contain outbreaks and so avoid future lockdowns. 3/3
-
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
2 years ago today, the first person entered the RECOVERY trial.
Since then, together we have found 4 treatments that reduce mortality - results that have been adopted worldwide and saved countless lives.
Thank you to every one of those people who have made such a difference. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Professor Sarah Gilbert on the legacy of lockdown
We should never again have to experience the same failure for vaccines with proven efficacy to be made available equitably around the world.
@PSIOxford
www.theguardian.com/world/2022/mar/18/professor-sarah-gil… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
🎇RECOVERY trial: first patient enrolled in Ghana, Komfo Anokye Teaching Hospital
Congratulations John Amuasi, Esther Matey, Oumou Maiga, Kumasi Centre for Collaborative Research #kccr 🇬🇭 and the whole team at KATH
www.recoverytrial.net/news/recovery-trial-launches-in-ghana -
Peter Horby @peterhorby.bsky.social reposted
Nicola Perrin
@NMRPerrin
My favourite picture from #appgonmedicalresearch reception last night. #recovery @MartinLandray @PeterHorby @OxfordVacGroup together - the incredible UK #covidresearchresponse - not often you get them all together in one room - thank you 🙏
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Best wishes for International Women’s Day to all the amazing women I know professionally and personally - here’s hoping we can move much faster towards equality of respect, pay, safety etc etc etc….
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
And of course, Gail Carson too
Gail Carson
@gail_carson
Thank you to some of the fab women @ISARIC1 Sarah Moore Nina Jamieson @PRICE_critcare @abi_beane @DrToniHo @louise_sigfrid @JTSglobalhealth @mugecevik Janice Caoili Laura Merson Barbara Melina Valeria Muriel & Emm 💕
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Covid: How new drugs are finally taming the virus www.bbc.co.uk/news/health-60390187
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Stunning work by Kenneth Baillie, #genomic, #isaric4c
Kenneth Baillie
@kennethbaillie
Out at 4pm today: our latest paper from GenOMICC reveals 16 new, robust genetic associations with critical Covid-19, some of which might lead directly to effective new treatments, just like our study in 2020 did. 1/n
www.nature.com/articles/s41586-022-04576-6 -
Peter Horby @peterhorby.bsky.social reposted
Epidemic diseases Research Group Oxford
@ERGO_Horby
Great holographic demo on today at the @NDMOxford where @emmanuelleden has the starring role of being beamed in to our meeting room!
Lots of ideas from the team on how this tech can be applied this virtual era.
#holocomms #technology #hologram #holograph #virtualmeetings -
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY Baricitinib medRxiv manuscript now available:
www.medrxiv.org/content/10.1101/2022.03.02.22271623v1
Peter Horby @peterhorby.bsky.social
@PeterHorby
New RECOVERY result: Baricitinib
8156 patients randomly allocated to receive usual care plus baricitinib versus usual care alone.
28-day mortality lower in patients allocated baricitinib: 513/4148 (12%) vs 546/4008 (14%) (age-adjusted rate ratio 0.87; 95% CI 0.77-0.98; p=0.026) -
Peter Horby @peterhorby.bsky.social
@PeterHorby
New RECOVERY result: Baricitinib
8156 patients randomly allocated to receive usual care plus baricitinib versus usual care alone.
28-day mortality lower in patients allocated baricitinib: 513/4148 (12%) vs 546/4008 (14%) (age-adjusted rate ratio 0.87; 95% CI 0.77-0.98; p=0.026)Post not available here, view on X
Peter Horby @peterhorby.bsky.social
@PeterHorby
The total randomised evidence to date suggests that JAK inhibitors reduce mortality in patients hospitalised for COVID-19 by about one-fifth.
Results support use of baricitinib in addition to other immunosuppressive therapies in patients hospitalised with COVID-19.
Peter Horby @peterhorby.bsky.social
@PeterHorby
MedRxiv paper to follow very soon.
Thank you to all #nhs #nihr #ukri staff and trial teams who made this possible. Thanks to #dhsc for supply of drug.
Thanks mostly to all the patients who volunteered for RECOVERY. -
Peter Horby @peterhorby.bsky.social reposted
David Paterson
@davidantibiotic
Wellcome Trust funded ADVANCE ID network aims to address this imbalance of where ID clinical trials are performed @GordonDougan1 @TimothyJinks1 @hsuliyang
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Announcing the new Pandemic Sciences Institute youtu.be/m3CBATLy8wQ via @YouTube
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
Our new Pandemic Sciences Institute website is now live! The PSI will draw upon experience and lessons learnt from COVID-19 pandemic to identify and counter future pandemic threats www.psi.ox.ac.uk
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Beware the misrepresentation of this data on ivermectin as showing benefit - the trial does not show benefit.
Nick Mark MD
@nickmmark
Ah the classic “divide a non-significant secondary endpoint by a non-significant primary endpoint” to get a number you like better. Then turn that number into a ratio and incorrectly apply RRR… 😂
For every negative trial they innovate new ways to “re-analyze” the data -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Efficacy of Ivermectin on Disease Progression in Patients With COVID-19 jamanetwork.com/journals/jamainternalmedicine/fullarticle… A 5-day course of oral ivermectin administered during the first week of illness did not reduce the risk of developing severe disease compared with standard of care alone.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Complain to Lancet - they re-draw them, and choose the colours!
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Yes, very bad idea.
Charlotte Summers
@charlot_summers
Discontinuing this valuable research seems like a VERY bad idea to me.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
It is recommended for non-omicron hospitalised patients.
See here:
www.england.nhs.uk/coronavirus/wp-content/uploads/sites/5…
EStrange
@Neelie001
An interesting outcome. What are the next steps after this trial. Will it be adopted as part of the SOC for non Omicron patients ? ( Do hospitals routinely screen patients to determine what variant they have ?)
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
It was published as a pre-print in early June 2021.
www.medrxiv.org/content/10.1101/2021.06.15.21258542v1
Unfortunately it takes a long time to get through the formal peer review and publishing pipeline.
EStrange
@Neelie001
This trial finished in May 2021. I am interested why it being published now? Has the analysis taken that long, or has the recently found futility of this drug against Omicron driven this publication.?
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
That would be nice..and probably also cost-saving in the long term.
Rob Hughes
@R_Hughes1
Please can we have (1) a RECOVERY trial platform for the top 10 causes of premature death in the UK, funded forever with some of the billions from @wellcometrust's covid endowment bonus + @UKRI_News, and (2) a RECOVERY-type platform for community based public health trials?
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY manuscript now fully published: Casirivimab and imdevimab in patients admitted to hospital with COVID-19
Randomised trial of 9785 patients.
Casirivimab and imdevimab reduces mortality in seronegative patients.
authors.elsevier.com/sd/article/S0140673622001635 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY manuscript now fully published: Casirivimab and imdevimab in patients admitted to hospital with COVID-19
Randomised trial of 9785 patients.
Casirivimab and imdevimab reduces mortality in seronegative patients.
authors.elsevier.com/sd/article/S0140673622001635
Peter Horby @peterhorby.bsky.social
@PeterHorby
396 (24%) of 1633 seronegative patients allocated to casirivimab and imdevimab versus 452 (30%) of 1520 seronegative patients usual care died within 28 days (rate ratio [RR] 0·79, 95% CI 0·69–0·91; p=0·0009).
Peter Horby @peterhorby.bsky.social
@PeterHorby
First proof that an antiviral drug can reduce mortality in hospitalised COVID-19 patients.
Although casirivimab and imdevimab is not active against Omicron variant, this result encourages evaluation of other monoclonal and antiviral drugs in hospitalised COVID-19 patients. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
I feel your pain
Lance Turtle
@LanceTurtle
I really, really, really hate editorial manager. It is becoming almost impossible to get in!! I have absolutely no idea of how many accounts I have . Dozens probably. And is the level of security really necessary??
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Happy Lunar New Year to all.
Wishing you health and happiness in the year of the Tiger
Chúc Mừng Năm Mới
恭喜发财
gōng xǐ fā cái -
Peter Horby @peterhorby.bsky.social
@PeterHorby
We are using a factorial design, so we will have combination therapy data.
Simon Tiberi
@SimonTiberi
How about an arm with two antivirals? Rationale with more than one antiviral we might increase efficacy and reduce resistance?
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Vexatious FOI requests - another monster unleashed by COVID.
-
Peter Horby @peterhorby.bsky.social reposted
Eric Topol
@EricTopol
Omicron's immune evasive property has changed the landscape for what drugs and monoclonal antibodies (mAbs) maintain efficacy. @NEJM today, the anti-Covid pills hold up well, but not true for most of the mAbs
www.nejm.org/doi/full/10.1056/NEJMc2119407 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Absolutely - evidence base for public health interventions remains poor - key question is how to optimise for control whilst minimising adverse impacts.
Dr Tim Chadborn
@DrChadborn
Hi Peter (long time!) Would you agree and support the need for large scale trials of behavioural and social interventions similarly to clinical/pharmaceutical interventions? It seems there is an imbalance that would be good to rectify in future....
All the best, Tim -
Peter Horby @peterhorby.bsky.social reposted
Professor Chris Whitty
@CMO_England
Antivirals will be important in the early treatment of COVID. Many thanks to participants, researchers and support teams in the PANORAMIC antiviral trial.
If you test positive for COVID-19 please consider taking part. Eligibility at www.panoramictrial.org.
OxPrimaryCareSci
@OxPrimaryCare
We just hit 5000 people recruited!
This is a huge accomplishment and thanks to all who made it happen!
But we still need your help!
www.panoramictrial.org
@NIHRresearch @DHSCgovuk -
Peter Horby @peterhorby.bsky.social
@PeterHorby
And a (limited) meta-analysis of CP in hospitalised patients
jamanetwork.com/journals/jamanetworkopen/fullarticle/2788377
Evidence of benefit of monoclonal antibody therapy in seronegative hospitalised COVID patients suggest this may be a dosing issue with CP
www.medrxiv.org/content/10.1101/2021.06.15.21258542v1 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Martin Landray on the importance of large scale, efficient clinical trials to improve the care of common, life-threatening diseases.
www.bbc.co.uk/iplayer/episode/m0013w56/morning-live-serie… -
Peter Horby @peterhorby.bsky.social reposted
nature
@Nature
The first crop of COVID antivirals is promising, but new drugs will be needed to counter the looming threat of resistance go.nature.com/3fX2NaA
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RCT of respiratory strategies in COVID.
Great work from the RECOVERY-RS team.
Helping improve outcomes in COVID.
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality in Patients With AHRF and COVID-19 jamanetwork.com/journals/jama/fullarticle/2788505 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Merck trial enrolled only 304 in-patients, of which only 1/4 received 800mg - that's roughly 75 patients.
Just look at history of tocilizumab and mAbs in hospitalised COVID patients: nearly discarded these useful drugs because of futility assessments in under-powered trials.
EStrange
@Neelie001
www.empr.com/home/news/molnupiravir-merck-ridgeback-oral-…
Merck halted their hospitalised trial for futility. Why do you think Recovery will find it works.?? 🤔 Even their Outpatient EUA says it needs to be given early, less than 5 days after symptoms.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Let's not make same mistake here. Give Molnupiravir a proper test in enough patients.
It may work, or it may not, but we have so few antiviral options that we really need to know for sure before we consign any to the bin. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
It seems to remain stable at about the 25-30% level. Remdesivir is definitely not as popular in the UK as it is in USA.
Charlotte Summers
@charlot_summers
I think prescribing is pretty variable (appeared to decrease when WHO stopped recommending it, despite it remaining recommended in UK) - the RECOVERY aspirin publication states 26% people received remdesivir, so~ 25-30% of those who participate in research receive it.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
We're working on getting paxlovid into RECOVERY.
Todd C. Lee
@DrToddLee
I'd rather see paxlovid in inpatients than molnupravir.
-
Peter Horby @peterhorby.bsky.social reposted
George Freeman MP. FRGS. FRSA.
@MPGeorgeFreeman
The UK Covid #recovery Clinical Trial was bigger than the next 10 trials in the world. Put together.
With patients recruited in record fast time.
Nowhere is the opportunity for UK #lifescience bigger than in #clinicaltrials
Exciting innovations coming👇 www.thetimes.co.uk/article/covid-blueprint-to-transform-n… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Molnupiravir is now being evaluated in RECOVERY.
Whilst we have proof-of-concept, through monoclonals, that antivirals can be beneficial in severe COVID, we are struggling to find effective antivirals.
Combination antiviral therapy the way forward?
www.recoverytrial.net/news/molnupiravir-to-be-investigate… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Thank you to Vietnam Oxford Society, His Excellency Ambassador Long and Linacre College for a wonderful Tết lunch.
Jeremy Farrar
@JeremyFarrar
A wonderful (early) Vietnamese Tết lunch today with @Ambassador_Long & Vietnamese students in U.K. @PeterHorby Professor Dame Sarah Gilbert & colleagues - Chúc Mừng Năm Mới, cảm ơn. As the Year of the Buffalo soon becomes the Year of the Tiger.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Very early on we wished to trial remdesivir in RECOVERY, but unfortunately we could not access the drug.
Tony Rostron
@RostronTony
Does this need to be trialled by RECOVERY?
-
Peter Horby @peterhorby.bsky.social reposted
Marion Koopmans, publications: https://pure.eur.nl
@MarionKoopmans
Great to see indepth studies of the complexities of quantifying airborne transmission. Inactivation in droplets, relation to relative humidity. Competing risks here; drier is better from perspective of virus infectivity loss, but not for person in the room www.medrxiv.org/content/10.1101/2022.01.08.22268944v1.ful…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
New RCT data on remdesivir in hospitalised patients. In line with ACTT-1 - a modest but significant effect on outcomes important to patients and health systems, such as the need for mechanical ventilation. www.cmaj.ca/content/early/2022/01/19/cmaj.211698
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY Data Monitoring Committee - case study.
"RECOVERY has demonstrated that, even in a pandemic, we need to test treatments through clinical trials rather than just giving them to patients without any evidence in the hope of some benefit"
www.recoverytrial.net/case_studies/professor-peter-sander…
Peter Horby @peterhorby.bsky.social
@PeterHorby
The RECOVERY DMC have made an enormous, unsung, contribution to improving care for patient with COVID.
They meticulously monitor the data, waiting until there is "proof beyond reasonable doubt" to make sure the result is definitive and will change practice for the better.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Enormous thanks to all the RECOVERY DMC members, who selflessly volunteer their time and expertise.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
JVT is a national treasure.
Sad to see him step-down as Deputy CMO, pleased that we will still keep working together, proud to have worked alongside him through the COVID crisis.
The Best Bits
www.bbc.co.uk/news/uk-59979504 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
I feel it is high-time for a Trifle renaissance
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic contribution from RECOVERY International teams in Nepal, Vietnam, Indonesia and South Africa.
#recoverytrial #covid19 🇿🇦🇮🇩🇻🇳🇳🇵
Oxford Population Health (OxPop)
@Oxford_NDPH
🌏 #recoverytrial International has recruited 1,000 participants 👏 👏
Thank you to our colleagues and the patients in Indonesia, Nepal, South Africa and Vietnam for taking part, to develop global solutions for #covid19
@MartinLandray @NIHRresearch @The_MRC @wellcometrust -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Don't look up!
Stephen
@hawksdotlife
Nuclear Seismologists may give you the variety you seek
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Just published - a model for co-developing plans for clinical evaluation of new treatments for high-threat pathogens @ISARIC1 @NCDCgov @wellcometrust
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever pubmed.ncbi.nlm.nih.gov/34990453/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Massively deserved recognition of Mike Ryan's contribution to global health over decades. The man is a star. Congratulations Mike.
President of Ireland
@PresidentIRL
Statement from Áras an Uachtaráin after President Higgins received @DrMikeRyan of the @WHO on a courtesy call this afternoon:
president.ie/en/diary/details/president-receives-dr-micha… -
Peter Horby @peterhorby.bsky.social reposted
Sajid Javid
@sajidjavid
2 MILLION appointments for booster jabs are available over the next week.
As we kick off 2022, #getboostednow to secure the best possible protection against Omicron. -
Peter Horby @peterhorby.bsky.social reposted
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
What I find the most depressing is getting less profane but no less abusive messages, often couched in innuendo and insinuation, from professionals and peers.
Charlotte Summers
@charlot_summers
On the plus side, this article by John Edmunds tells me I’m not alone in receiving crazy letters/emails, but how on earth does anyone think this behaviour is acceptable? www.theguardian.com/world/2021/dec/31/im-a-uk-covid-scien…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Wonderful news that the incredible contributions of Richard and Lucy have been recognised. Congratulations.
#recovery trial team members appointed MBEs www.ndph.ox.ac.uk/news/recovery-trial-team-members-appoin… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Congratulations Peter. Very well deserved.
Peter Openshaw
@p_openshaw
I'm so pleased to get this award, which is actually a tribute to all fantastic people I've worked with and all those who have promoted immunology, collaboration and mutual kindness in science. Thank you all.
-
Peter Horby @peterhorby.bsky.social reposted
NHS Million
@NHSMillion
If everyone who has been grateful for NHS staff over the last two years followed and retweeted, we would reach a million in no time.
It will only take a few seconds, and your support would really mean a lot to a huge number of people who continue to fight Covid-19. -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY - new treatment comparison for the UK:
Today the first NHS patients were enrolled into the comparison of higher dose vs. standard dose dexamethasone (corticosteroid)
They join >800 patients in SE Asia & S Africa
www.recoverytrial.net/news/recovery-trial-to-investigate-… -
Peter Horby @peterhorby.bsky.social reposted
COVID-19 Actuaries Response Group
@COVID19actuary
A further update on hospitals in England with one more day of data.
Over 2,000 admissions today - still ahead of @cmmid_lshtm modelling. Almost a vertical rise in NE&Yorks, up 91%.
Occupancy up 68% and over 11,000 but still little increase in mechanical ventilation beds. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
A milestone as we move into 2022: 46,000 patients have selflessley volunteered, at a time of great stress, to improve the care of future patients. Incredible. Thank you.
Still, there is more to do. We can save even more lives with even better treatments.
Martin Landray
@MartinLandray
RECOVERY trial update:
The 46,000th participant was enrolled @GWH_NHS (Swindon UK) today
As we near the end of 2021, this trial remains key to addressing the uncertainties of which treatments truly benefit patients with COVID-19
Thank you to all who help us randomise & learn -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY trial update:
The 46,000th participant was enrolled @GWH_NHS (Swindon UK) today
As we near the end of 2021, this trial remains key to addressing the uncertainties of which treatments truly benefit patients with COVID-19
Thank you to all who help us randomise & learn -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Animal model data suggest infection with the Omicron variant may be less severe than Delta
www.biorxiv.org/content/10.1101/2021.12.26.474085v1 -
Peter Horby @peterhorby.bsky.social reposted
Marc Mendelson
@SouthAfricanASP
You mean ‘All patients with mild/moderate #covid19’ in the rich Global North. For everyone else it’s a hospital bed (if available), oxygen (if available) and steroids (if available). Two worlds, two realities
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟
@ABsteward
The science is moving fast
My algorithm outpt:
All patients with mild/moderate #covid19 :
Paxlovid 1st line
⬇️
If NA
⬇️
IV Remdesivir
⬇️
If NA
⬇️
Genotyping*
⬇️
Delta & Seronegative ➡️Ronapreve "casirivimab & imdevimab"
⭕micron➡️S⭕trovimab
If NA
⬇️
Molnupiravir OR Fluvoxamine -
Peter Horby @peterhorby.bsky.social reposted
James Ward
@JamesWard73
this is, once again, complete nonsense. if you click through to the source for this “data” you’ll see it is a misreading of NHS stats which suggest ~30% of infections are hospital-acquired: x.com/avonandsomerrob/status/1475610563107512330
Allison Pearson
@AllisonPearson
The UKHSA confirms 70% of patients counted as “Covid admissions” in our hospitals were admitted for other ailments.
As I said.
To say this skews the view of the impact Covid has on the NHS doesn’t capture the full jiggery pokery going on here. -
Peter Horby @peterhorby.bsky.social reposted
John-Arne Røttingen
@jarottingen
The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill healthpolicy-watch.news/the-moonshot/
-
Peter Horby @peterhorby.bsky.social reposted
Government Office for Science
@uksciencechief
Epidemiological modellers have an unenviable task in trying to make sense of COVID-19 and its impact on our society. Read my article in the @thetimes setting out how SAGE uses this modelling to better understand the COVID-19 pandemic. www.gov.uk/government/speeches/its-not-true-covid-19-mode…
-
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
I would add public also need this information directly from SAGE unfettered by politics. Ensuring all SAGE summaries & all background work is available for scrutiny was made possible by @uksciencechief & @CMO_England. Trust & transparency of this science has been critical
-
Peter Horby @peterhorby.bsky.social reposted
Government Office for Science
@uksciencechief
📢 The latest scientific evidence informing the advice from SAGE has been published. Click here to access it 👉 www.gov.uk/government/collections/scientific-evidence-sup…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Exciting opportunity and a great team.
ISARIC
@ISARIC1
WE ARE HIRING!
We're looking for a Administration & Finance Assistant to join the ISARIC team | deadline 14 January 2022 | Apply now: my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY Trial to investigate sotrovimab as a possible treatment for hospitalised COVID-19 patients.
Sotrovimab, a monoclonal antibody that targets a conserved region of the coronavirus spike protein, retains activity against the Omicron variant.
www.recoverytrial.net/news/sotrovimab-to-be-investigated-… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Because scientists aren't human?
Kate Masterofwhine
@Masterofwhine
Or the “blame the scientists for taking my fun” position
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels: A Randomized Controlled Trial: Annals of Internal Medicine: Vol 0, No 0 www.acpjournals.org/doi/10.7326/M21-3507
Peter Horby @peterhorby.bsky.social
@PeterHorby
Aligns with RECOVERY result of ronapreve - reduced 28-day mortality among patients who were seronegative (and therefore had not mounted their own humoral immune response) at baseline but not among those who were seropositive at baseline.
Peter Horby @peterhorby.bsky.social
@PeterHorby
All the data are showing us that treatment of severe COVID needs to be individualised - status of viral replication & immune response; status of inflammatory response.
-
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
Unfortunately, this oft-quoted Spectator tracker of COVID 'scenarios vs outcomes' seems at best muddled and at worst actively misleading. A thread on some weird comparisons - and how to do better critiques...
data.spectator.co.uk/category/sage-scenarios 1/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Some nice examples from Adam of how good UK COVID models have been - thanks, been waiting for someone to do that!
Adam Kucharski
@adamjkucharski
Any writer who claims 'UK models always overestimate COVID numbers' is either lazy or trying to mislead their readers. A few illustrations... 1/
-
Peter Horby @peterhorby.bsky.social reposted
Prof Francois Balloux
@BallouxFrancois
Something that may have been missed in the UK furore over covid-modelling is that until fairly recently, the 'official models' produced by UK scientists have been remarkably accurate in their 'predictions'.
1/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Meera Chand +++, and Julia Gog, Ros Eggo and so many more.
Susan Hopkins
@SMHopkins
Loving this celebration of great women involved in COVID data. Great to see @ukhsa on the list. And there are loads more… @meera_chand who leads variant tech group @JVRobotham modelling nosocomial COVID @stat_sarah chief ix coronavirus survey @Susannajd leading PITCH & many more
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
The (rather brilliant) models are absolutely, categorically NOT designed to justify policies.
They are designed to inform policies.
Completely different.
The SPI-M papers, that are openly published, clearly demonstrate this.
Graham Medley
@GrahamMedley
I am going to give up on this, but just to finish by saying that this absolutely the wrong take. We model the scenarios that are most informative to help decisions be made
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great thread from Francois, pulling together some really interesting new data. Thoughtful and considered.
Prof Francois Balloux
@BallouxFrancois
The Omicron variant is spreading very fast globally. It is already dominant in London, but likely at high frequency in many other places in the world that do not have a viral surveillance infrastructure comparable to that of the UK.
1/This post is unavailable. See it on X. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
More data on escape of Omicron from neutralising sera and monoclonal antibodies.
Minor variant with addition of R346K substitution further enhances escape.
Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2 www.biorxiv.org/content/10.1101/2021.12.14.472719v1 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
ECDC Omicron Risk Assessment
"With the Omicron VOC probably having a higher growth advantage, large and immediate reductions in contact rates are needed to keep the COVID-19-related burden manageable."
www.ecdc.europa.eu/sites/default/files/documents/covid-19… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Well done Calum. So pleased for you, and well earned. A fabulous contribution to the UK response through CO-CIN, SAGE, ISARIC4C and more
Gail Carson
@gail_carson
Richly deserved 🥂A key member of @ISARIC1 for past 10 years.
-
Peter Horby @peterhorby.bsky.social reposted
John Burn-Murdoch
@jburnmurdoch
Quick situation update from Gauteng, showing all key metrics including excess deaths.
Cases and test positivity peaking, admissions slowing.
Deaths still climbing at same pace as past waves, but based on slowdown in cases we can be sure deaths will not get close to Delta peak. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Asking whether the reaction to omicron is appropriate is valid.
Questioning the science without understanding it is not.
See thread.
Carl Heneghan
@carlheneghan
We’re in danger of letting bad science force us into a cycle of Covid restrictions www.telegraph.co.uk/news/2021/12/15/danger-letting-bad-sc…
Post not available here, view on X
Peter Horby @peterhorby.bsky.social
@PeterHorby
5. Hospitalisations lag cases by several weeks. Hospitalisations are now increasing in SA.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Current concerns are based on "good intelligence, clear thought and strong evidence." I'm afraid this article is not.
-
Peter Horby @peterhorby.bsky.social reposted
Olivier Schwartz Lab
@Virus_Immunity
Most of the 9 anti-SARS-CoV-2 monoclonal antibodies in clinical use or pre-clinical development that we tested in collaboration with @MOUQUETHugo1 lost totally or partially activity against #omicron. Results in line with work by other labs
www.biorxiv.org/content/10.1101/2021.12.14.472630v1 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Transformative, and immensely generous, £50m donation from the Poonawalla family will create the Poonawalla Vaccines Research Building - a massive boost for Oxford's pandemic science initiative.
www.theguardian.com/business/2021/dec/15/india-poonawalla… -
Peter Horby @peterhorby.bsky.social reposted
Natalie E. Dean, PhD
@nataliexdean
So when I look at data out of South Africa or elsewhere, I am thinking not just about the proportion of cases that are severe, but also the sheer number of severe cases, which demonstrates the public health impact of the variant. 8/END
Ridhwaan Suliman
@rid1tweets
Finally, a look at hospitalisations in Gauteng?
New admissions doubling ~ every 5 days, and up to 31% of previous peak levels
Note: hospitalisations lag cases by 1-3 weeks, and with reporting delays need to wait a week to understand actual hospital admissions for previous week -
Peter Horby @peterhorby.bsky.social reposted
Tulio de Oliveira
@Tuliodna
Let's hope that the transparent work of scientists and our government in SA can help the world. We also hope that the selfishness of countries finally stop as we are on this boat together and only together with solidarity we can beat this virus.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY Trial launches in South Africa
www.recoverytrial.net/news/recovery-trial-launches-in-sou…
Congratulations to the team in South Africa. Another fantastic achievement from the incredible health and research professionals in South Africa. -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
“And so we (ISARIC) very quickly evolved from study #database #management into a large international platform that was capturing curating and running analytics for more than 60 countries around the world.” Laura Merson, Head of Data, ISARIC
-
Peter Horby @peterhorby.bsky.social reposted
Florian Krammer
@florian_krammer
PPS: I do not know what all of this means for long COVID.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
EMA recommends approval for use of RoActemra in adults with severe COVID-19 | European Medicines Agency europa.eu/!K8W7nW via @EMA_News
-
Peter Horby @peterhorby.bsky.social reposted
Inst. Pasteur Bangui
@I_P_Bangui
@I_P_Bangui et @UniofOxford débutent une étude compassionnelle d'efficacité du Tecovirimat pour traiter des patients atteints de variole du singe en impasse thérapeutique à M’baïki. pasteur-bangui.org/6-decembre-2021-siga-obtient-lapprobat… @ISARIC1 @ALERRT_Global #centrafrique #monkeypox
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Oh dear, does that mean that I am "A knight that says Ni"
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
How should it be pronounced?
-
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
Reminder that reactive travel bans typically slow but don’t stop importations. If new B.1.1.529 variant genuinely more transmissible/can evade immunity to some extent, reasonable to assume already undetected cases in other regions... 1/
Adam Kucharski
@adamjkucharski
In December, many countries reactively banned travel from the UK (www.theguardian.com/uk-news/2020/dec/20/europe-bans-trave…), but this didn’t stop the rise of B.1.1.7 across the continent (www.nytimes.com/interactive/2021/04/09/world/europe/europ…). 2/
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
‘Another War Is Coming’, Kate Bingham DBE, delivers Romanes lecture | University of Oxford www.ox.ac.uk/news/2021-11-24-another-war-coming-kate-bing…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY Trial wins ‘Oscar of Higher Education’ for STEM Research Project of the year www.ndph.ox.ac.uk/news/times-higher-stem-award
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Academia can make a vital contribution to achieving the 100 Days Mission. Need to be at the table.
Government Office for Science
@uksciencechief
It was great to meet my @G7 counterparts today alongside guests @WHO @CEPI @Deepmind @gatesfoundation to discuss the ambitious 100 Days Mission - which is to make diagnostics, therapeutics and vaccines available within 100 days. Our implementation report is out next week 📝
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
"it is shameful that in some low-income countries only 5% of the population have received at least one dose"
Andrew Pollard and Brian Angus
www.theguardian.com/commentisfree/2021/nov/23/unvaccinate… -
Peter Horby @peterhorby.bsky.social reposted
Christine Middlemiss 🇺🇦
@ChiefVetUK
‼️this is REALLY REALLY important. It’s not all about housing, I am calling on all bird keepers in this area to implement STRINGENT biosecurity measures end to end across your systems NOW‼️ @BPVA @BPCChiefExec @BEICTeam
APHA
@APHAgovuk
Due to increased #avianinfluenza risk, housing measures are in place across Hambleton, Harrogate & Richmondshire Districts. All bird keepers must now house their birds (kept commercially or as pets) & follow new enhanced mandatory biosecurity guidance: www.gov.uk/guidance/avian-influenza-bird-flu
-
Peter Horby @peterhorby.bsky.social reposted
COG-UK Mutation Explorer
@COGUK_ME
The @CovidGenomicsUK Mutation Explorer sars2.cvr.gla.ac.uk/cog-uk/ is now tracking the combinations of spike substitutions known to reduce binding by either casirivimab or imdevimab, the constituents of the therapeutic antibody cocktail Ronapreve
-
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY recruitment update:
45,000 patients randomised
Currently in UK, Nepal, Indonesia & Vietnam
3 treatments shown to reduce mortality
6 others shown to have no meaningful benefit
A huge collaborative effort
Enormous credit to all involved
Many thanks
And we keep going... -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
Sorry: I realise that I failed to include the reference.
This is published (open access) in @TheLancet if you wish to read the details:
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
COVID no longer only show in town?
-
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
In 2020, we developed a #covid19 vaccine for the world
Today, we are proud to say that two billion doses have been released for supply with @AstraZeneca and its partners to more than 170 countries across seven continents.
Hear from some of the people behind the #oxfordvaccine⬇️ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Azeem Rafiq - "“You had people who were openly racist and you had the bystanders. No one felt it was important.”
Doing nothing, is doing something.
www.theguardian.com/sport/2021/nov/16/azeem-rafiq-cricket… -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
To mark the exceptional work ISARIC & members have since the beginning of the #pandemic, we just launched ISARIC's timeline.
Explore:
isaric.org/covid-19-pandemic-response-timeline/ -
Peter Horby @peterhorby.bsky.social reposted
Government Office for Science
@uksciencechief
"Great to see continued uplift in R&D spending. Research and innovation are key to our ambitions to be a science superpower and reaching net zero." PV
#budget2021 #spendingreview
HM Treasury
@hmtreasury
£20bn in R&D by 2024/25, a record investment to secure the UK’s future as a global science superpower and create high-skill, high-wage jobs across the country.
#budget2021 #spendingreview -
Peter Horby @peterhorby.bsky.social reposted
Academy of Medical Sciences
@acmedsci
"We should all be proud that the UK has been at the forefront of some of the cutting edge treatments for #covid19." @sajidjavid
But UK research depends on investment. At the #spendingreview, the Gov & @RishiSunak must not backtrack on supporting research. acmedsci.ac.uk/news-and-insights/news -
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
The SAGE minutes in September and October seem very clear www.gov.uk/government/collections/scientific-evidence-sup…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
They were not forecasts!
See - In defence of Sage’s models
www.spectator.co.uk/article/what-the-media-gets-wrong-abo…
"They are not meant to be predictions of what will actually happen"
Chris Giles
@ChrisGiles_
The main response to this has been people saying that economists get away with bad forecasts all the time.
They don't - and that's a very useful disciplining device
I haven't, for example, heard the Queen asking scientists publicly "why did no one see it coming"
Chris Giles
@ChrisGiles_
I remember the time when the UK science community said schools were not a vector of spread for Covid...
...Economists would not get away with forecast errors such as this
#justsaying -
Peter Horby @peterhorby.bsky.social
@PeterHorby
In defence of Sage's models.
The models produced are "scenarios to inform government decisions......They are not meant to be predictions of what will actually happen"
www.spectator.co.uk/article/what-the-media-gets-wrong-abo… via @spectator -
Peter Horby @peterhorby.bsky.social reposted
Government Office for Science
@uksciencechief
The latest scientific evidence informing the advice from SAGE has been published. Click here to access it 👉 www.gov.uk/government/collections/scientific-evidence-sup…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Chris, those statements were (correct) observations at the time, not forecasts.
Chris Giles
@ChrisGiles_
I remember the time when the UK science community said schools were not a vector of spread for Covid...
...Economists would not get away with forecast errors such as this
#justsaying -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
ISARIC just launched the #covid-19 preparedness response timeline to mark the amazing work #isaric & members did to help further the knowledge since the beginning of the #pandemic.
Find out more:
isaric.org/covid-19-pandemic-response-timeline/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Indeed, been known for a little while...
Am J Hyg 1959; 70:185-196
Infectious Diseases
@InfectiousDz
This isn't news to anyone working on TB
www.nytimes.com/2021/10/19/health/tuberculosis-transmissi… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Absolutely, 100% deserved - Kenny is brilliant.
Sara Clohisey Hendry
@dr_sara_c
A massive congratulations to our boss @kennethbaillie on his appointment as Professor of Experimental Medicine!
Couldn’t be more proud! -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Unfortunately, another negative result for interferon in hospitalised COVID-19 patients.
See also WHO trial result: NEJM 2021 Feb 11;384(6):497-511.
In fact, some suggestion of worse outcomes with interferon seen in both studies.
www.thelancet.com/journals/lanres/article/PIIS2213-2600(2…
Peter Horby @peterhorby.bsky.social
@PeterHorby
Question in accompanying article about potential influence of concomitant glucocorticoids.
However, WHO trial was able to undertake analysis excluding patients on glucocorticoids and saw same, negative result.
www.thelancet.com/journals/lanres/article/PIIS2213-2600(2…
Peter Horby @peterhorby.bsky.social
@PeterHorby
Overall case fatality rate in this new trial was 3-5%. Appears lower than average for US: see -
JAMA Netw Open. 2021;4(4):e216556.
Perhaps exclusion criteria have selected a less severe sub-group of patients. Although doubt this has influenced the overall conclusion. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
No cake for me thanks.
Helen Fallside 🇺🇦
@bello_hz
I've never liked dapple grey equines.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Latest RECOVERY publication: Colchicine is not beneficial in patients admitted to hospital with COVID-19. www.sciencedirect.com/science/article/pii/S2213260021004355
-
Peter Horby @peterhorby.bsky.social reposted
Pete Macharia
@Pete_M_M
"The critical work done by #african experts has helped shatter old stereotypes about the continent and laid the groundwork to take on persistent killers including #malaria, HIV and tuberculosis. "
www.telegraph.co.uk/global-health/science-and-disease/var… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
“We must not lose the energy behind this”
@GeorgeFreemanMP I could not agree more. In the last two years the UK has showcased the transformative potential of science. We cannot go back to business as usual.
BioIndustry Association (BIA)
@BIA_UK
‘This sector is fundamental to our economy. I’ve never seen this country so grateful to the #lifesciences community. We must not lose the energy behind this’ @GeorgeFreemanMP #biotech
-
Peter Horby @peterhorby.bsky.social reposted
David Probert
@probert_david
-
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
ISARIC #covid19 clinical data platform collates more than half million global patient records. Explore the #clinicaldata & research proposals | Learn how you can get involved 👇👇👇isaric.org/research/covid-19-clinical-research-resources/…
-
Peter Horby @peterhorby.bsky.social reposted
CEPI
@CEPIvaccines
‘No one is safe until we are all safe’
CEO of CEPI @DrRHatchett and Prof. Dame Sarah Gilbert @UniofOxford have authored a letter in @ScienceTM calling for urgent action to address global vaccine inequity ⬇️
cepi.net/news_cepi/university-of-oxfords-prof-dame-sarah-… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Same door - 1986 for me.
Unforgettable threshold to a wonderful career.
Jeremy Farrar
@JeremyFarrar
Walking past this evening. Walked through these door for the first time, almost exactly on this day, October 1981 for my first day at college. Anatomy Department @ucl
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Yes: Invest in science to better prepare and prevent diseases from getting out of control.
Wellcome
@wellcometrust
What do we know?
🦠 Where there's been life, there's been disease.
What can we do about it?
👩🔬 Invest in science to better prepare and prevent diseases from getting out of control. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Baricitinib in adults with COVID-19 on IMV or ECMO.
Baricitinib (n=51) significantly reduced 28-day all-cause mortality compared to placebo (n=50) (39·2% vs 58·0%; hazard ratio [HR]=0·54 [95%CI 0·31–0·96]; p=0·030)
www.medrxiv.org/content/10.1101/2021.10.11.21263897v1
Peter Horby @peterhorby.bsky.social
@PeterHorby
86% of participants were taking systemic corticosteroids at baseline as standard of care.
So consistent with additional reduction in mortality from Baricitinib on top of steroids in this very severely ill group of patients = good news.
Peter Horby @peterhorby.bsky.social
@PeterHorby
But IL-6 inhibitors were excluded. So does not tell us whether Baricitinib has better, worse, or same effect as IL-6 inhibitors, or if giving both is worthwhile.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
The value of open-source clinical science in pandemic response: lessons from ISARIC www.thelancet.com/journals/laninf/article/PIIS1473-3099(2…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Covid by numbers: 10 key lessons separating fact from fiction www.theguardian.com/world/2021/oct/10/covid-by-numbers-10…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
No benefit from high-titre convalescent plasma in critically adults with COVID.
REMAP-CAP COVID-19 Convalescent Plasma Randomized Clinical Trial jamanetwork.com/journals/jama/fullarticle/2784914 via @JAMA_current part of @JAMANetwork -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Not entirely true - the WHO list of priority pathogens included coronaviruses, separate from disease X. We already had prototype MERS vaccines. Imagine if we really did have a true disease X.
CEPI
@CEPIvaccines
COVID-19 represents the first occurrence of Disease X since its designation was established by @WHO in 2018 ⬇️
CEPI
@CEPIvaccines
In 2018, @WHO updated its R+D Blueprint to include #diseasex, representing the knowledge that a serious international epidemic could be caused by a unknown pathogen ➡️ www.who.int/activities/prioritizing-diseases-for-research…
-
Peter Horby @peterhorby.bsky.social reposted
CEPI
@CEPIvaccines
COVID-19 represents the first occurrence of Disease X since its designation was established by @WHO in 2018 ⬇️
CEPI
@CEPIvaccines
In 2018, @WHO updated its R+D Blueprint to include #diseasex, representing the knowledge that a serious international epidemic could be caused by a unknown pathogen ➡️ www.who.int/activities/prioritizing-diseases-for-research…
-
Peter Horby @peterhorby.bsky.social reposted
NHS Million
@NHSMillion
Honest tweet now. This account is run by frontline NHS staff. There’s just 3 of us. We have tried our best to get out what is happening on the ground. But we are completely exhausted. If you support what we are doing pls will you follow & RT this to your followers? Thank you 🙏🏻
-
Peter Horby @peterhorby.bsky.social reposted
Kenneth Baillie
@kennethbaillie
Congratulations to @Cambridge_Uni today on their new Professor of Intensive Care Medicine: @charlot_summers. Much of her outstanding leadership in UK critical care through the Covid crisis was behind scenes (in UK CTAP, @ICS_updates, NHS) but believe me, she deserves a knighthood
-
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
An Oxford co-authored paper has won UK Research Paper of the Year Award for the 2nd year in a row. 👏
The RECOVERY trial paper documents the discovery of the world's first effective, readily available treatment for #covid19 – dexamethasone.
Read more ⬇️
www.ox.ac.uk/news/2021-09-30-recovery-trial-paper-wins-bm… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Oh, here is the link to Merck press release
www.merck.com/news/merck-and-ridgebacks-investigational-o… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Encouraging result. Molnupiravir reduced risk of hospitalisation or death by about 50%. 7.3% of patients who got molnupiravir were hospitalized or died through Day 29 following randomization (28/385), compared to 14.1% placebo-treated patients (53/377); p=0.0012
Peter Horby @peterhorby.bsky.social
@PeterHorby
Based on interim analysis of just 775 subjects, so needs confirming in larger sample. >90% of the target 1550 patients have been recruited (>1395), so more precise data should become available - as long as the trial subjects are not unblinded - which I really hope they are not.
Peter Horby @peterhorby.bsky.social
@PeterHorby
A safe, affordable, oral antiviral would be a huge advance. Need to watch for resistance though, and think about combination therapies.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
23 cases of avian influenza H5N6 reported this year. Quite an increase from previous years. Need to see genetic analyses and results of lab growth studies to understand if there is any change in the virus that increases risk. www.info.gov.hk/gia/general/202109/30/P2021093000861.htm
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
REGEN-COV antibody combo shows efficacy in outpatients - including in patients who were SARS-CoV-2 serum antibody–positive at baseline. www.nejm.org/doi/full/10.1056/NEJMoa2108163
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
A privilege to accept the award on behalf of the enormous and exceptional RECOVERY collaborative group.
Massive thanks to the trial team @UniofOxford led by Professor Richard Haynes and the many thousands of dedicated people at @NHSuk @NIHRresearch @DHSCgovuk
The BMJ
@bmj_latest
Congratulations to The RECOVERY Collaborative Group for their paper Dexamethasone in Hospitalized Patients with Covid-19, and winning UK Research Paper of the Year @PeterHorby @MartinLandray #thebmjawards
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Rabies is the most awful disease - yet completely preventable. #worldrabiesday
Tedros Adhanom Ghebreyesus
@DrTedros
Although #rabies is vaccine-preventable it still kills one person every 9 minutes, mostly children. Every life lost is a preventable tragedy. @WHO and partners aim to achieve "Zero human deaths from dog-mediated rabies by 2030". Together we can do it. #worldrabiesday
-
Peter Horby @peterhorby.bsky.social reposted
Gordon H. Guyatt
@GuyattGH
The latest #who #recommendations on use of monoclonal #antibodies in severe and critical #covid19 patients with seronegative status includes an easy to use #infographic www.bmj.com/content/370/bmj.m3379 @Bram_Rochwerg
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Professor Gordon Dougan FRS
@GordonDougan1
We can get better at identifying and controlling the next infection threats through the application of science.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Further impact of the RECOVERY trial.
WHO recommend casirivimab and imdevimab in severe and critical COVID patients who are seronegative (do not have own antibodies to SARS-CoV-2).
A living WHO guideline on drugs for covid-19 www.bmj.com/content/370/bmj.m3379Post not available here, view on X
Peter Horby @peterhorby.bsky.social
@PeterHorby
Several previous trials of monoclonal antibodies in hospitalised patients failed to show a benefit because they were too small and did not stratify by baseline antibody status.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Enormous thanks to the thousands of health care and research staff, and tens of thousands of patients who have contributed so much.
You have improved care for COVID patients worldwide and saved many many lives.
@NHSuk @NIHRresearch @DHSCgovuk @UniofOxford -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Couldn’t agree more Marc. We need to keep pushing.
Marc Mendelson
@SouthAfricanASP
A time for reflection to remember all those that we lost, celebrate those who survived, and to re-dedicate ourselves to preventing and mitigating this awful #covid19 pandemic with every tool at our disposal #getvaccinatednow #socialdistancing #masking #avoidmassgatherings
-
Peter Horby @peterhorby.bsky.social reposted
IDDO @iddonews.bsky.social
@IDDOnews
Standardised #covid19 clinical data collection helps inform clinical decisions and public health responses. Contribute and request access to COVID-19 data held in the IDDO @ISARIC1 data sharing platform www.iddo.org/covid19/data-sharing @LSHTM @TropMedOxford @wellcometrust
📷@NIH -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Trials begin on Covid booster jab hoped to protect against new variants www.theguardian.com/society/2021/sep/21/trials-begin-on-c…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Apologies, my account appears to have been hacked. Have changed login.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Lovely evening with my son at Viet Nam national day celebrations. Thank you 🇻🇳
-
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
Kind words. Thank you
Enormous, collaborative effort
>200 organisations, >4000 professionals & >40,000 patients made this happen & should share in the credit
Now: we MUST NOT REGRESS to the comfort of old habits
Together, we’ve shown what good looks like - let’s build on this
Tim Cook
@doctimcook
An exceptional effort by trialists, regulators, bedside researcher teams with & on behalf of patients & their families are condensed within this & the tweets in Martin Landray’s thread.
The scientific & humanitarian achievements of #recovery are jaw-dropping -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
*Making trials part of good clinical care*
Many have asked about secrets to the success of the RECOVERY trial.
What were the magic ingredients?
What are the lessons for the future?
This paper describes our approach - and sets out the actions needed:
www.ncbi.nlm.nih.gov/pmc/articles/PMC8285150/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Results of DisCoVeRy trial of remdesivir in COVID now out. No significant effect of remdesivir on death, other clinical outcomes or viral kinetics. Big question about the role of this drug.
www.thelancet.com/journals/laninf/article/PIIS1473-3099(2… -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
Help us please:
The Good Clinical Trials Collaborative has consulted widely to develop draft guidelines for Randomised Clinical Trials.
Available in English, French, Spanish, Arabic, Japanese, and Chinese.
Global, open consultation now open:
www.goodtrials.org -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Three studies show COVID-19 vaccines don't raise miscarriage risk
jamanetwork.com/journals/jama/fullarticle/2784193
www.nejm.org/doi/full/10.1056/NEJMc2113891
www.nejm.org/doi/full/10.1056/NEJMoa2104983 -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
If you have been a participant in a clinical trial,
If you are interested in clinical trials, or
If you care that your treatment is based on the very best evidence...
We want to hear from you - please
(deadline extended to 30th September)
Oxford Population Health (OxPop)
@Oxford_NDPH
💬 The Good #clinicaltrials Collaborative are looking for members of the public to provide feedback on new guidance for Randomised Controlled Trials #rcts
⏳ The consultation will end on 15 September
👉 goodtrials.org
@wellcometrust -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant
wwwnc.cdc.gov/eid/article/27/12/21-1792_article?ACSTracki… via @CDCgov -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Nice to see trial data on NPIs - much needed.
Vinay Prasad MD MPH
@VPrasadMDMPH
Bangladesh RCT - encouraging adults to wear surgical mask slows covid spread among older people
Cloth masks do not work
USA has spent 18 months pushing the wrong mask mandates.
Kids mask in schools untested, & now DESPERATELY NEEDS CLUSTER RCT -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Inspired choice. @Chikwe_I has huge experience and is a true leader.
Tedros Adhanom Ghebreyesus
@DrTedros
Glad to appoint @Chikwe_I as Head of the new @WHO Hub for pandemic & epidemic intelligence. He brings a wealth of experience, & will serve a dual role as the head of the Hub in 🇩🇪, & as Assistant Director-General for Health Emergency Intelligence in🇨🇭. Welcome to WHO, my brother!
-
Peter Horby @peterhorby.bsky.social reposted
Kingsley Moghalu OON
@MoghaluKingsley
Congratulations to Dr. @Chikwe_I of Nigeria on his appointment as Assistant Director-General of @WHO in charge of the Pandemic and Epidemic Response Hub in Berlin. A very well deserved appointment. Proud of Chikwe, who handled Nigeria’s #covid19 response brilliantly.
-
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
"Despite affecting humans for more than 5000 years, we still don’t have any robust clinical evidence for the drugs currently used to treat plague." Josie Bourner, #isaric
Read our latest article on #plague : blogs.biomedcentral.com/on-health/2021/09/01/plague-is-no…
@BioMedCentral #imasoytrial #clinicaltrial -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Another great piece of science information from Muge Cevik
Muge Cevik
@mugecevik
There is a lot of concern/confusion about vaccine effectiveness against the delta variant. How effective are the vaccines against Delta & how to interpret real-world observational data? So much misinformation is being circulated, so this thread brings key data together. 🧵(1/n)
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Vaccine inequality - The statistics are stark and shaming. www.theguardian.com/commentisfree/2021/aug/25/the-guardia…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY trial - first patients recruited in Vietnam. Congratulations to the Vietnam study team and everyone at HTD, HCMC.
My thoughts are with my Vietnamese friends and colleagues at this difficult time for the country. -
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
Sad and regrettable when an issue such as wearing of masks becomes a party political issue www.telegraph.co.uk/politics/2021/08/18/face-mask-divide-…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Another disappointing result for convalescent plasma. Did not prevent disease progression when given to high-risk outpatients within 1 week of symptom onset.
www.nejm.org/doi/full/10.1056/NEJMoa2103784 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
As well as preventing infections and severe disease, COVID vaccination also reduces household transmisson.
Get vaccinated to protect yourself and others.
www.nejm.org/doi/full/10.1056/NEJMc2107717 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Good news for patients - First monoclonal antibody treatment for COVID-19 approved for use in the UK www.gov.uk/government/news/first-monoclonal-antibody-trea…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Sharing vaccines is in everyones interest. The scientific and moral cases are crystal clear.
Vaccine nationalism and the dynamics and control of SARS-CoV-2 science.sciencemag.org/content/early/2021/08/16/science.a… -
Peter Horby @peterhorby.bsky.social reposted
Marc Mendelson
@SouthAfricanASP
Thank you for your honest and ethical re-appraisal of the [lack of] evidence for #ivermectin in the treatment and prevention of #covid19. Much appreciated! @FrancoisVenter3 @ShabirMadh @dailymaverick @GroundUp_News @TeamNews24 @SABCNews @NewzroomAfrika @mailandguardian
-
Peter Horby @peterhorby.bsky.social reposted
Andrew Pollard
@ajpollard1
Vaccines are saving lives today, for those who already have them. It’s ethical, moral, logical, and just fair, that those who have none deserve to get the next doses. www.theguardian.com/commentisfree/2021/aug/13/covid-boost…
-
Peter Horby @peterhorby.bsky.social reposted
Marc Mendelson
@SouthAfricanASP
"Let me say this as an African: our world as we know it is on the brink we face massive death tolls & collapse of economies & nations. What is the real meaning of human-ity? For all lives to be given the same value, irrespective of geography or economy" www.nature.com/articles/d41586-021-01964-2
-
Peter Horby @peterhorby.bsky.social reposted
Charlotte Summers
@charlot_summers
Oxygen stewardship is important - watch this great video from @aroradrn to see how easy it is to waste O2 in large quantities.
Nitin Arora
@aroradrn
Have you ever put a patient on a non-rebreathe mask (O2 mask with reservoir bag), and cranked the O2 up?
We tested to see what happens
And were stunned
Tried with various brands…This media couldn't be displayed. See it on the original post. -
Peter Horby @peterhorby.bsky.social reposted
Institute for Government
@instituteforgov
"We have to make the vaccine available globally. And I’m afraid, to date, we’ve failed to do that."
@JeremyFarrar discusses vaccine sharing and warns new, dangerous variants will emerge if we leave poorer countries with inequitable access to vaccines
www.instituteforgovernment.org.uk/events/jeremy-farrarThis media couldn't be displayed. See it on the original post. -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY Update:
Now >41,000 patients hospitalised with COVID-19 enrolled:
- UK 40638
- Nepal 249
- Indonesia 118
& accelerating once more.
Thank you to all involved in this incredible search for more treatments -
Peter Horby @peterhorby.bsky.social
@PeterHorby
So many examples of normally sensible people losing the plot during the pandemic - a real eye opener
Peter Openshaw
@p_openshaw
“Thousands of highly educated scientists, doctors, pharmacists, and at least four major medicines regulators missed a fraud so apparent that it might as well have come with a flashing neon sign. "
Charlotte Summers
@charlot_summers
Clinical trial supporting ivermectin as Covid treatment withdrawn over ethical concerns www.theguardian.com/science/2021/jul/16/huge-study-suppor…
-
Peter Horby @peterhorby.bsky.social reposted
Peter Openshaw
@p_openshaw
“Thousands of highly educated scientists, doctors, pharmacists, and at least four major medicines regulators missed a fraud so apparent that it might as well have come with a flashing neon sign. "
Charlotte Summers
@charlot_summers
Clinical trial supporting ivermectin as Covid treatment withdrawn over ethical concerns www.theguardian.com/science/2021/jul/16/huge-study-suppor…
-
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
Thanks to the dedication of #isaric partners worldwide, the ISARIC Clinical Data Platform has reached a milestone of more than half a million hospitalised #covid-19 patients from 788 institutions in 63 countries.
👉 isaric.org/isaric-covid-19-clinical-database-passes-the-h…
@APPRISE_CRE @GloPID_R @RECOVER_EUROPE -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Fantastic recognition of heroic efforts of so many people in NHS, NIHR and @UniofOxford. Really amazing achievement- special thanks to Richard Haynes and the trial teams @Oxford_NDPH
Martin Landray
@MartinLandray
Wonderful recognition for the whole team - colleagues @Oxford_NDPH @NDMOxford, research staff @NIHRresearch, frontline staff at nearly 200 #nhs hospitals, and 40,000 amazing patients. All in the most difficult circumstances.
And we continue our search for more treatments. -
Peter Horby @peterhorby.bsky.social reposted
Marc Mendelson
@SouthAfricanASP
Huge study supporting #ivermectin as #covid19 treatment withdrawn over ethical [fraudulent] concerns - important as this study skewed systematic reviews towards benefit for ivermectin 🙄www.theguardian.com/science/2021/jul/16/huge-study-suppor…
-
Peter Horby @peterhorby.bsky.social reposted
Professor Chris Whitty
@CMO_England
As we move to the next stage of the COVID response, it is essential we change behaviour slowly and steadily.
These papers give some of the data which show why going slowly will reduce the risk to all.
www.gov.uk/government/collections/sage-meetings-july-2021 -
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
SAGE 93 minutes: Coronavirus (COVID-19) response, 7 July 2021 www.gov.uk/government/publications/sage-93-minutes-corona…
-
Peter Horby @peterhorby.bsky.social reposted
James Ward
@JamesWard73
So it’s time for me to come off the fence re 19th July. I’m in favour of:
a) Opening up on 19/7, but with stronger mitigating baseline measures than the govt is proposing
b) Opening up vaccinations to 12-17s as supply permits, starting with the vulnerable.
Long🧵follows... -
Peter Horby @peterhorby.bsky.social reposted
Marc Mendelson
@SouthAfricanASP
For all the doctors and family/friends of patients in public sector hospitals in 🇿🇦we are not treating severe #covid19 patients with #ivermectin. It does not form part of our national guidelines & the evidence base for that conclusion can be read 👉www.health.gov.za/wp-content/uploads/2021/07/Rapid-review… 1/n
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
WHO issue a new COVID treatment recommendation regarding interleukin-6 (IL-6) receptor blockers, including both tocilizumab and sarilumab www.who.int/publications-detail-redirect/WHO-2019-nCoV-th…
-
Peter Horby @peterhorby.bsky.social reposted
PHILA
@PHILA_ZW
“The richest guys grabbed the baker...”
Strive Masiyiwa, who heads Africa’s vaccination acquisition task team, lays into the ‘deliberate’ hoarding of vaccines by Western nations, which he says has left Africa short of vaccines
(🎥 Milken) milkeninstitute.org/video/covid-vaccines-global-coordination
[THREAD] -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY Impact: Tocilizumab
@US_FDA grants Emergency Use Authorisation for hospitalised patients with COVID-19 who are receiving oxygen (+/-ventilation) & corticosteroids
Good news for patients
Thanks to all involved
Clinical trials save lives www.fda.gov/news-events/press-announcements/coronavirus-c… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Last chance for this exciting, international opportunity.
ISARIC
@ISARIC1
We have extended the application deadline until Monday 28/06/2021 - apply now and come join our team!
-
Peter Horby @peterhorby.bsky.social reposted
-
Peter Horby @peterhorby.bsky.social reposted
Nuffield Department of Medicine
@NDMOxford
How the world can stop future pandemics in their tracks www.telegraph.co.uk/global-health/science-and-disease/wor…
-
Peter Horby @peterhorby.bsky.social reposted
Peter Openshaw
@p_openshaw
Comparing high and low antibody responders in 78 infected HCWs, stability correlated with IFN-γ ELISpot T cell immunity and was associated with higher levels of neutralising antibodies against the infecting 117 (Victoria) strain and variants B.1.1.7 (alpha) and B.1.351 (beta).
UK-CIC
@UKCICstudy
ICYMI | A 🆕 study by @PITCHstudy & #ukcic researchers has found highly variable immune responses 6 months after infection with #covid19, reinforcing the need for everyone to be vaccinated.
The pre-print was posted on @ResearchSquare 📚 Read more www.uk-cic.org/news/latest-data-immune-response-covid-19-… -
Peter Horby @peterhorby.bsky.social reposted
Lucy Chappell
@LucyChappell2
Thank you to everyone - colleagues, patients, public, pregnant women, children - who have transformed our understanding of #covid19 and enabled #recovery treatments and vaccines to be rolled out. I'm #red4research today to acknowledge their phenomenal contribution. @NIHRresearch
National Institute for Health and Care Research
@NIHRresearch
Researchers, study participants and members of the public are today recognising #covid19 research by supporting the #red4research campaign.
Join us and show your appreciation by sharing a picture of yourself wearing red and tagging us in your posts: www.nihr.ac.uk/news/nihr-supports-red4research-campaign/2… -
Peter Horby @peterhorby.bsky.social reposted
Wellcome
@wellcometrust
Potential consequences of new variants are ⤵️
🦠 A change in transmissibility
😷 Changes in disease severity
🧪 An ability to evade detection by tests
💊 Reduced susceptibility to treatments
💉 An ability to evade natural or vaccine-induced immunity
wellc.me/2QiHNSB -
Peter Horby @peterhorby.bsky.social reposted
Matt Hancock
@MattHancock
Today marks the one-year anniversary of dexamethasone being rolled out in the NHS, the world’s first coronavirus treatment proven to reduce the risk of death.
Finding dexamethasone has been a true success of British research & has led to over a million lives saved worldwide. -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
I know the feeling. So good to get clear results from all that hard work.
Thank you for all your efforts.
And many thanks to your patients for their contribution to this discovery.
⭐💙Kathryn Simpson💙
@Kathryn57993406
Myself and other @WhitHealthresearch team members were somewhat tearful with this news - happy tears of course! So proud to be making a difference, kudos to @drcdparmar @KayleighGilber9 @zuu_ana @bookerlauren_ @fatmanu09328453 Anezka, Sam, Champa et al @Whittingtonphar #proud
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY monoclonal pre-print now out here:
www.medrxiv.org/content/10.1101/2021.06.15.21258542v1
Figure of Primary and secondary outcomes by baseline serostatus.
p-values for test for heterogeneity show that the estimate of the treatment effect is different in seronegative and seropositive patients. -
Peter Horby @peterhorby.bsky.social reposted
Imperial Medicine
@ImperialMed
"Monkeypox cases not a threat but a reminder of our vulnerability to viruses"
www.imperial.ac.uk/news/223754/monkeypox-cases-threat-rem… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY has shown that it is possible to massively accelerate medical advances and massively decrease costs. Estimated cost of £250 per patient enrolled - a fraction of other clinical trials.
-
Peter Horby @peterhorby.bsky.social reposted
Wellcome
@wellcometrust
The result is hugely important.
But monoclonal antibodies are expensive.
“There really must be initiatives to make these drugs accessible … you have to scale up manufacturing, and they have to be affordable” 💬 @PeterHorby
www.theguardian.com/world/2021/jun/16/new-drug-cuts-death… -
Peter Horby @peterhorby.bsky.social reposted
Wellcome
@wellcometrust
GOOD NEWS 📢 A cocktail of two monoclonal antibodies has been found to cut #covid19 deaths by a fifth among the sickest patients in hospital.
Here’s how they work ⤵️ -
Peter Horby @peterhorby.bsky.social reposted
remap-cap
@remap_cap
Preprint version of the manuscript ‘’Convalescent Plasma in Critically ill Patients with Covid-19’’ now available online: www.medrxiv.org/content/10.1101/2021.06.11.21258760v1
#remapcapfamily @AndelLestcourt @statberry @agordonICU @DrJohnCMarshall @cjmca @B_McVerry @PaulMouncey @srinmurthy99 @alistair_nichol -
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
Importance of #patient bed pathways and length of stay differences in predicting #covid-19 hospital bed occupancy in #england
@CCPUKstudy @ProfCalumSemple @NLM_NIH @NCBI
READ: pubmed.ncbi.nlm.nih.gov/34107928/ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Key figure from monoclonal treatment pre-print that will come out later today
Peter Horby @peterhorby.bsky.social
@PeterHorby
⏩ New RECOVERY trial result.
Monoclonal antibody combination reduces deaths in seronegative patients hospitalised with COVID-19.
- 9785 patients randomised
- primary analysis population 3153 patients without own SARS-CoV2 antibodies detectable at randomisation (seronegative) -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Here is the full public statement www.recoverytrial.net/news/recovery-trial-finds-regeneron…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
⏩ New RECOVERY trial result.
Monoclonal antibody combination reduces deaths in seronegative patients hospitalised with COVID-19.
- 9785 patients randomised
- primary analysis population 3153 patients without own SARS-CoV2 antibodies detectable at randomisation (seronegative)Post not available here, view on X
Peter Horby @peterhorby.bsky.social
@PeterHorby
Raises questions and delivery issues:
- Need for serology testing at point of care
- Can these drugs be made available to anyone who needs them? Access = availability and pricing.
- Would this drug be beneficial in patients who are "vaccine failures"?
- + many more I am sure
Peter Horby @peterhorby.bsky.social
@PeterHorby
Pre-print coming shortly.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Monoclonal antibodies cut risk of dying from COVID-19—but only in some patients www.sciencemag.org/news/2021/06/monoclonal-antibodies-cut…
-
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
All thoughts friends,colleagues & people Viet Nam. Challenge of a country done so well so far to reduce infections,now facing new waves & at same time as “dengue season”. With limited access vaccines VN facing v difficult few wks/mths. Global equitable access vaccines so critical
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Congratulations Tom. Very well deserved.
Prof Tom Solomon CBE
@RunningMadProf
Thank you - it's a great honour and I feel very proud, but also very thankful of all the support from many people over many years!
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Just call me Pete. Thanks Charlotte
Rupert Beale
@bealelab
You have to call them Sir now.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
⏩40,000 COVID patients now recruited to RECOVERY trial.
Phenomenal effort by front-line staff @NHSuk, @NIHRresearch, @NHSDigital, @Oxford_NDPH, @NDMOxford
Remarkable contribution by patients and their families.
Together improving COVID care & saving lives.
Thank you. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Good result on use of wolbachia to reduce dengue transmission. Congratulations Katie Anders and team. 'Miraculous' mosquito hack cuts dengue by 77% - BBC News www.bbc.co.uk/news/health-57417219
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
As promised. RECOVERY aspirin pre-print here: www.medrxiv.org/content/10.1101/2021.06.08.21258132v1
Peter Horby @peterhorby.bsky.social
@PeterHorby
🔥 RECOVERY result Aspirin
14892 COVID patients randomised to aspirin vs. usual care alone - no significant difference in 28-day mortality (17% aspirin vs. 17% usual care; rate ratio 0.96 [95% CI 0.89-1.04]; p=0.35). Pre-print imminent.
www.recoverytrial.net/news/recovery-trial-finds-aspirin-d… -
Peter Horby @peterhorby.bsky.social reposted
Peter Horby @peterhorby.bsky.social
@PeterHorby
🔥 RECOVERY result Aspirin
14892 COVID patients randomised to aspirin vs. usual care alone - no significant difference in 28-day mortality (17% aspirin vs. 17% usual care; rate ratio 0.96 [95% CI 0.89-1.04]; p=0.35). Pre-print imminent.
www.recoverytrial.net/news/recovery-trial-finds-aspirin-d… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
🔥 RECOVERY result Aspirin
14892 COVID patients randomised to aspirin vs. usual care alone - no significant difference in 28-day mortality (17% aspirin vs. 17% usual care; rate ratio 0.96 [95% CI 0.89-1.04]; p=0.35). Pre-print imminent.
www.recoverytrial.net/news/recovery-trial-finds-aspirin-d… -
Peter Horby @peterhorby.bsky.social reposted
James Ward
@JamesWard73
Model update klaxon!! I’ve spent a while this weekend refitting my model to current data and trends, and as a result I’ve changed my mind on at least 3 things – and also got closer to a policy recommendation for Step 4 re-opening scheduled for 21st June. Thread follows: 1/n
-
Peter Horby @peterhorby.bsky.social reposted
delthia ricks 🔬
@DelthiaRicks
New nanopore sequencing contradicts a hypothesis posited by a Harvard/MIT team who said SARSCoV2 integrates into the human genome. New preprint reports that's not possible: SARS2 lacks a reverse transcriptase enzyme required to convert the RNA into DNA www.news-medical.net/news/20210602/Nanopore-sequencing-co…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Completely agree. The technical reports are superb. A big thanks to all those who have put in so many hours to get these out so quickly.
Prof Francois Balloux
@BallouxFrancois
I'm extremely impressed by the quality of the UK #covid19 data. Their near-real time analyses or the PHE reports are unparalleled in their quality. I'm also in awe of the efforts to present those findings in an approachable way on social media for instance by @kallmemeg.
1/ -
Peter Horby @peterhorby.bsky.social reposted
Nature Reviews Microbiology
@NatureRevMicro
SARS-CoV-2 variants, spike mutations and immune escape
nature.com/articles/s41579-021-00573-0
Members of @CovidGenomicsUK (COG-UK) & co summarize SARS-CoV-2 spike mutations, their structural context and impacts on antigenicity, and discuss variants of interest or concern and vaccine efficacy. -
Peter Horby @peterhorby.bsky.social reposted
Global Health Strategies
@GHS
Enough with vaccine nationalism.
Africa has administered just 1.5% of the doses given across the 🌍.
“This is tragic,” says @DrTedros. We must focus on building long-term capacity AND the immediate solution of vaccine sharing. www.aa.com.tr/en/africa/-tragic-that-just-over-25m-vaccin… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
If forgetfulness scales with impact, we may have max ten years this time, and then pandemic preparedness will wither again. Sustainable safety is the conundrum. Need dual use: day 2 day utility that also increases pandemic security.
Edward Nirenberg 🇺🇦
@ENirenberg
It really worries me that in a few years everyone will forget the importance of pandemic preparedness and then when the next pandemic comes we will be in a similar position as in this one and repeat all the same mistakes.
-
Peter Horby @peterhorby.bsky.social reposted
Todd C. Lee
@DrToddLee
Observational therapeutic studies in covid-19 caused
-
Peter Horby @peterhorby.bsky.social reposted
Government Office for Science
@uksciencechief
📢🔎📋 The latest evidence informing the advice from SAGE has just been released taking the total number of papers to over 700. Check them out here ➡️www.gov.uk/government/collections/scientific-evidence-sup…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
I’m immensely proud to be leading the new Pandemic Sciences Centre @UniofOxford
The global scientific community have delivered huge societal benefits during the COVID pandemic.
Our aspiration is to apply that same energy and innovation to prevent this ever happening again.
University of Oxford
@UniofOxford
🆕 | Oxford University announces the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre.
The centre's mission will be to ensure that the world is better equipped to identify and counter future pandemic threats.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Multidisciplinary collaboration is a must - infectious diseases, veterinary sciences, vaccinology, immunology, structural biology, diagnostics, drug discovery, clinical trials, data science, public health, and social and political sciences.
Peter Horby @peterhorby.bsky.social
@PeterHorby
And inter-sectoral partnerships - academia, industry, public health and NGOs.
Only together can we tackle the existential threat of emerging and pandemic threats. -
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
Vice-Chancellor Louise Richardson has shared her thoughts following the announcement of the Pandemic Sciences Centre.
Find out more ➡️ www.ox.ac.uk/news/2021-05-28-university-oxford-launch-pan… -
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
🆕 | Oxford University announces the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre.
The centre's mission will be to ensure that the world is better equipped to identify and counter future pandemic threats. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
"we project large future outbreaks of both diseases [RSV and influenza] may occur following a period of extended NPIs."
Need to be preparing now for a challenging winter.
Jeremy Farrar
@JeremyFarrar
Well worth a read - “The impact of COVID-19 nonpharmaceutical
interventions on the future dynamics of
endemic infections” eur01.safelinks.protection.outlook.com?url=https%3A%2F%2F… -
Peter Horby @peterhorby.bsky.social reposted
UK Health Security Agency
@UKHSA
Our new study shows for the first time that 2 doses of the #covid19 #vaccines are highly effective against the B.1.617.2 variant first identified in India. Read more: www.gov.uk/government/news/vaccines-highly-effective-agai…
-
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
Preliminary UK data on vaccine effectiveness against B.1.617.2 (originally detected in India) now available: khub.net/documents/135939561/430986542/Effectiveness+of+C…. A few things to note... 1/
-
Peter Horby @peterhorby.bsky.social reposted
The Lancet
@TheLancet
NEW—First data suggest Africa has higher death rate among critically ill #covid19 patients than any other world region. High mortality may be partly explained by shortage of critical care resources and underuse of those available, say researchers. Read www.thelancet.com/journals/lancet/article/PIIS0140-6736(2….
-
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
🎬| The #recoverytrial is the world's largest COVID-19 drug trial.
Thanks to the work of RECOVERY, patients hospitalised with severe #covid19 now have two treatments that are known to improve survival.
Find out all you need to know about the trial ⬇️
#clinicaltrialsday -
Peter Horby @peterhorby.bsky.social
@PeterHorby
#recoverytrial named David Sackett Trial of the Year 2020.
The trial has been possible only because so many people and organisations got behind the concept and worked unimaginably hard under very difficult circumstances.
Tropical Medicine Oxford
@TropMedOxford
#recoverytrial named David Sackett Trial of the Year 2020
RECOVERY is a large, pragmatic randomised trial for the treatment of hospitalised patients with COVID-19. It was designed and implemented at extraordinary speed in the midst of the COVID-19 pandemic
www.tropicalmedicine.ox.ac.uk/news/recovery-trial-named-d…
Peter Horby @peterhorby.bsky.social
@PeterHorby
Enormous thanks to the stellar trial team, research services, finance and communications @UniofOxford; @NIHRresearch; @UKRI_News; @FCDOResearch; @wellcometrust ; and @NHSDigital.
But most of all thank you to the front line nurses, doctors and pharmacists and +++ the patients -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Ditto from me and the RECOVERY team. Congratulations to Comms team @UniofOxford and thank you.
Andrew Pollard
@ajpollard1
Congratulations to the Comms team @UniofOxford and thanks for your support @OxfordVacGroup www.prweek.com/article/1716295/prweek-global-awards-winne…
-
Peter Horby @peterhorby.bsky.social reposted
The Global Health Network
@info_TGHN
If you need to design and test diagnostics for new or re-emerging infectious disease outbreaks be sure to join tomorrow's workshop: Implementation of novel laboratory diagnostics for emerging infectious diseases: zoom.us/webinar/register/6016203822863/WN_E4B6N-6aQxGD3Vs…
#covid19 -
Peter Horby @peterhorby.bsky.social reposted
Lord Bethell
@JimBethell
THANK YOU: Today is International Clinical Trials Day. After the massive national 🚀 of the vaccine, we should all say a huge 🙏 for those engaged in the meticulous work of trials. It makes science safe and effective. Thank you!
#clinicaltrialsday -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Clinical trials are just protocols without participants. So important. Thank you to everyone who has ever volunteered for a clinical trial.
Oxford Population Health (OxPop)
@Oxford_NDPH
This #clinicaltrialsday, we'd like to say a big thank you to all the participants that make our #clinicaltrials possible 👏 👏
Dennis took part in the #recoverytrial of COVID-19 treatments after being admitted to hospital
➡️ www.recoverytrial.net -
Peter Horby @peterhorby.bsky.social reposted
Oxford Population Health (OxPop)
@Oxford_NDPH
This #clinicaltrialsday, we'd like to say a big thank you to all the participants that make our #clinicaltrials possible 👏 👏
Dennis took part in the #recoverytrial of COVID-19 treatments after being admitted to hospital
➡️ www.recoverytrial.net -
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY Colchicine result out now as pre-print
medrxiv.org/content/10.1101/2021.05.18.21257267v1
11340 patients hospitalised with COVID-19 randomised to colchicine vs usual care
Unfortunately no evidence of clinical benefit in primary or secondary outcomes, or in any patient subgroups.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Not the answer we wanted.
But a clear answer nevertheless.
We now move on to other potential treatments.
Thank you to @NHSuk, patients, @NIHRresearch, @UKRI_News, @wellcometrust and also to international sites in Nepal and Indonesia who have joined RECOVERY.
Peter Horby @peterhorby.bsky.social
@PeterHorby
The RECOVERY trial only studied hospitalised COVID-19 patients and, therefore, is not able to provide evidence on the safety and efficacy of colchicine used in other patient groups.
-
Peter Horby @peterhorby.bsky.social reposted
University of Oxford
@UniofOxford
'We were determined from the outset that if our vaccine proved effective it would not be limited to wealthy countries.'
Our partnership with @AstraZeneca is how we're providing the world with the two-dose vaccine at cost, forever, in low and middle-income countries.
Read more⬇️ -
Peter Horby @peterhorby.bsky.social
@PeterHorby
We all benefit from and can contribute to research. Research is a social endeavour and a public good. #bepartofresearch
Prof. Dame Sally Davies
@DameSallyDavies
Collaborative research means that we can tackle the world’s biggest health challenges together.
Life-changing treatments depend on volunteers who can #bepartofresearch 💊💉 -
Peter Horby @peterhorby.bsky.social reposted
Professor Calum Semple OBE
@ProfCalumSemple
In-hospital #covid mortality declined in UK from 32% at the start to 16% at the end of the first wave in 2020. See "Changes in in-hospital mortality in the first wave of COVID-19" by @abdocherty79 and ISARIC4C investigators @CCPUKstudy www.thelancet.com/journals/lanres/article/PIIS2213-2600(2…
-
Peter Horby @peterhorby.bsky.social reposted
Eric Topol
@EricTopol
All studies are consistent about vaccines holding up to B.1.617. Latest:
"The modest neutralization resistance of the variant spike proteins to vaccine elicited antibody suggests that current vaccines will remain protective vs B.1.617 and B.1.618 variants"
www.biorxiv.org/content/10.1101/2021.05.14.444076v1.full.pdf -
Peter Horby @peterhorby.bsky.social reposted
Prof. Devi Sridhar
@devisridhar
UK in a precarious position w/ B.1617. We have tools to help stop spread. Get vaccinated, get tested (& isolate if you're positive), avoid crowded places, meet people outdoors, wear masks indoors & remember that the end is in sight, but we need to tread cautiously now.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Please see earlier message.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
RECOVERY had all three:
1. All plasma tested with an assay ≥ 99% sens and spec for SARS-CoV-2 Abs
2. No mortality benefit in patients allocated to CP ≤4 days from illness onset (n=1908).
3. All plasma units far exceeded FDA definition of "high titre"
Arturo Casadevall
@ACasadevall1
Sadly not a scientific win. Many of the early trials including RECOVERY were not designed taking into account 100 years of experience with antibody therapies - see pubmed.ncbi.nlm.nih.gov/33653885/
Of the principles recovery had 1, maybe 3, but not 2
Nicholas A. Christakis
@NAChristakis
We must accept that convalescent plasma, despite its prior use in other diseases and despite a sensible rationale in COVID-19, does not work.
Another scientific win for the remarkable effort that is the British RECOVERY family of RCTs.
Martin Landray
@MartinLandray
RECOVERY publication: Convalescent plasma in 11569 hospitalised patients
- no significant reduction in mortality
- no significant increase in chances of being discharged alive at 28 days
- no significant reduction in progression to invasive mechanical ventilation or death
Peter Horby @peterhorby.bsky.social
@PeterHorby
Most of the assessments of CP failed to take into account the almost 80 year history of the vital importance of randomisation and the inherent unreliability of observational data.
Peter Horby @peterhorby.bsky.social
@PeterHorby
We did not exclude the possibility of small improvements in the probability of successful discharge from hospital by day 28 or of progressing to invasive mechanical ventilation or death in seronegative patients - but a benefit in that group needs to be shown in RCTs, not assumed.
-
Peter Horby @peterhorby.bsky.social reposted
Arturo Casadevall
@ACasadevall1
Sadly not a scientific win. Many of the early trials including RECOVERY were not designed taking into account 100 years of experience with antibody therapies - see pubmed.ncbi.nlm.nih.gov/33653885/
Of the principles recovery had 1, maybe 3, but not 2
Nicholas A. Christakis
@NAChristakis
We must accept that convalescent plasma, despite its prior use in other diseases and despite a sensible rationale in COVID-19, does not work.
Another scientific win for the remarkable effort that is the British RECOVERY family of RCTs.
Martin Landray
@MartinLandray
RECOVERY publication: Convalescent plasma in 11569 hospitalised patients
- no significant reduction in mortality
- no significant increase in chances of being discharged alive at 28 days
- no significant reduction in progression to invasive mechanical ventilation or death -
Peter Horby @peterhorby.bsky.social reposted
Martin Landray
@MartinLandray
RECOVERY publication: Convalescent plasma in 11569 hospitalised patients
- no significant reduction in mortality
- no significant increase in chances of being discharged alive at 28 days
- no significant reduction in progression to invasive mechanical ventilation or death -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Michael, those comparison are not statistically significant. We did not identify a mortality benefit in patients allocated to CP ≤4 days from illness onset, which by itself comprised more patients than the total number of patients enrolled in all other CP trials combined.
Peter Horby @peterhorby.bsky.social
@PeterHorby
We did not exclude the possibility of small improvements in the probability of successful discharge from hospital by day 28 or of progressing to invasive mechanical ventilation or death in seronegative patients - but a benefit in that group needs to be shown in RCTs, not assumed.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Convalescent plasma in patients admitted to hospital with COVID-19 (RE... www.sciencedirect.com/science/article/pii/S0140673621008977
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Love this - admitting errors of judgement, not just errors of fact, is a rare strength. What we got wrong: the Guardian’s worst errors of judgment over 200 years www.theguardian.com/media/2021/may/07/guardian-200-what-w…
-
Peter Horby @peterhorby.bsky.social reposted
The Global Health Network
@info_TGHN
Do you need to design and test diagnostics for new or re-emerging infectious disease outbreaks? Join our workshop: Implementation of novel laboratory diagnostics for emerging infectious diseases
19-20 May 2021
13:00-17:00 PM BST (London, UK)
Register: zoom.us/webinar/register/6016203822863/WN_E4B6N-6aQxGD3Vs… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
And the public are meant to trust the media, who feed on finding reasonable but different views and making a story of it?
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
To save lives?
Matthew Lesh
@matthewlesh
This is an insanely stupid idea — why ever produce a vaccine if your property rights will be stolen?
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
What a toxic load of rubbish from a right wing think tank whose funding is opaque.
Wall Street Journal Opinion
@WSJopinion
Oxford University scientists insisted that nobody profit from the vaccine they’d helped develop. The result, with AstraZeneca, has been a debacle, writes @matthewlesh www.wsj.com/articles/stakeholder-capitalism-caused-the-ox…
-
Peter Horby @peterhorby.bsky.social reposted
Wall Street Journal Opinion
@WSJopinion
Oxford University scientists insisted that nobody profit from the vaccine they’d helped develop. The result, with AstraZeneca, has been a debacle, writes @matthewlesh www.wsj.com/articles/stakeholder-capitalism-caused-the-ox…
-
Peter Horby @peterhorby.bsky.social reposted
Leticia Kawano-Dourado (I'm on BlueSky/LinkedIn)
@leticiakawano
So last season, but....here it is another argument against HCQ for COVID-19
Nature Portfolio
@NaturePortfolio
Hydroxychloroquine shows no substantial antiviral activity in cynomolgus macaques infected with SARS-CoV-2 regardless of the timing of treatment initiation, either before infection, soon after infection or late after infection, according to a Nature paper. go.nature.com/30PVGsG
-
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
30April "Very real risk that this will ripple out, west India, Pakistan, Afghanistan, north to Nepal, east Myanmar & hence SEAsia. There are many links btw South Asia & East Africa & hence a continued risk to the continent despite massive efforts to date.
Jeremy Farrar
@JeremyFarrar
Time for the unfolding global crisis to be discussed & immediate collective action at the @UN Security Council. The public health & humanitarian crisis in India will not stop at the borders & risks a regional & global wider catastrophe. www.ft.com/content/ad200d93-3247-409a-8afb-482234b4655c
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Any and all initiatives to increase COVID vaccine availability should be embraced. Protectionism has no place in a global health disaster.
US backs waiver on vaccine intellectual property - BBC News www.bbc.co.uk/news/world-us-canada-57004302 -
Peter Horby @peterhorby.bsky.social reposted
Eric Topol
@EricTopol
There's been a relative fixation on the #sarscov2 spike protein's RBD, but most of the many clones of antibodies we make are directed to non-RBD, the N-terminal domain (NTD) —increasingly recognized for their immune evasion potential
science.sciencemag.org/content/early/2021/05/03/science.a… New @ScienceMagazine -
Peter Horby @peterhorby.bsky.social reposted
Buddha Basnyat
@BasnyatBuddha
Nepal facing deadly Covid wave similar to India, doctors warn www.theguardian.com/global-development/2021/apr/30/nepal-…
-
Peter Horby @peterhorby.bsky.social reposted
Louise Sigfrid
@louise_sigfrid
Great opportunity - come join our fantastic team in Oxford supporting our busy international epidemic clinical research response teams 👇 #datascience @ERGO @ISARIC1 @TropMedOxford
ISARIC
@ISARIC1
Are you a Senior Biostatistician looking for your next big challenge? Join @ERGO_Horby | Provide support in #research design, methodological development, and the analysis and reporting of observational and intervention studies.
Deadline 5 May
Apply: my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Meta-analysis of RECOVERY + 8 other trials - overall benefit on 28-day mortality. No statistical evidence of heterogeneity between RECOVERY and eight previous trials combined, χ12=0·2 (p=0·7).
Peter Horby @peterhorby.bsky.social
@PeterHorby
Benefit on 28-day mortality and discharge from hospital within 28 days of randomisation.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Benefit on 28-day mortality and discharge from hospital within 28 days of randomisation.
Peter Horby @peterhorby.bsky.social
@PeterHorby
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
-
Peter Horby @peterhorby.bsky.social reposted
Jeremy Farrar
@JeremyFarrar
Tragic every perspective. A safe effective vaccine, developed with public, private & philanthropic funding over years, a founder & company committed to not for profit vaccine, that can be manufactured at scale & used globally now subject to legal actions
www.bbc.co.uk/news/world-europe-56891326 -
Peter Horby @peterhorby.bsky.social reposted
IDDO @iddonews.bsky.social
@IDDOnews
Standardised #covid19 clinical data collection helps inform clinical decisions and public health responses. Contribute and request to access to COVID-19 data held in the @ISARIC1 data sharing platform www.iddo.org/covid19/data-sharing
@LSHTM @TropMedOxford @wellcometrust -
Peter Horby @peterhorby.bsky.social
@PeterHorby
This is heartbreaking. Those of us starting to enjoy new freedoms must be reminded that this grim pandemic continues to rage elsewhere. Us scientists must not lose out sense of urgency.
Charlotte Summers
@charlot_summers
Utterly utterly heartbreaking.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
More fantastic vaccine news - just not COVID this time.
Oxford Malaria vaccine proves highly effective in Burkina Faso trial www.theguardian.com/world/2021/apr/23/oxford-malaria-vacc… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
I do think so @sophieyacoub
-
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
Have you explored the current analyses using data from the ISARIC #covid19 clinical data platform?
#clinicaldata #clinicalresearch #datascience
Explore, join and propose one of your own: isaric.org/research/covid-19-clinical-research-resources/… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Maria you are doing the most fabulous, incredible work.
Those who indulge themselves in personal attacks should be ashamed; unfortunately I doubt they ever will be. Remember that this is their problem and burden, not yours.
Maria Van Kerkhove
@mvankerkhove
Enough with personal attacks. I can take a lot, but it’s enough.
I am a scientist. In my work, we work with 1000s, we follow the whole of science. We update regularly.
Stop retweeting 1 old tweet, 1 answer from >1yr ago. Listen to my statements, read our updated guidance. -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Some progress on COVID treatments but still a lot more to be done. Monoclonal antibodies missing from this list.
The drugs that have shown promise in treating Covid www.theguardian.com/world/2021/apr/20/the-drugs-that-coul… -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Great new initiative to accelerate the development and evaluation of antivirals for COVID. Hopefully will be extended to other viral threats to global health.
Government Office for Science
@uksciencechief
“The speed which vaccines and therapeutics such as dexamethasone have been identified and deployed against #covid19 has been critical to the pandemic response. The Taskforce will help ensure the most promising antivirals are available for deployment as quickly as possible.” - PV
-
Peter Horby @peterhorby.bsky.social reposted
ISARIC
@ISARIC1
We're #hiring! #isaric is looking for a Senior Biostatistician | come and join the team
Apply: my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.displa… -
Peter Horby @peterhorby.bsky.social reposted
C. Michael Gibson MD
@CMichaelGibson
This could have been avoided had we gotten organized and done a proper randomized trial to assess the effectivensss of plasma from the outset ...
NYT Health
@NYTHealth
The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled. www.nytimes.com/2021/04/17/health/covid-convalescent-plas…
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
A great choice. Congratulations Lucy.
-
Peter Horby @peterhorby.bsky.social reposted
Chikwe Ihekweazu
@Chikwe_I
Important letter in @NatureMedicine for those really interested in a new public health order.
It's not just about restructuring old or creating new institutions, it's a new way of thinking.
Thanks @udnore et al.
Ngozi
@udnore
‼️Out today in @NatureMedicine
In our open letter to international funders of science & development in Africa, we call on funders to invest in #african institutions, empower #local capacity & enable equitable partnerships
Authors: @IfyAniebo @allyeko @CKyobutungi @Fredros_Inc -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Hydroxychloroquine and chloroquine should not be used to treat hospitalised COVID patients.
Meta-analysis of 14 unpublished trials (1308 patients) and 14 publications/preprints (9011 patients).
disq.us/t/3w7xgun -
Peter Horby @peterhorby.bsky.social
@PeterHorby
P.1 lineage has faster growth rate than non-P1. variants in Manaus, Brazil.
B.1.1.7 lineage has faster growth rate than non-1.1.7. variant and spread rapidly in UK & internationally.
Will P.1. outcompete B.1.1.7?
science.sciencemag.org/content/early/2021/04/13/science.a… -
Peter Horby @peterhorby.bsky.social reposted
Adam Kucharski
@adamjkucharski
If populations are highly vaccinated, we'd expect a higher proportion of future cases to have been previously vaccinated (because by definition, there aren't as many non-vaccinated people around to be infected). But what sort of numbers should we expect? A short thread... 1/
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Get updated on COVID treatments in less than a minute
Wellcome
@wellcometrust
What’s happening with #covid19 treatments? ⤵️
x.com/i/events/1313436618792071170 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Allowing widespread use of unproven treatments creates confusion and undermines chances of improving care through proper science. US allows emergency use of blood plasma treatment for coronavirus patients www.bbc.co.uk/news/world-us-canada-53884710q
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
Pre-print now out.
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. www.medrxiv.org/content/10.1101/2020.07.15.20151852v1 -
Peter Horby @peterhorby.bsky.social
@PeterHorby
Dexamethasone saves lives in COVID-19. RECOVERY trial shows dexamethasone decreases risk of death in those needing oxygen by 20%, and by 35% in those on a ventilator. On the shelf, cheap and can be taken by everyone - a real breakthrough.
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
The (many) challenges of COVID-19 testing, think "pre-test probability". Interpreting a covid-19 test result www.bmj.com/content/369/bmj.m1808
-
Peter Horby @peterhorby.bsky.social
@PeterHorby
A phenomenal achievement. Every major hospital in the UK & all patients eligible - any age, pregnancy. Thank you everyone. #evidenceforall #recoverytrial





















































































































































































































































































































































































